Molecular and physiological assessment of metabolic health : adipose tissue, transcriptome analysis and challenge tests by Duivenvoorde, L.P.M.
  
Molecular and physiological assessment of 
metabolic health 
 
Adipose tissue, Transcriptome analysis and Challenge tests 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loes P.M. Duivenvoorde  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis committee 
 
Promotor 
Prof. Dr J. Keijer 
Professor of Human and Animal Physiology 
Wageningen University 
 
Co-promotor 
Dr E.M. van Schothorst 
Assistant professor, Human and Animal Physiology 
Wageningen University 
 
Other members 
Dr G. Goossens, Maastricht University 
Prof. Dr A.H. Kersten, Wageningen University  
Prof. Dr S. Klaus, German Institute of Human Nutrition, Potsdam, Germany 
Dr P.Y. Wielinga, TNO-Metabolic Health Research, Leiden 
 
This research was conducted under the auspices of the Graduate School of Wageningen 
Institute of Animal Sciences (WIAS) 
Molecular and physiological assessment of 
metabolic health 
 
Adipose tissue, Transcriptome analysis and Challenge tests 
 
 
 
 
 
Loes P.M. Duivenvoorde 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis 
submitted in fulfilment of the requirements for the degree of doctor 
at Wageningen University 
by the authority of the Rector Magnificus 
Prof. Dr M.J. Kropff, 
in the presence of the 
Thesis Committee appointed by the Academic Board 
to be defended in public 
on Tuesday 26 May 2015 
at 11 a.m. in the Aula. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loes P.M. Duivenvoorde 
Molecular and physiological assessment of metabolic health - Adipose tissue, Transcriptome 
analysis and Challenge tests, 
186 pages. 
 
PhD thesis, Wageningen University, Wageningen, NL (2015) 
With references, with summaries in Dutch and English 
 
ISBN 978-94-6257-301-7
5 
 
Contents 
 
Chapter 1 General introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7 
 
Chapter 2 Dietary restriction of mice on a high-fat diet induces substrate efficiency 
and improves metabolic health. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .21 
 
Chapter 3 Assessment of metabolic flexibility of old and adult mice using three non-
invasive, indirect calorimetry-based treatments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49 
 
Chapter 4 Oxygen restriction as challenge test reveals early high-fat-diet-induced 
changes in glucose and lipid metabolism. . . . . . .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73 
 
Chapter 5 A difference in fatty acid composition of isocaloric high-fat diets alters 
metabolic flexibility in male C57BL/6JOlaHsd mice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .101 
 
Chapter 6 Metabolic adaptation of white adipose tissue to acute short-term oxygen 
restriction in mice. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .123 
 
Chapter 7 General discussion. . . . . . . .  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .143 
 
 
Appendices 
Summary of main findings. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .169 
Samenvatting. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .173 
Dankwoord. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .179 
List of publications. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .181 
About the author. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183 
Education statement. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185 
 
  
 
 
 
 
 
 
 
 
Chapter 1 
 
General introduction 
 
 
 
 
 
 
  
 
 
 
GENERAL INTRODUCTION   l   9 
 
1  
Metabolic health and metabolic flexibility 
Metabolic health can be defined as the ability to properly adapt metabolism to 
variations in environmental and nutritional circumstances. A reduction in metabolic 
health can lead to several serious diseases, such as type 2 diabetes mellitus, 
gallbladder disease, coronary heart disease, dyslipidaemia, and osteoarthritis (33, 34, 
38). Overweight and obesity are major risk factors for impaired metabolic health. The 
prevalence of obesity has increased dramatically over the past decades, probably 
because of the increased abundance of easily accessible, energy-dense food products 
and the increase in sedentary life-styles. As a result, about 35% of the world population 
is now classified as being overweight (15) and it is estimated that around 300,000 US 
adults die of causes attributable to obesity each year (31). Next to obesity, metabolic 
health can decline due to aging (36), physical inactivity (19) or by genetic predisposition 
(26).  
Metabolic health can be measured as metabolic flexibility, which is the capacity to 
match substrate oxidation to substrate availability (24, 47). A subject that displays 
metabolic flexibility e.g. increases fat storage in adipose tissue when circulating fat 
levels are elevated and increases fat oxidation during fasting. Furthermore, in healthy 
individuals, insulin inhibits fatty acid oxidation and glucose oxidation is inhibited when 
fatty acid oxidation increases, which ensures predominantly fat oxidation during fasting 
and glucose oxidation during food intake or during vigorous physical activity (30, 41). 
Adequate regulation of glucose and fat oxidation prevents excessive accumulation of 
stored lipids and preserves glucose for essential tasks, such as intense physical 
exercise or brain functioning.  
The high prevalence of obesity, but also the increase in mean life span in most 
developed countries (27), highly increased the proportion of humans that are at risk for 
impaired metabolic health. Research to better understand the factors that influence 
metabolic health may offer opportunities to confine this threat to human health 
worldwide.  
 
White adipose tissue and metabolic health 
White adipose tissue (WAT) plays an important role in energy homeostasis and 
maintenance of metabolic health. WAT mainly consists of lipid-loaded adipocytes, but 
also contains macrophages, pre-adipocytes, and neuronal, endothelial and epithelial 
cells. Adipocytes not only store excess energy in the form of triglycerides, but also have 
an important endocrine function. Adipocytes communicate with other organs via 
adipokines and lipokines, which are signalling molecules that are released in the 
circulation (1, 8, 50). Adipokines influence many other metabolic organs, such as the 
liver, muscle tissue and the hypothalamus, and can e.g. regulate appetite and energy 
expenditure, but also immune response, fertility, depression and anxiety (reviewed in 9, 
23). Dysregulation of adipokine secretion is associated with reduced metabolic health. 
Leptin, for example, which is the first identified (59) and probably the best known 
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adipokine, is thought to be involved in the development of obesity and insulin 
resistance. In healthy subjects, leptin decreases appetite and increases energy 
expenditure (55), preventing further adipose mass expansion. In obese individuals, 
however, circulating leptin levels are elevated (12), but this does not lead to inhibition of 
appetite and the subsequent WAT expansion. Such deviations in adipokine signalling 
occur, in the first place, when adipose tissue mass expands. Leptin secretion simply 
increases when adipose mass, and therefore the productive capacity of the organ, 
increases (45). An increase in circulating adipokine levels may decrease sensitivity to 
the cytokine (35), which decreases the potential of WAT to regulate whole-body energy 
balance. Second, WAT functionality can be affected by internal factors, such as tissue 
inflammation. Obesity is, in fact, associated with chronic low-grade inflammation in 
adipose tissue (2, 14). WAT inflammation increases the release of inflammatory 
cytokines, such as tumor necrosis factor alpha (TNFα) and interleukin 6 (IL6) (58) and 
decreases the secretion of anti-inflammatory and insulin-sensitising adipokines, such 
as adiponectin (56). WAT inflammation is expected to play a causal role in the 
development of metabolic diseases, such as insulin resistance and other associated 
pathologies of obesity (22, 57) and might arise from local oxygen depletion (hypoxia) in 
WAT. Local hypoxia in WAT probably occurs because during WAT expansion, parts of 
the tissue become remote from the vascular supply, which leads to limitation of oxygen 
availability (51). Alternatively, WAT hypoxia may occur due to the enlargement of 
adipocytes (hypertrophy), reaching the diffusion limit for oxygen (48).  
Excessive adipocyte hypertrophy also increases cell death and subsequent 
macrophage infiltration in WAT (10). WAT macrophages are recruited to phagocytose 
dying adipocytes and can be divided into two categories: pro-inflammatory M1 
macrophages that are associated with obesity, and anti-inflammatory M2 macrophages 
that are more prevalent in healthy adipose tissue (28). Clusters of macrophages around 
death or dying adipocytes can be visualized with immunohistochemistry and are called 
crown like structures (CLSs, Figure 1).  
 
 
Figure 1 WAT macrophages and 
crown-like structures. Crown-like 
structures (CLSs) are clusters of 
macrophages around dying 
adipocytes. CLSs can be visualised 
with light microscopy and MAC-2 
immunoreactive stainings (A). The 
number of CLSs in WAT is higher in 
obese mice (B) than in lean mice (C). 
White adipocyte size in mice positively 
correlates (r = 0.72, P < 0.0001) with 
the amount of CLSs in the fat depot 
(D). (adapted from (10) and (33)) 
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The occurrence of enlarged adipocytes, moreover, indicates a reduced capacity to 
recruit new adipocytes via adipogenesis, which decreases the storage capacity of the 
tissue and promotes lipid storage in other organs, such as muscle tissue or the liver 
(21). Lipid accumulation in muscle and liver, or ectopic lipid accumulation, is associated 
with severe metabolic dysfunction (44).  
To summarize, altered adipokine secretion, WAT inflammation and adipocyte 
hypertrophy indicate WAT dysfunction. WAT dysfunction is positively correlated with 
metabolic inflexibility and is, therefore, seen as an important hallmark of reduced 
metabolic health. 
 
Mitochondrial function and metabolic health 
To further understand the factors that influence metabolic health and metabolic 
flexibility, we should first focus on the cell organelle that stands at the basis of substrate 
selection and oxidation: the mitochondrion. Mitochondria are dynamic organelles that 
are essential for energy metabolism and also play an important role in apoptosis (54) 
and heat production (32). Mitochondria are responsible for efficient ATP production 
from acetyl-CoA, which can be derived from fat, sugar or protein catabolism (Figure 2). 
Mitochondria are surrounded by an inner and outer membrane; the inner membrane 
contains the respiratory complexes that are responsible for oxidative phosphorylation 
and ATP production. The mitochondrial matrix can be found inside the inner membrane 
and contains enzymes for i.e. the tricarboxylic acid (TCA) cycle, fatty acid oxidation and 
decarboxylation of pyruvate (from glucose or amino acid catabolism) (46). The 
conversion of fatty acids to acetyl-CoA during β-oxidation results in the formation of 
nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH2). 
The conversion of acetyl-CoA to citrate and further oxidation to oxaloacetate in the TCA 
cycle (also known as the citric acid cycle or Krebs cycle) also results in the formation of 
NADH and FADH2. NADH and FADH2 are co-factors that carry hydrogens and 
electrons to the electron transport chain (ETC), or respiratory chain. Electrons can also 
be transferred directly from β-oxidation to the ETC via electron transfer flavoproteins. In 
the ETC, electrons are used to pump protons from the matrix to the intermembrane 
space, generating a potential difference across the inner mitochondrial membrane. The 
membrane potential is used to drive the synthesis of ATP in the final step of oxidative 
phosphorylation at complex V.  
Oxygen is essential for the functioning of the ECT because it captures the electrons 
that emerge from the ETC. When oxygen availability is limited, the mitochondrial 
membrane potential increases and electrons may leak from the ETC, which results in 
the formation of reactive oxygen species (ROS) (Figure 3) (6). High levels of ROS 
cause cellular oxidative damage and are associated with metabolic disorders, such as 
insulin resistance and obesity (17, 43).  
Mitochondria play an important role in metabolic flexibility because they can sense the 
cellular energy status and match ATP synthesis, metabolism, and other physiological 
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processes to energy requirements. Due to their capacity to complete either fat, sugar or 
protein oxidation, and their interconversions, mitochondria are crucial for cellular 
substrate selection. Mitochondrial β-oxidation and pyruvate oxidation, for example, 
directly respond to changes in mitochondrial fatty acid levels (40). Alterations in 
mitochondrial function and substrate switching are associated with several metabolic 
disorders, such as obesity and type 2 diabetes (25, 37).  
 
 
 
Analysis of metabolic health 
Metabolic health can be studied with various tools and methods. The choice for a 
certain method depends on the focus and aim of the study; there is no biomarker or test 
that singly defines metabolic health. Metabolic health can be studied directly in 
humans, but also other species can be used as a model for human health. Model 
organisms, such as laboratory mice or rats, are often used to study the molecular and 
physiological aspects of diseases, including obesity. Like humans, mice can become 
obese and display metabolic inflexibility when supplied with high-energy diets and the 
possibility to exercise is reduced (18, 49). Moreover, like many other mammals, 
metabolic health of mice greatly improves with dietary restriction, which is one of the 
best known methods to promote healthy aging in a variety of species (4). During dietary 
restriction, an animal receives only a proportion of its normal dietary intake, generally 
between 50 and 90%, which has been shown to improve metabolic health in mice, rats, 
nematodes, insects, fish, spiders (reviewed in 39) and, possibly, primates (11, 29). 
Although the best ‘model’ to study human metabolic health is generally considered to 
be the human itself, a big advantage of the use of model organisms is that most 
confounding factors, such as life style, education, dietary habits, social interactions, and 
physical activity, that highly influence health status can be levelled out or fully 
controlled. Mouse models are, therefore, a useful tool to characterize molecular and 
physiological aspects of metabolic health.  
The methods to study metabolic health in mice can roughly be divided into two 
categories: methods that assess static parameters and methods that measure adaptive 
responses in the form of a challenge test. 
Figure 2 Cellular conversion of 
nutrients to ATP. Fatty acids, 
glucose and amino acids can be 
catabolised to acetyl-CoA, which is 
oxidized to carbon dioxide in the 
TCA cycle in the mitochondrial 
matrix. Both the TCA cycle and β-
oxidation provide electrons and 
hydrogens to the electron transport 
chain (ETC) where ATP is 
produced through oxidative 
phosphorylation. A smaller amount 
of ATP is produced cytoplasmic by 
glycolysis of glucose into pyruvate. 
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Static measurements of metabolic health can focus on a single analyte, such as 
circulating insulin, glucose or adipokine levels during fasting. Also adipocyte size, the 
occurrence of CLSs in WAT and the level of ectopic lipid storage can be seen as static 
parameters to analyse metabolic health. Static measurements can, however, also 
involve analysis of multiple analytes in a single assay, e.g. with metabolomics, 
measuring metabolites, or with transcriptomics, measuring gene expression by its 
transcripts levels. The -omics approach is valuable since it extends the scale and depth 
of understanding biological processes.  
Challenge tests measure the response to an environmental or nutritional stressor and 
are frequently used in nutritional research because they enlarge the effect of a 
nutritional intervention (52). Early diet-induced health effects are, in fact, often hidden 
under static conditions, but can be revealed under challenged conditions.  
In this thesis we used whole-genome micro-arrays to study gene expression in WAT 
and evaluated and developed several challenge tests to measure metabolic flexibility in 
mice. Both approaches and the rationale to use those methods will now be explained in 
more detail.  
  
 
Figure 3 ROS formation in the electron transport chain. Reactive oxygen species (ROS) are 
continuously made as a side product of electron transport during oxidative phosphorylation. Oxidative 
stress may occur when ROS formation increases (when oxygen availability is either low or high or when 
the mitochondrial membrane potential (ΔΨm) increases or when antioxidant defences are hampered. 
Metabolic pathways supply electrons (e
−
) and hydrogens (H
+
) to complex I and II of the electron 
transport chain, where electrons are used to create a membrane potential that drives ATP synthesis via 
ATP synthase (complex V). Occasionally, electrons are transferred to oxygen to form superoxide (O2
−
) . 
O2
−
 is mainly formed in complex I and III and is a precursor of most other reactive oxygen species, such 
as hydrogen peroxide (H2O2) by the enzyme superoxide dismutase (SOD), and the hydroxyl radical 
(OH) from the reduction of H2O2 by catalase or glutathione peroxidase (adapted from (7)). 
 
Analysis of metabolic health with whole-genome analysis  
With whole-genome gene expression analysis, mRNA levels of all known genes in a 
specific tissue can be measured within a single assay. The comparison between 
different (dietary) treatments and a control group indicates the impact of the treatment 
on gene expression. Changes in gene expression appear relatively short after exposure 
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to a treatment. Food consumption after a period of fasting, for example, increases the 
expression of several genes involved in protein synthesis already 1.5 hours after food 
provision (13). Gene expression, therefore, displays acute metabolic adaptation. An 
increase in gene expression mostly leads to an increase in protein abundance of the 
encoded protein (53), revealing which (metabolic) process is mostly affected by the 
treatment. Transcriptome analysis, moreover, does not only reveal which genes 
respond to a certain (dietary) treatment, but also reveals when a treatment group fails 
to respond to the treatment, which can either implicate health improvement or health 
deterioration. Mice fed a low-calorie diet, for example, have a different transcriptomic 
profile compared with mice fed a high-calorie diet. High-caloric intake e.g. increases 
lipid metabolism and mitochondrial oxidative phosphorylation in liver, but this profile is 
shifted back towards the low-calorie profile when the high-calorie diet is supplemented 
with a substance that improves metabolic health, such as resveratrol (3).  
The enormous amount of data that results from transcriptome analysis can be used as 
a strategy to ‘fish’ for results, in which new candidate biomarker genes or pathways for 
a certain treatment or condition can be identified, or as a strategy to ‘hunt’ for results, in 
which the effect of a treatment on one or several specific metabolic genes or pathways 
is requested. The possibility to measure thousands of end points in one single assay, 
makes transcriptome analysis very suitable to study the effect of dietary or 
environmental treatments on metabolic health, especially when combined with 
additional assays that link the molecular response to a relevant physiological response.  
 
Analysis of metabolic health with challenge tests 
Transcriptome analysis reveals all changes in gene expression that are affected by an 
experimental intervention in a specific organ. Metabolic health, however, also highly 
depends on the adaptive capacity of the body as a whole. This thesis, therefore, also 
focusses on the development and characterization of challenge tests to study metabolic 
health at whole body-level. Challenge tests disrupt homeostasis with an environmental 
or nutritional stressor, which triggers an animal to change its metabolism and prevent 
accumulation of harmful substances or other unfavourable physiological states. 
Figure 4 Glucose tolerance of 
lean and obese mice. Example of 
an oral glucose tolerance test in 
lean and genetically obese (ob/ob) 
mice. The time course following 
glucose administration (A) 
represents uptake of glucose to and 
from the blood stream. The curve of 
blood glucose levels can also be 
expressed as the area under the 
curve (AUC) (B), in which glucose 
intolerant mice have a larger AUC 
(data from (5)). 
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Animals that are metabolically healthy and flexible can adequately adapt to the 
challenge test and maintain homeostasis. Individuals that are less flexible cannot adapt 
adequately and will display an aberrant response. One of the best-known challenge 
tests to measure metabolic flexibility is the oral glucose tolerance test (OGTT; Figure 
4). For an OGTT, mice are fasted and receive an oral dose of glucose. Baseline 
(fasting) blood glucose measurements are taken before glucose administration, and 
further measurements are made at regular intervals thereafter. An OGTT reveals the 
rate of glucose uptake in the intestine and the release of glucose to and from the 
bloodstream, but especially the insulin-stimulated uptake in peripheral organs like 
muscle and adipose tissue. This depends on the release of insulin from the pancreas in 
response to circulating glucose and on the sensitivity of target tissues to insulin. 
Challenge tests are, indeed, helpful to reveal relevant impairments in energy 
homeostasis. A disadvantage of many used challenge tests, however, is the 
requirement of invasive methods, such as injection, blood sampling or oral gavage. 
These invasive methods induce stress and modify the physiological status, which does 
not only affect animal wellbeing but also increases variability of experimental data and 
reduces data quality and reproducibility. For this thesis we, therefore, aimed to identify 
and evaluate non-invasive methods to assess metabolic flexibility in mice. For this 
purpose we used indirect calorimetry (InCa) to monitor the response to a challenge. 
Three InCa-based challenge tests were used: a challenge with glucose consumption, 
fasting followed by re-feeding, and an environmental challenge with oxygen restriction. 
Each challenge test and the principle of InCa will now be described in more detail. 
 
Indirect calorimetry and non-invasive challenge tests  
Indirect calorimetry is a non-invasive method to estimate energy metabolism based on 
oxygen consumption and carbon dioxide production. InCa can be used to calculate 
real-time energy expenditure and substrate use (reviewed by 16). Rodent InCa systems 
have evolved over the past decades towards a system in which mice can remain in 
their home cage and only the cage lid is replaced to enable controlled air flow and air 
sampling from the cage. Energy expenditure depends on metabolic rate, diet-induced 
Figure 5 RER during restricted or ad 
libitum feeding of a high- or low-fat diet. 
The RER after food consumption depends 
on diet composition. High-fat or high-calorie 
rodent diets generally contain less 
carbohydrates than low-fat or low-calorie 
diets. Consequently, mice that receive a low-
fat-diet ad libitum (LF-AL) or restricted (LF-
DR) reach higher mean RER values than 
mice that receive a high-fat diet at ad libitum 
(HF-AL) or dietary restricted (HF-DR) basis. 
(adapted from (20)). Restricted feed is 
accessible during time frame indicated in 
yellow. 
16   l   CHAPTER 1 
 
thermogenesis and physical activity (42). The ratio of carbon dioxide production over 
oxygen consumption, also known as the respiratory quotient (RQ) at the cellular level; 
or respiratory exchange ratio (RER) at whole body level, displays which macronutrient 
is mainly being oxidized. Fat oxidation requires, compared with glucose oxidation, more 
oxygen per mole carbon dioxide produced. The RQ or RER depends on mitochondrial 
substrate selection and equals 1 for primarily glucose oxidation and 0.7 for primarily fat 
oxidation. In normal subjects, protein catabolism only contributes around 1% to the total 
energy expenditure and increases only during prolonged starvation. Therefore, when 
fat and glycogen stores are not depleted, fatty acids, glucose and oxygen form the 
principal substrates for mitochondrial energy production. Restriction or rather (re)-
supplementation of either of these mitochondrial substrates requires metabolic 
adaptation and forms the basis of most InCa-based challenge tests. Fasting, for 
example, causes RER values to decrease towards 0.7 in mice, whereas re-feeding 
increases the RER, in which the amplitude of the increase depends on the 
carbohydrate content of the diet (Figure 5). The higher the carbohydrate content of the 
meal consumed, the larger the increase in RER should be - if metabolism adapts 
properly. This principle forms the basis of most nutrient-based challenge tests in the 
InCa system, in which mice are fasted and then re-supplied with feed. Re-feeding can 
occur with a single nutrient, such as glucose, or a combination of nutrients, such as 
rodent chow. A delay, reduction or absence in the response to re-feeding indicates an 
incapacity to switch from fat oxidation during fasting to carbohydrate oxidation during 
feeding, which is an important hallmark of metabolic inflexibility.  
Next to nutrient-based challenge tests, InCa can also be used to assess the response 
to an environmental challenge, e.g. a change in ambient temperature, humidity, 
duration of the light-dark cycle or in oxygen levels.  
In this thesis a reduction in oxygen availability (oxygen restriction; OxR) was used as a 
novel non-invasive InCa-based challenge test. During OxR, mice remain in a fasted 
state but the possibility to maintain ATP production via mitochondrial oxidation is 
reduced. Strategies to match energy metabolism to oxygen availability and possible 
deviations in the capacity to respond to oxygen restriction are largely unknown, which 
motivated the design and validation of a metabolic challenge test based on OxR. An 
adequate response to OxR may include a reduction of total metabolic rate or changes 
in mitochondrial substrate use or in total mitochondrial activity.  
 
Aims and outline of this thesis 
Detailed understanding of the factors that influence metabolic health will contribute to 
the development of interventions that improve metabolic health and thus to a decrease 
in the prevalence of metabolic diseases. Transcriptome analysis is a well-established 
method to evaluate genome-wide gene expression and can be used to increase the 
scale and depth of understanding biological processes underlying metabolic health. 
Challenge tests are able to detect physiological differences before static (health) 
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markers are changed and physical differences that are obscured under static 
conditions. We, therefore, aim to assess metabolic health using transcriptome analysis 
and non-invasive challenge tests. Special focus is on the development and validation of 
InCa-based non-invasive challenge tests. Next to the validation of two nutrient-based 
challenge tests (based on fasting and re-feeding, and fasting and glucose 
consumption), this thesis introduces a novel challenge test that is based on exposure to 
OxR.  
 
Chapter 2 aimed to assess metabolic health effects of dietary restriction of a high fat 
diet and to identify associated molecular changes in WAT. Metabolic health was 
analysed with several conventional health markers, such as oral glucose tolerance and 
circulating glucose and adipokine levels. Whole genome gene expression in WAT was 
used to identify the molecular changes underlying alterations in metabolic health. 
Chapter 3 aimed to assess whether InCa could be used to measure age-impaired 
metabolic health in mice. The aging-model was used as a first validation of OxR as a 
novel, non-nutrient based challenge test in comparison to two other InCa-based health 
assessment approaches. Chapter 4 continues with the OxR challenge and aimed to 
assess whether OxR can be used to distinguish changes in metabolic health that are 
caused by short term overfeeding. Metabolic flexibility was measured in mice that were 
either fed a moderate high-fat diet or a low-fat diet for only five days. The potential to 
use OxR to detect early health effects decreases costs and may facilitate health 
improvement strategies. After the promising effects in chapter 3 and 4, the OxR 
challenge was used in chapter 5 to assess differences in metabolic health of two 
isocaloric high fat diets differing only in fatty acid profile. In addition to the OxR 
challenge, metabolic flexibility was tested with a fasting and re-feeding challenge and 
several conventional methods to analyse metabolic health, such as the analysis of body 
composition, glucose tolerance and WAT health, which enabled us to make a direct 
comparison. Finally, chapter 6 aimed to increase our understanding of the OxR 
challenge by analysis of whole genome gene expression in WAT and by analysis of 
WAT and circulating metabolites. Chapter 7 consists of a discussion of the research 
presented in this thesis. 
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Abstract 
 
High energy intake and, specifically, high dietary fat intake challenges the mammalian 
metabolism and correlates with many metabolic disorders, such as obesity and 
diabetes. Dietary restriction (DR) is, on the other hand, known to prevent the 
development of metabolic disorders. The current Western diets are highly enriched in 
fat and it is as yet unclear whether DR on a certain high-fat (HF) diet elicits similar 
beneficial effects on health. Here, we report that HF-DR improves metabolic health of 
mice, compared to mice receiving the same diet on an ad libitum basis (HF-AL). 
Already after five weeks of restriction the serum levels of cholesterol and leptin were 
significantly decreased in HF-DR mice, while their glucose sensitivity and serum 
adiponectin levels were increased. The body weight and measured serum parameters 
remained stable in the following 7 weeks of restriction, implying metabolic adaptation. 
To understand the molecular events associated with this adaptation, we analysed gene 
expression in white adipose tissue (WAT) with whole genome microarrays. HF-DR 
strongly influenced gene expression in WAT; in total 8,643 genes were differentially 
expressed between both groups of mice, with a major role for genes involved in lipid 
metabolism and mitochondrial functioning. This was confirmed by qRT-PCR and 
substantiated by an increase in mitochondrial density in WAT of HF-DR mice. These 
results provide new insights in the metabolic flexibility of dietary restricted animals and 
suggest the development of substrate efficiency.  
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Introduction 
 
Obesity is a major health concern that affects millions of people worldwide (26, 42). 
While white adipose tissue (WAT) plays an important role in mammalian energy 
homeostasis by preventing lipotoxicity and providing a source of energy in times of 
need, excess amounts of WAT relate to reduction in the number of mitochondria and 
inflammation of the tissue (9, 54), subsequently resulting in metabolic dysfunction (23, 
58). Obesity is associated with several serious complications; including type 2 diabetes, 
coronary heart disease, and certain types of cancer; and therefore significantly 
increases morbidity risks into those affected (55). The current prevalence of obesity 
most likely resulted from the notable decrease in overall physical activity and increase 
in consumption of readily available energy dense foods (30). Fast foods, for example, 
as supplied by some typical outlets, contain an average energy density that is more 
than twice the energy density of a recommended healthy diet; and the energy density of 
food highly correlates with the fat content of a meal (48). Consistently, the WHO 
concluded that, in the period from 2000 to 2003, the average European diet consisted 
of 35-40% of energy available from fat; in France and Spain this proportion was even 
higher (67).  
Restriction on dietary intake (DR) is known to robustly improve metabolic health (32, 
50). Long term DR extends maximum lifespan and opposes the development of a 
broad array of age-associated biological and pathological changes in a diverse range of 
organisms (65). Dietary restriction studies in mice and other species have led to 
detailed descriptions of changes in gene expression in different tissues (15, 31, 32, 37, 
63) and various mechanisms that are implicated in the beneficial health effects. Among 
the DR-related biomarkers are an increase in mitochondrial density in adipocytes (28) 
and an increase in insulin sensitivity (29). Most studies examining the effects of DR, 
however, have been performed in standard rodent diets that are characterized by a low 
fat content (7-9 en%). Only few studies focused on the effect of dietary restriction using 
high fat diets (HF-DR) (11, 21, 47); which is, in fact, more relevant to the current dietary 
status in most developed countries.  
Here, we therefore examined the effects of DR in the context of a semi-synthetic AIN93 
based diet that contains 30 en% of fat and compare metabolic adaptation and 
metabolic health of mice that received the diet either on a restricted (30%) or ad libitum 
(HF-AL) basis. We show that, although an animal is fed a high-fat (Western) diet, the 
moderate reduction in the total amount of calories improves metabolic health; as 
measured by a number of parameters, such as glucose tolerance and serum 
cholesterol, leptin and adiponectin levels. Whole genome gene expression analysis of 
WAT revealed a strong upregulation of genes involved in mitochondrial function and 
lipid metabolism by HF-DR. Relative to results obtained with standard diets, in 
particularly lipid handling is affected, implying the development of substrate efficiency in 
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HF-DR mice. Finally, we observed an increase in mitochondrial density in WAT of HF-
DR mice. 
 
Materials and methods 
 
Animals and Dietary manipulations 
Thirty-six male C57BL/6JOlaHsd mice (Harlan Laboratories, Horst, The Netherlands) 
aged 10 weeks were used for this study. The experimental protocol was approved by 
the Animal Welfare Committee of Wageningen University, Wageningen, The 
Netherlands. Mice were individually housed and maintained under environmentally 
controlled conditions (temperature 21ºC, 12 h/12 h light–dark cycle, 45% humidity) and 
had, during the first three weeks (the adaptation phase), ad-libitum access to food and 
water. The food consisted of a palletized diet (Research Diets Services B.V., Wijk bij 
Duurstede, the Netherlands) with a fat content of 30%, which resembles a Western 
human diet (Table 1). The amount of lard and corn oil are also based on average 
human intake levels. The diet that was used for dietary restriction was in ratio 
supplemented with a vitamin and mineral premix to guarantee the same level of intake 
as in the non-restricted group to prevent deficiencies. Since the mineral and vitamin 
premixes contain corn-starch, the HF-DR diet is corrected in the carbohydrate fraction. 
 
Table 1 Diet composition of the HF-AL and HF-DR diets in g/kg of the diet and based 
on relative intake.  
Component  HF-AL  
(g/kg feed) 
HF-DR  
(g/kg feed) 
AL intake    DR intake 
HF-AL x1   HF-DR x0.7 
Acid casein 220 220 220 154 
L-Cystine 3 3 3 2.1 
Starch 336.7 331.3 336.7 231.9 
Maltodextrose 112.25 110.4 112.25 77.3 
Sucrose 85.5 84.1 85.5 58.9 
Cellulose (Arbocel B800) 50 38.3 50 26.8 
Lard 101.5 101.5 101.5 71.1 
Corn oil 43.5 43.5 43.5 30.5 
Mineral premix AIN-93G 35 50 35 35 
Vitamin premix AIN-93 10 14.3 10 10 
Choline bitartrate 2.5 3.5 2.5 2.5 
     
Energy (kcal/kg)  4375 4375   
en% from fat 30 30   
en% from proteins 20 20   
en% from carbohydrates 50 50   
The HF-AL diet was fed ad libitum; the HF-DR animals received 70% energy of the HF-DR diet 
compared with the HF-AL animals. Both diets were iso-caloric in the lipid, protein, and carbohydrate 
fraction. The HF-DR diet was adjusted for the amount of vitamins and minerals to ensure a homologous 
intake between both groups 
 
At t=0 weeks, animals were stratified on body weight and divided into groups of twelve 
animals. The first treatment group (t=0) was directly culled after the adaptation phase, 
the high-fat ad-libitum (HF-AL) group remained under the same conditions, while the 
high-fat dietary restriction (HF-DR) group received a dietary restriction of 30%, which 
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lasted for twelve weeks. The amount of restricted food depended on the amount 
individual mice consumed at the end of the adaptation phase and remained unchanged 
during the whole intervention phase. The bodyweight and food intake of individual mice 
were monitored on a weekly basis. The HF-DR group received a fixed amount of feed 
on a daily basis. All mice were culled at the end of the twelve week intervention. 
 
WAT and blood collection (at time of section) 
The HF-AL and t=0 mice were fasted for two hours before sectioning. To match the 
level of food intake before sectioning to the HF-AL group, HF-DR mice received the 
regular (restricted) amount of food on the habitual time in the morning and were 
sectioned 6 hours afterwards. At the time point of section, mice were anesthetized by 
inhalation of 5% isoflurane. Blood was sampled after eye extraction and collected in 
Mini collect serum tubes (Greiner Bio-one, Longwood, USA), and centrifuged for 10 min 
at 3000 g and 4 °C to obtain serum. Serum samples were aliquoted and stored at –80 
°C. After blood collection, mice were killed using cervical dislocation and epididymal 
white adipose tissue was dissected, weighted and snap frozen in liquid nitrogen and 
stored at –80 °C.  
 
RNA isolation, cDNA synthesis and microarray hybridization 
RNA isolation from WAT was performed as described (62). Briefly, WAT was 
homogenized in liquid nitrogen using a cooled mortar and pestle. Total RNA was 
isolated using TRIzol reagent, chloroform, and isoamyl alcohol (PCI) (Invitrogen, Breda, 
The Netherlands) followed by purification with RNeasy columns (Qiagen, Venlo, The 
Netherlands) using the instructions of the manufacturer. RNA concentration and purity 
were measured using the Nanodrop (IsoGen Life Science, Maarsen, The Netherlands). 
Approximately 30 μg of total RNA was isolated with A260/A280 ratios above 2 and 
A260/A230 ratios above 1.9 for all samples, indicating good RNA purity. RNA quality 
was additionally checked on the Experion automated electrophoresis system (Bio-Rad, 
Veenendaal, The Netherlands) using Experion StdSense chips (Bio-Rad). 
For transcriptome analysis, the 4 x 44k Agilent whole-mouse genome microarrays 
(G4122F, Agilent Technologies Inc., Santa Clara, USA) were used. Preparation of the 
samples and the microarray hybridizations were carried out according to the 
manufacturer’s protocol with a few modifications as described previously (59, 64). All 
materials and reagents are from AgilentTechnologies, Palo Alto, USA unless stated 
otherwise. In brief, cDNA was synthesized for each animal from 1 μg WAT RNA using 
the Agilent Low-RNA Input Fluorescent Linear Amplification Kit without addition of 
spikes. Thereafter, samples were split into two equal amounts, to synthesize Cyanine 
3-CTP (Cy3) and Cyanine 5-CTP (Cy5) labelled cRNA, using half the amounts per dye 
as indicated by the manufacturer. Labelled cRNA was purified using RNeasy columns 
(Qiagen). Yield and Cy–dye incorporation were examined for every sample using the 
Nanodrop. All samples met the criteria of a cRNA yield higher than 825 ng and a 
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specific activity of at least 8.0 pmol Cy-dye per µg cRNA. Then, Cy3-labeled cRNA 
samples were pooled on an equimolar basis and used as a common reference pool. 
Individual 825-ng Cy5-labeled cRNA and 825-ng pooled Cy3-labeled cRNA were 
fragmented in 1x fragmentation and 1x blocking agent at 60ºC for 30 min and thereafter 
mixed with GEx Hybridization Buffer HI-RPM. Individual Cy5-labeled cRNA and pooled 
Cy3-labeled cRNA were hybridized to the arrays in a 1:1 ratio at 65ºC for 17h in the 
Agilent Microarray Hybridization Chamber rotating at 10 rpm. Samples were randomly 
divided over the slides and positions on the slides. After hybridization, slides were 
washed according to the manufacturer’s wash protocol. Arrays were scanned with an 
Agilent Technologies Scanner G2505B with 10 and 100% laser-power intensities. 
 
Normalization and statistical analysis of microarray data 
Signal intensities for each spot were quantified using Feature Extraction version 9.5.3.1 
(Agilent Technologies). Median density values and background values of each spot 
were extracted for both the individual samples (Cy5) and the pooled samples (Cy3). 
Quality control for every microarray was performed visually by using ‘Quality control 
graphs’ from Feature extraction and M-A plots and box plots, which were made using 
limmaGUI in R (66). Data were imported into GeneMaths XT 2.0 (Applied Maths, Sint-
Martens-Latem, Belgium). Spots with an average Cy5 and Cy3 signal twice above 
background were selected and log transformed. The Cy5 signal was normalized 
against the Cy3 intensity as described before (45). All arrays are deposited in GEO 
under number GSE27213. Supervised principal component analysis and heat mapping 
were performed using GeneMaths XT. Volcano plots were made using GraphPad 
Prism version 5.03 (Graphpad Software, San Diego, USA). Gene expression levels of 
the HF-DR versus the HF-AL groups were analysed by Student’s t tests using a 
multiple testing correction according to Benjamini-Hochberg (16). Corrected P-values 
smaller than 0.01 were considered as statistically significant. Fold change is expressed 
as the ratio of the HF-DR group over the HF-AL group. For downregulated genes, the 
fold change is converted to the corresponding negative value. Pathway analysis was 
performed using MetaCore (GeneGo, St. Joseph, Michigan, USA), GO 
overrepresentation analysis and literature mining. 
 
Quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) 
qRT-PCR was performed on individual samples as previously described (10, 61) to 
validate the microarray data. One microgram of RNA of all individual samples was used 
for cDNA synthesis using the iScript cDNA synthesis kit (Bio-Rad). qRT-PCR reactions 
were performed with iQ SYBR Green Supermix (Bio-Rad) using the MyIQ single-colour 
real-time PCR detection system (Bio-Rad). Each reaction (25 μl) contained 12.5 μl iQ 
SYBR green supermix, 1 μl forward primer (10 μM), 1 μl reverse primer (10 μM), 8.5 μl 
RNase-free water and 2 μl 100x diluted cDNA. The following cycles were performed: 1 
x 3 min at 95ºC, 40 amplification cycles (40 x 15 s 95ºC, 45 s optimal annealing 
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temperature, which was followed by 1 x 1 min 95ºC and 1 x 1 min 65ºC and a melting 
curve was prepared (60 x 10 s 65ºC with an increase of 0.5ºC per 10 s). A standard 
curve using serial dilutions of pooled sample (cDNA from all samples), a negative 
control without cDNA template, and a negative control without reverse transcriptase (-
RT) were taken along with every assay. Only standard curves with efficiency between 
90-110% and a correlation coefficient above 0.99 were accepted. Individual samples 
were measured in duplicate. Data were normalized against the geometrical mean of the 
reference genes calnexin (Canx), beta-2 microglobulin (B2m), ribosomal protein S15 
(Rps15), and endoplasmic reticulum chaperone SIL1 homolog (Sil1), which were 
chosen based on stable gene expression levels between the mice on the microarray 
and confirmed with the resulting qRT-PCR data (geNorm, Ghent University Hospital, 
Ghent, Belgium). Primers were designed using the NCBI Primer-Blast (NCBI Web site) 
and Beacon designer (Premier Biosoft International, Palo Alto, USA). The primer 
sequences and PCR annealing temperatures for each gene are summarized in table 2. 
 
Table 2 Primer sequences and PCR annealing temperatures of the primers used for 
quantitative real-time reverse transcription-PCR (qRT-PCR). 
Genes denoted with an asterisk were used as reference genes 
 
Oral glucose tolerance test (OGTT) 
Oral glucose tolerance was tested in all mice of the HF-AL and HF-DR group at t= 5, 8 
and 11 weeks of the dietary intervention. At t=0 weeks, before the switch to the different 
dietary interventions, glucose tolerance was tested in three mice per group. On the 
days that the OGTTs took place, HF-DR mice received their daily amount of food after 
the OGTT. Food of all mice was removed at the start of the light phase and 5 hours 
afterwards tail blood (approximately 50 μl) was collected and partly used to determine 
the glucose concentration with an automated blood glucose monitoring system 
(Freestyle, Abbott Diabetes Care, Amersfoort, The Netherlands). Remaining blood was 
transferred to Mini collect serum tubes (Greiner Bio-one, Longwood, USA), and 
centrifuged for 10 min at 3000 g and 4 °C to obtain serum; serum samples were stored 
at –80 °C. Glucose (2 g/kg BW) was given orally by gavage at the start of each 
experiment. 15, 30, 60, 90, and 120 min after glucose administration, 3 μl of tail blood 
was collected and used to determine the glucose concentration with the automated 
Gene  Forward primer 5’ – 3’    Reverse primer 5’ – 3’ PCR temp. 
Acaca AGCAGATCCGCAGCTTGGTC CGGGAAGCTCCTCCTACGTG 60.0ºC 
Acly TGGGCTTCATTGGGCACTACC AGGGCTCCTGGCTCAGTTACA 62.0ºC 
Elovl3 TGTTGAACTGGGAGACACGGC GTCATGAACCAGCCACCCGA 62.0ºC 
Elovl6 GGCACTAAGACCGCAAGGCA GCTACGTGTTCTCTGCGCCT 60.0ºC 
Fasn AGTTAGAGCAGGACAAGCCCAAG GTGCAGAGCTGTGCTCCTGA 60.0ºC 
Sqle CCGGAAAGCAGCTATGGCAGA GCGTGGAGCTCCTTGGTGTC 62.0ºC 
Srebf1 TCCAGTGGCAAAGGAGGCAC CAGCATGCTCATTCGCTGCC 60.0ºC 
B2m * CCCCACTGAGACTGATACATACGC AGAAACTGGATTTGTAATTAAGCAGGTTC 60.0ºC 
Canx * GCAGCGACCTATGATTGACAACC GCTCCAAACCAATAGCACTGAAAGG 62.0ºC 
Rps15 * CGGAGATGGTGGGTAGCATGG ACGGGTTTGTAGGTGATGGAGAAC 62.0ºC 
Sil1 * GGCCGCCTTTTCCAGCAATC CGGGGAGAGGCTGGTTTGTG 62.0ºC 
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blood glucose monitoring system. The incremental area under the curve (AUC) of the 
changes in blood glucose over time per mouse was calculated using GraphPad Prism. 
 
Serum measurements 
Serum samples of the starting point (t=0 min.) of each of the OGTTs were used to 
measure serum leptin, insulin and adiponectin in fasted animals with the mouse serum 
adipokine Lincoplex Kit (Linco Research, Nuclilab, Ede, The Netherlands). Preparation 
of the samples and binding to the antibody-coupled beads were carried out according 
to the manufacturer’s protocol with a few modifications as described previously (60). In 
short, sera were diluted 5x in HPE buffer (Sanquin, Amsterdam, The Netherlands), 
debris was removed by spinning the sample using SpinX columns (Corning, Schiphol-
Rijk, The Netherlands), and possible inhibition of the immunological Ig fraction in serum 
was circumvented by an incubation at gentle shaking for 1 h at room temperature in 96-
well Reacti-BindTM protein L-coated plates (Pierce, Rockford, IL, USA) before 
adipokine assaying. The assays were measured using the Luminex X100 system 
(Biorad, Veenendaal, The Netherlands) with Starstation software (Applied Cytometry 
Systems, Dinnington, Sheffield, UK). Sample concentrations were calculated using a 
standard curve of the metabolite of interest (supplied by the kit). All individual samples 
were analysed in duplicate and averaged.  
Serum total cholesterol, HDL-cholesterol and triglycerides were measured using 
liquicolor enzymatic colorimetric tests (Human, Wiesbaden, Germany). Measured 
serum triglyceride concentrations were corrected for free serum glycerol 
concentrations, using a glycerol colorimetric method (Instruchemie, Delfzijl, The 
Netherlands). Serum samples (2 μl) were measured in duplicate and averaged. Sample 
concentrations were calculated using a standard curve of the metabolite of interest 
(supplied by the kit). Serum LDL-cholesterol concentrations were calculated using the 
modified (for rodents) Friedewald formula (LDL-cholesterol = Total cholesterol – HDL 
cholesterol – (triglycerides*0.16)) (13).  
 
Mitochondrial mass measurement 
To estimate the mitochondrial density in WAT of HF-AL, HF-DR and t=0 mice, we 
determined the ratio of mitochondrial DNA to nuclear DNA with qRT-PCR according to 
Lagouge et al. (27) Total DNA was isolated from 25 mg WAT using the QIAamp DNA 
minikit (Qiagen). Quality and quantity of DNA in each sample was analysed with the 
Nanodrop and each sample was diluted to the same concentration. qRT-PCR was 
performed with mitochondrial DNA and genomic DNA-specific primers (27). A standard 
curve for both genes was generated using serial dilutions of a pooled sample (DNA 
from all samples). Only standard curves with an efficiency between 90-110% and a 
correlation coefficient above 0.99 were accepted. Samples were measured in duplicate. 
The individual relative mitochondrial density was calculated as the Ct value of the 
mitochondrial gene compared to the Ct value of the nucleic gene in the same sample.  
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Statistical analysis of serum samples, WAT weight and OGTT 
Data are expressed as mean ± SEM; statistical analyses were performed using 
GraphPad Prism. All individual measurements within the different treatment groups 
were checked for normality using the D'Agostino-Pearson normality test. Test results 
that were not normally distributed were log-transformed. Measurements at single time 
points between 2 groups were analysed by Student’s t tests. Measurements at single 
time points between 3 groups were analysed by one-way ANOVA and Bonferoni 
Posthoc analysis. P< 0.05 was considered as statistically significant. 
 
Results 
 
High- fat dietary restriction decreased body weight and WAT weight  
Body weight of HF-DR animals declines after the start of the intervention and stabilizes 
after approximately 5 weeks, while HF-AL fed mice gained weight throughout the study 
(Fig 1a). At the time point of section, twelve weeks after the adaptation phase, HF-DR 
mice showed a significant decrease in absolute and relative epididymal WAT, 
compared to HF-AL mice (Fig 1b+c).  
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HF-DR mice performed better on the oral glucose tolerance tests (OGTT) and had 
decreased fasting glucose and insulin levels 
In a fasted state, HF-AL and HF-DR mice differed significantly in serum levels of 
markers that predict the onset of insulin resistance; at 5, 8, and 11 weeks after the start 
of the intervention OGTTs indicated that the insulin sensitivity of the HF-DR mice was 
considerably higher than that of HF-AL mice (Fig. 2a+b). Second, the HF-DR group had 
significantly lower serum levels of glucose and insulin (Fig 2c+d). It should be noted 
that insulin levels of most of the HF-DR animals (approximately 9 per measurement) 
Figure 1 Changes in body 
and white adipose tissue 
(WAT) weight of mice fed 
either a dietary restricted 
(HF-DR) or ad libitum (HF-
AL) high-fat diet. During the 
adaptation phase, HF-AL, HF-
DR, and t=0 mice had similar 
body weights. During the first 
5 weeks of the restriction 
period, HF-DR mice gradually 
lost body weight, after which 
body weight stabilized (A). 
HF-DR mice exhibit a 
significant decrease in 
absolute (B) and relative (C) 
epididymal WAT weight at the 
time of section. Data are 
mean ± S.E.M. of 12 mice. 
***P<0.0001. 
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were below the detection limit of the serum adipokine kit; these values were set to half 
the value of the detection limit (0.13 nM). 
 
Serum leptin, adiponectin and cholesterol levels were significantly altered in HF-
DR mice 
Leptin concentrations were significantly lowered in HF-DR animals (Fig. 3a), while 
serum adiponectin levels were significantly elevated after 5, 8 and 11 weeks of dietary 
restriction (Fig. 3c). At the end of the dietary intervention, total cholesterol was 
significantly lowered in HF-DR mice (Fig. 3b). Triglycerides and HDL cholesterol levels 
remained unchanged between both groups (data not shown). Serum LDL cholesterol 
was decreased in HF-DR mice at time point of section, which caused a significant 
increase in the HDL/LDL – cholesterol ratio in these mice (Fig. 3d).  
A
B C D
0 30 60 90 120
0
5
10
15
20 Week 0
Time (min)
B
lo
o
d
 g
lu
c
o
s
e
 (
m
M
)
0 30 60 90 120
Week 5
Time (min)
0 30 60 90 120
Week 8
Time (min)
0 30 60 90 120
Week 11
HF-DR
HF-AL
Time (min)
0
200
400
600
800
*
wk 0
* *
wk 5 wk 8 wk 11
A
U
C
 (
m
M
 g
lu
c
o
s
e
*m
in
)
0
1
2
3
4
5
6
7
8 ***
wk 0 wk 5 wk 8 wk 11
*** ***
B
lo
o
d
 g
lu
c
o
s
e
 (
m
M
)
0
5
10
15
20
25 HF-AL
HF-DR
wk 0 wk 5 wk 8 wk 11
*** *** ***
S
e
ru
m
 i
n
s
u
lin
 (
n
M
)
 
 
 
 
 
 
 
Gene expression in epididymal white adipose tissue was drastically altered 
between HF-DR and HF-AL mice 
Gene expression in epididymal WAT was measured after 12 weeks of HF-DR or HF-AL 
diet. Of the more than 43,000 transcripts that were studied, 24,146 transcripts were 
found to be expressed in WAT (Supplementary Table 1). After filtering the transcripts 
that encode for the same gene and are similarly regulated, 16,995 genes appeared to 
be expressed in WAT (Fig 4a), of which 8,643 genes were significantly different 
Figure 2 HF-DR improved glucose tolerance and decreased fasted glucose and insulin levels. 
Oral glucose tolerance was tested at the start of the intervention and after 5, 8, and 11 weeks and 
improved during the course of the experiment (A). 5, 8, and 11 weeks after the start of the restriction, 
HF-DR mice had increased glucose sensitivity, as measured by the incremental area under the 
curve (B). At 5, 8, and 11 weeks, HF-DR mice exhibit a decrease in serum glucose (C) and insulin 
(D) levels. Data are mean ± S.E.M. of 12 mice. (results of the tests in week 0 are based on three 
mice per group). *P<0.05; ***P<0.0001. 
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expressed between HF-DR and HF-AL mice (p<0.01 Benjamin-Hochberg FDR 
adjusted). Initially, we focused on the 96 genes that have a p-value <10
-11 
(Table 3). 
The majority of these 96 genes is involved in lipid metabolism and mitochondrial 
function. A substantial part is involved in other metabolic processes (particularly in 
carbohydrate metabolism) and in the cellular response to stress (fig 5). Twenty-four 
genes have an unknown function. The 96 genes that were differentially expressed 
between HF-DR and HF-AL mice were not significantly modulated by high-fat feeding 
on itself, as analysed between HF-AL and t=0 mice (Fig. 4b+c). 
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Microarray analysis on highly significantly regulated genes revealed a major role 
for genes involved in lipid metabolism and mitochondrial functioning 
Lipid metabolism 
A large proportion of the significantly regulated genes (p<10
-11
) play a role in lipid 
metabolism. All genes in this group exhibit a strong upregulation compared to the 
expression in HF-AL mice, except for BC005764 that serves a function in triglycerides 
formation and was downregulated. Among the upregulated genes in this group, Srebf2 
functions as a key transcriptional regulator of genes involved in fatty acid and 
cholesterol synthesis. The majority of the genes in this group are known to be under 
transcriptional control of Srebf2 (denoted with asterisks in Table 3). Indeed, all genes 
involved in cholesterol synthesis (Cyp51, Fdps, Hmgcr, Insig1, Lss, Mvd, Sqle, Tm7sf2) 
and fatty acid synthesis and elongation (Acaca, Acly, Elovl3, Elovl6, Pecr) were 
significantly upregulated, as was Me1 which plays a central role in adipose metabolism, 
linking gluconeogenesis and fatty acid metabolism by producing NADPH. This confirms 
earlier findings of long and short term DR, although on a low fat diet (15, 63), but is in 
contrast with short term HF-DR of only 12 days (63). Interestingly, Sqle and Hmgcr are 
rate limiting enzymes in cholesterol synthesis, while Elovl6 controls the first, rate 
Figure 3 Fasting serum adipokine 
and cholesterol levels of HF-DR mice 
altered during dietary restriction. HF-
DR mice exhibit decreased leptin (A) 
and total cholesterol (B) levels and 
increased adiponectin (C) levels. (D) 
The dietary intervention elevated the 
ratio of HDL-cholesterol to LDL-
cholesterol in HF-DR animals. Fasting 
leptin and adiponectin concentrations 
were determined at the start of the 
intervention and 5, 8, and 11 weeks 
afterward. The level of cholesterol was 
determined at the end of the study. 
Data are mean ± S.E.M. of 12 mice. 
**P<0.01; ***P<0.001. 
32   l   CHAPTER 2 
 
limiting condensation step of fatty acid elongation (33). The transcription of Ppara and 
Pparg, two other key regulators of lipid metabolism, were not altered by the restriction 
regime (also see Table 4). HF-DR upregulated the expression of two genes encoding 
lipolysis-related proteins (Aspg, Lpcat3) and it upregulated the expression of two StAR-
related lipid transfer proteins (Stard4, Stard5) that play a role in the transfer of 
cholesterol to different cellular compartments, such as the endoplasmic reticulum and 
the Golgi apparatus (52); and Rdh11 and Sorl1 that play a role in the reduction of short-
chain (fatty) aldehydes and the uptake of lipoproteins and proteases, respectively.  
 
Mitochondrial functioning 
All 8 mitochondrial genes that were highly significantly regulated by HF-DR (with p<10
-
11
) seem to promote mitochondrial functioning and biogenesis, except for C80638, a 
mitochondrial sodium/hydrogen exchanger, of which transcription is downregulated by 
HF-DR. The majority of genes in this group fulfil a role in mitochondrial activity. 
Transcription of Fxn, for example, a gene that promotes mitochondrial function and 
oxidative phosphorylation was increased by HF-DR. The same holds true for L2hgdh 
and Slc25a1 that both play a promoting role in the mitochondrial citric acid cycle. 
Transcription of mitochondrial-localized Ifi27 protein that is expected to inhibit adipocyte 
differentiation and mitochondrial biogenesis and function (34), was downregulated.  
Since the genes mentioned above are not known as the ‘classical’ regulators of 
mitochondrial functioning, we further analysed the complete list of regulated genes 
(p<0.01) for genes that are better established as key regulators in mitochondrial 
biogenesis, dynamics and autophagy (Table 4). Ppargc1a, Ppargc1b, Esrra, Nrf1 and 
Tfam, which are known to be of major importance for mitochondrial biogenesis (53) 
were indeed all upregulated in HF-DR animals. The same holds true for Dnm1l, Mtfr1, 
March5, Mfn1, Opa1, Oma1 and Stoml2, the genes that play an important role in 
mitochondrial fission and fusion (68). Mtor, a transcription factor that is involved in the 
suppression of autophagy and cell death (20) is upregulated in HF-DR animals. Ulk2 
promotes autophagy and cell death in the absence of Mtor and is consistently 
downregulated. The expression of Park2 that is involved in the induction of mitophagy 
and the promotion of cell survival (40) is, on the other hand, increased in these animals; 
the same holds true for the expression of Rab7 and Bnip3l that are involved in the 
induction of autophagy (19, 69). 
 
Other metabolic genes 
Next to the genes involved in lipid metabolism and mitochondrial function, we found a 
number of genes that are involved in other metabolic processes. Most of the genes in 
this category are involved in carbohydrate metabolism. Pdk1, for example, inhibits 
glycolysis and was strongly upregulated by the restriction regime. Similarly, Ppp1r3b 
promoting glycogen synthesis and Slc2a5 promoting glucose uptake are both increased 
in HF-DR animals. 
HIGH-FAT DIETARY RESTRICTION AND METABOLIC HEALTH   l   33 
  
2  
Table 3 Categorization and expression profiles of strongly regulated genes (P<10K11) 
between HF-AL and HF-DR mice. 
Gene symbol    Protein name                          FC     P-value    Function 
Lipid metabolism 
Cyp51 * Cytochrome P450, family 51  8.0 2.50E-13 Cholesterol synthesis 
Fdps Farnesyl pyrophosphate synthetase  4.3 2.50E-13 Cholesterol synthesis 
Hmgcr * 3-hydroxy-3-methylglutaryl-
coenzyme A reductase 
 2.9 2.40E-12 Cholesterol synthesis 
Insig1 Insulin-induced gene 1 protein  8.7 7.50E-12 Cholesterol synthesis 
Lss Lanosterol synthase  6.7 7.00E-13 Cholesterol synthesis 
Mvd Diphosphomevalonate 
decarboxylase 
 8.4 4.90E-13 Cholesterol synthesis 
Sqle * Squalene epoxidase  7.4 1.10E-13 Cholesterol synthesis 
Tm7sf2 Delta(14)-sterol reductase  5.0 7.50E-12 Cholesterol synthesis 
BC0057
64 
Lipid phosphate phosphatase-
related protein type 3 
-2.8 2.50E-13 1,2-diacylglycerol synthesis 
Elovl3 Elongation of very long chain fatty 
acids protein 3 
 28.6   0 Fatty acid elongation 
Elovl6 * Elongation of very long chain fatty 
acids protein 6 
 47.2   0 Fatty acid elongation 
Pecr Peroxisomal trans-2-enoyl-CoA 
reductase 
 2.8 3.50E-12 Fatty acid elongation 
Acaca * Acetyl-Coenzyme A carboxylase α  5.7 2.30E-12 Fatty acid synthesis 
Acly * ATP-citrate synthase 12.3 3.90E-12 Lipogenesis 
Aspg 60 kDa lysophospholipase 12.8 2.70E-12 Lipolysis 
Lpcat3 Lysophospholipid acyltransferase 5  2.7 2.10E-12 Lipolysis 
Rdh11 * Retinol dehydrogenase 11  9.6 6.10E-13 Reduction of short-chain aldehydes 
Srebf2 Sterol regulatory element-binding 
protein 2 
 2.0 7.90E-12 Transcriptional regulation of lipid 
metabolism 
Stard4 * StAR-related lipid transfer domain 
containing 4 
 2.1 3.80E-13 Intracellular transport of cholesterol 
Stard5 StAR-related lipid transfer protein 5  3.3 2.80E-12 Intracellular transport of cholesterol 
Sorl1 * Sortilin-related receptor  6.2 9.10E-13 Uptake of lipoproteins and 
proteases 
Mitochondrial function 
1700020
C11 Rik 
Mitochondrial 18 kDa protein  6.3 3.56E-12 Maintenance of the mitochondrial 
network 
C80638 Mitochondrial sodium/hydrogen 
exchanger 
-9.0 0 H+/Na+ exchange across 
mitochondrial  inner membrane 
Fxn Frataxin, mitochondrial  2.3 6.58E-12 Mitochondrial iron transport and 
respiration 
Ifi27 Interferon, alpha-inducible protein 
27 like 2A 
-11.1 6.15E-12 Adipocyte differentiation and 
mitochondrial biogenesis 
L2hgdh L-2-hydroxyglutarate dehydrogenase  2.0 2.77E-12 Synthesis of 2-oxoglutarate 
Ppif Peptidyl-prolyl cis-trans isomerase, 
mitochondrial 
 3.2 6.42E-12 Inhibition of the mitochondrial 
permeability transition pore 
Slc25a1 Solute carrier family 25 
(mitochondrial citrate transporter), 1  
 8.2 7.59E-12 Citrate transport / Krebs cycle 
Timm9 Translocase of inner mitochondrial 
membrane 9 homolog  variant 1 
 3.1 5.83E-13 Import and insertion of 
mitochondrial membrane proteins 
Other metabolic genes  
Acp1 Acid phosphatase 1 -5.6 0 Amino acid dephosphorylation  
Adh1 Alcohol dehydrogenase 1  2.4 3.30E-12 Alcohol metabolism 
Me1 NADP-dependent malic enzyme  9.0 0 Gluconeogenesis 
Pdk1 Pyruvate dehydrogenase kinase 
isozyme 1 
 5.0 1.12E-13 Gluconeogenesis 
Pgk1 Phosphoglycerate kinase 1  2.8 9.36E-13 Glycolysis 
Pgp Phosphoglycolate phosphatase  2.1 2.51E-13 Carbohydrate metabolic process 
Ppp1r3b Protein phosphatase 1 regulatory 
subunit 3B 
17.8 0 Glycogen synthesis 
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Table 3 continued from page 33 
Genes are ordered based on function and within functional categories based on alphabetic order. 
Genes indicated with an asterisk are transcriptionally regulated by Srebf2 
Gene symbol   Protein name                              FC     P-value    Function 
Prei4 Putative glycerophosphodiester 
phosphodiesterase  
 2.7 6.70E-13 Carbohydrate/ glycerol metabolic 
process 
Psph Phosphoserine phosphatase  5.0 7.31E-13 Amino acid biosynthesis  
Rorc Nuclear receptor ROR-gamma  5.7 8.49E-13 Transcriptional regulation of metabolism 
Slc2a5 Solute carrier family 2 (facilitated 
glucose transporter), member 5 
35.0 5.69E-12 Glucose uptake 
Cellular response to stress 
Blcap Bladder cancer-related protein -4.5 9.77E-12 Regulation of cell proliferation and 
apoptosis (by similarity) 
C8g Complement component 8, gamma  2.5 3.26E-12 Complement pathway 
Egln3 EGL nine homolog 3   7.4 2.36E-12 Cellular response to stress  
Fastkd3 FAST kinase domains 3  2.2 6.59E-12 Regulation of apoptosis  
Gclm Glutamate--cysteine ligase 
regulatory subunit 
 2.2 8.49E-13 Glutathione metabolism; response 
to oxidative stress 
Klf11 Krueppel-like factor 11 -1.8 4.69E-13 Transcriptional regulation of 
apoptosis 
Tmem49 Transmembrane protein 49 2.1 9.10E-12 Cellular response to stress  
Traf4 Tnf receptor associated factor 4  6.0 1.68E-12 Proapoptotic cellular signaling 
Other functions 
Abcc3 ATP-binding cassette, sub-family C  -3.0 4.35E-13 Transmembrane organic anion 
transport 
Ank Progressive ankylosis  4.3 5.29E-12 Transmembrane inorganic 
pyrophosphate transport 
Atp1a3 Na
+ 
/  K
- 
-transporting ATPase 
subunit 
16.9 0 Transmembrane ion transport 
Anxa6 Annexin A6 -2.6 1.12E-13 Transmembrane ion release 
Kcne1l K
-
 voltage-gated channel, Isk-
related family, member 1-like 
-4.6 3.52E-12 Transmembrane ion release 
Kctd15 K
-
 channel tetramerisation domain 
containing 15 
-2.4 3.13E-12 Transmembrane ion release 
Bmper BMP-binding endothelial regulator -3.3 1.95E-12 Cell differentiation 
Col1a1 Collagen alpha-1(I) chain -3.9 8.00E-13 Cell development 
Cry1 Cryptochrome 1 (photolyase-like)  3.6 0 Regulation of the circadian rhythm 
Dixdc1 DIX domain containing 1  3.1 1.94E-12 Multicellular organismal 
development 
Dock11 Dedicator of cytokinesis 11 -4.6 5.69E-12 Activation of G proteins  
Ift122 Intraflagellar transport 122 homolog -2.7 5.14E-12 Cilia formation  
Nnat Neuronatin, transcript variant 1 -4.0 0 Regulation of insulin secretion  
Pcsk4 Proprotein convertase 
subtilisin/kexin type 4 
 5.8 1.99E-13 Conversion of secretory precursor 
proteins 
Recql4 RecQ protein-like 4  9.7 4.87E-13 DNA recombination 
 S100b S100 protein, beta polypeptide -4.0 1.17E-12 Regulation of proinflammatory 
cytokines (in neurons) 
Sar1b SAR1 gene homolog B  2.0 1.43E-12 Protein transport from ER to Golgi  
Syngr1 Synaptogyrin 1, transcript variant 
1b 
 3.0 3.30E-12 Protein targeting for synaptic like 
microvesicles 
Tmem4
1b 
Transmembrane protein 41B  2.4 9.71E-13 Transmembrane protein 
Tmem79 Transmembrane protein 79 4.5 0 Transmembrane protein 
Polr3g Polymerase (RNA) III polypeptide G  4.1   0 (regulation of) transcription 
1500003
O22 Rik 
Ribosomal RNA processing 8, 
methyltransferase, homolog 
1.9 2.74E-12 Regulation of transcription 
Zbtb20 Zinc finger and BTB domain 
containing 20 
-2.0 3.56E-12 Regulation of transcription 
6330548
G22 Rik 
Small nuclear ribonucleoprotein 35 1.7 2.21E-12 RNA splicing 
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Pathway analysis 
In addition to analysis of strongly significantly regulated genes, we performed a 
pathway analysis on the complete set of regulated genes (Table 5). This analysis 
confirmed that the primary changes in gene expression are related to lipid metabolism 
and mitochondrial functioning. Of the top 10 named pathways, 8 pathways (Oxidative 
phosphorylation, Cholesterol biosynthesis, Citric acid cycle (Ubiquinone metabolism), 
Regulation of lipid metabolism, Mitochondrial fatty acid unsaturated and long chain β-
oxidation and Regulation of fatty acid metabolism) are involved in these functions. 
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Microarray results were confirmed with qRT-PCR 
qRT-PCR was used to validate the microarray results for 7 genes with an important role 
in lipid metabolism. This resulted in a significant upregulation of all 7 genes with fold 
changes ranging between 4.0 and 513.3 (microarray data ranged between 2.0 and 48.0 
for these genes) (Fig. 6). 
 
HF-DR mice have higher levels of mitochondrial mass in WAT 
Mitochondrial and nuclear DNA content in WAT of HF-AL, HF-DR and t=0 mice was 
compared with qRT-PCR in order to estimate mitochondrial density. HF-DR mice had a 
significantly higher mitochondrial DNA content compared to both HF-AL and t=0 mice 
(Fig. 7). High-fat feeding (HF-AL vs. t=0) reduced mitochondrial density; although non-
significantly.     
Figure 4 Volcano plot (A) of 16 995 genes 
expressed in WAT showing the t-test statistics 
P value plotted against the fold change of each  
transcript of the microarray analysis between 
HF-DR and HF-AL mice. P values were corrected 
for multiple testing using a Benjamini–Hochberg 
correction. Black dots represent the 96 genes that 
have a P value smaller than 10
-11
. The dotted line 
indicates the significance level of 0.01. The 96 
genes that were differentially expressed between 
HF-DR and HF-AL mice as observed by 
microarray analysis were not modulated between 
HF-AL and t=0 mice (based on P values (B) of the 
HF-DR and HF-AL compared to HF-AL and t=0 
mice (the dotted lines indicate a significance level 
of 0.01) and based on fold changes (FC; C) of HF-
DR and HF-AL compared to HF-AL and t=0 mice).  
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Table 4 Expression profiles of genes that are known to play an important role in 
mitochondrial function. 
Genes are ordered based on function and within functional category based on alphabetic order. Genes 
indicated with an asterisk are significantly differently expressed between HF-DR and HF-AL mice. 
Gene symbol   Gene name                                     FC    P-value    Function 
Mitochondrial biogenesis 
Cox4i1 * cytochrome c oxidase subunit IV 
isoform 1  
1.81 3.45E-05 Formation of respiratory chain 
complex IV 
Cox5b * cytochrome c oxidase, subunit Vb 2.10 5.36E-07 Formation of respiratory chain 
complex IV 
Esrra * estrogen related receptor, alpha 2.06 1.64E-06 Regulation of nuclear and 
mitochondrial respiratory proteins 
Gabpa * GA repeat binding protein, alpha 1.74 9.63E-08 Regulation of nuclear and 
mitochondrial respiratory proteins 
Nrf1 * nuclear respiratory factor 1 1.25 7.68E-04 Regulation of nuclear and 
mitochondrial respiratory proteins 
Polg polymerase (DNA directed), gamma -1.06 2.85E-01 mtDNA maintenance 
Ppara  peroxisome proliferator activated 
receptor alpha 
-1.19 2.44E-02 Regulation of fatty acid oxidation 
Pparg  peroxisome proliferator activated 
receptor gamma 
-1.13 4.09E-01 Regulation of fatty acid oxidation 
Ppargc1a * peroxisome proliferative activated 
receptor, gamma, coactivator 1 alpha 
2.39 2.13E-06 Regulation of mitochondrial 
biogenesis 
Ppargc1b * peroxisome proliferative activated 
receptor, gamma, coactivator 1 beta 
1.85 5.70E-05 Regulation of mitochondrial 
biogenesis 
Pprc1 peroxisome proliferative activated 
receptor, gamma, coactivator-related1 
-1.03 7.82E-01 Regulation of mitochondrial 
biogenesis 
Sirt3 sirtuin 3 1.10 1.78E-01 ROS detoxification + 
mitochondrial biogenesis  
Tfam * transcription factor A, mitochondrial 1.34 9.71E-06 Stabilization + maintenance of 
the mitochondrial chromosome 
Mitochondrial dynamics 
Dhodh * dihydroorotate dehydrogenase 1.37 6.65E-07 Regulation of mitochondrial fission 
Dnm1l * dynamin 1-like 1.32 3.46E-06 Mitochondrial fission 
Fis1 fission 1 1.16 3.58E-02 Mitochondrial fission 
Gdap1l1 ganglioside-induced differentiation-
associated protein 1-like 1 
-1.14 1.46E-01 Mitochondrial fission 
Mtfr1 * mitochondrial fission regulator 1 1.69 2.02E-08 Mitochondrial fission 
March5 * membrane-associated ring finger 
(C3HC4) 5 
1.65 4.76E-06 Activation of Dnm1l, Fis1 and 
Mfn2 
Mfn1 * mitofusin 1 1.22 4.70E-04 Outer membrane fusion 
Mfn2 mitofusin 2 1.18 9.38E-02 Outer membrane fusion 
Oma1 * OMA1 homolog,zinc Metallopeptidase 1.29 2.21E-05 Activation of OPA1 
Opa1 * optic atrophy 1 homolog 1.42 3.68E-05 Inner membrane fusion 
Stoml2 * stomatin (Epb7.2)-like 2 1.51 6.70E-09 Stress-induced fusion 
(mitochondrial) Autophagy 
Atg13 ATG13 autophagy related 13homolog 1.11 1.93E-01 Induction of autophagy 
Becn1 beclin 1, autophagy related 1.14 6.49E-02 Induction of autophagy 
Bcl2 B-cell leukemia/lymphoma 2 -1.73 2.97E-08 Inhibition of autophagy 
Bnip3 BCL2/adenovirus E1B interacting 
protein 3 
-1.06 6.54E-01 Induction of autophagy, cell death 
and mitophagy 
Bnip3l * BCL2/adenovirus E1B interacting 
protein 3-like 
1.53 1.28E-05 Induction of autophagy, cell death 
and mitophagy 
Mtor * mechanistic target of rapamycin  1.34 7.23E-05 Regulation of autophagy  
Rab7 * RAB7, member RAS oncogene family 1.31 4.67E-05 Maturation of autophagic 
vacuoles 
Ulk1 Unc-51 like kinase 1 1.10 1.79E-01 Induction of autophagy 
Ulk2 * Unc-51 like kinase 2 -1.82 2.73E-09 Induction of autophagy 
Park2 * Parkin 2 1.44 2.79E-03 Induction of mitophagy 
Pink1 PTEN induced putative kinase 1 -1.12 1.81E-01 Induction of mitophagy 
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Discussion 
 
Dietary restriction of a high-fat diet improves metabolic health and promotes a 
metabolic adaptation towards lipid metabolism 
We demonstrate that dietary restriction of a high-fat diet restores glucose sensitivity, 
increases the mitochondrial density in WAT, decreases the serum levels of cholesterol 
and leptin; and increases serum adiponectin levels. The bodyweight and serum 
parameters of HF-DR mice remained stable during the last 7 weeks of restriction, 
implying that within 5 weeks HF-DR mice have adapted to the restriction regime and 
exhibit a steady energy balance. The beneficial effects on health are comparable to 
previous reports that demonstrate that DR on a standard mouse diet improves health, 
by enhancing insulin sensitivity (12), decreasing serum cholesterol (6), glucose, and 
leptin levels (49), and increasing serum adiponectin (7). To our knowledge this is the 
first study that exclusively reports improvements in markers of the metabolic syndrome 
by dietary restriction with a high-fat diet. Two previous studies, in fact, reported 
unfavourable effects in mice that were pair-fed on a high-fat diet to match the caloric 
intake of mice on a low-fat diet. A certain iso-caloric treatment was found to result in a 
decrease in insulin sensitivity in the restricted high-fat group (47); whereas a second 
study reported that high-fat pair-fed mice develop insulin resistance, hepatic steatosis, 
and obesity (11). The diets used in both studies, however, contained almost twice as 
much energy available from fat compared to the diet we used in our study (58 and 
60en%, compared to 30en%), which might have evoked a different coping strategy. A 
third study on high-fat dietary restriction in mice, consistently, reported decreased 
Figure 5 Categorization of the 96 genes 
that were found to be strongly regulated 
(P value <10
-11
) between HF-DR and HF-
AL mice into functional categories. The 
majority of genes is involved in lipid 
metabolism and mitochondrial functioning. 
Nine genes are involved in cholesterol 
synthesis (CS), eight are involved in fatty 
acid synthesis and elongation (FASE), and 
four genes are involved in other processes 
in lipid metabolism (O). Four genes are 
involved in mitochondrial maintenance (M) 
and four genes are involved in 
mitochondrial activity (A). Most of the 
genes involved in other metabolic 
processes serve a role in carbohydrate 
metabolism (CM). 
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fasting insulin levels; although it also reported a decrease in serum adiponectin levels 
and only minor effects of high-fat restriction on inflammations in WAT (21). An 
important difference with our study is that the authors used a run-in period on the high-
fat diet that is much longer than the actual restriction period. In this case, two months of 
dietary restriction might simply be insufficient to reverse the negative effects of six 
months ad libitum high-fat feeding and to stabilize energy balance, as was seen in our 
study. The occurrence of beneficial effects of DR with a high-fat diet seems, 
consequently, to depend on both the duration of restriction and the fat content of the 
diet.  
 
Table 5 Top ten pathways that are significantly regulated between HF-AL and HF-DR 
mice. 
Pathway analysis was performed on the complete set of regulated genes (P<0.01). The top ten 
pathways (based on P value) consist of several pathways involved in lipid metabolism and mitochondrial 
function. The table additionally shows the total number of genes that is involved in the pathway and the 
number of these genes that was either upregulated or downregulated in our dataset. 
 
To additionally examine the molecular events associated with the observed adaptation 
to HF-DR, we analysed whole genome expression in WAT; the organ that was notably 
affected by HF-DR (Fig. 1b+c, 3a+c) and is known to play an important role in the 
development of metabolic complications in obesity (58). Among the drastic shifts in 
gene expression in WAT, the changes in genes involved in lipid metabolism and 
mitochondrial function were most pronounced (Table 3, Fig. 5). In our study, the 
majority of lipid metabolism-related genes plays a role in cholesterol synthesis and fatty 
acid synthesis and elongation and was upregulated by the restriction regime. For this 
analysis we initially focused on the functional interpretation of genes with the strongest 
P-values. To further validate this approach we also conducted a pathway analysis on 
the complete set of regulated genes, which revealed significant regulation of several 
pathways involved in both lipid metabolism and mitochondrial function (Table 5), which 
further supports the functional interpretation of our initial approach. To our surprise, 
pathway analysis also pointed towards an upregulation of mitochondrial fatty acid 
  Pathway                                      P-value       total # of genes         # of upreg.        # of downreg  
                                                                   involved in pathway   genes in dataset   genes in dataset 
1. Oxidative phosphorylation 1.80E-11 114 77 0 
2. Cholesterol biosynthesis 1.16E-06 22 20 0 
3. Citric acid cycle 2.49E-06 20 18 1 
4. Regulation of lipid metabolism 
via LXR, NF-Y and SREBF 
7.75E-06 35 18 9 
5. Ubiquinone metabolism 1.03E-05 52 37 0 
6. BAD phoshorylation 1.08E-05 88 29 12 
7. Mitochondrial long chain fatty 
acid  β-oxidation 
1.14E-05 18 14 2 
8. EDG3 signaling 3.11E-05 68 13 22 
9. Insulin regulation of fatty acid         
r  metabolism 
5.12E-05 55 25 9 
10. Mitochondrial unsaturated 
fatty acid β-oxidation 
5.13E-05 16 13 1 
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oxidation. A result that seems contradictory to the observed increase in fatty acid 
synthesis and elongation. Earlier studies to the effects of dietary restriction on gene 
expression in WAT, however, also reported changes in genes and pathways involved in 
both storage and usage of energy; although in these studies a standard rodent diet was 
use for dietary restriction and compared to our results, the effects on lipid metabolism 
are less pronounced (15, 44). We propose that the HF-DR mice have developed an 
enhanced substrate efficiency for the abundant fat component in the diet, and that 
upregulation of both fat storage and release pathways relates to the beneficial effects 
on metabolic health we observed in this study. 
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Since both groups of mice were kept under the same rearing conditions and on diets 
with equal vitamin and mineral intake and identical macronutrient composition, most 
plausible alternative explanations for the differences in gene expression between HF-
DR and HF-AL can be excluded. It should, nonetheless, be noted that, in order to 
match the levels of food intake, animals of both groups were treated differently. HF-DR 
animals received their restricted amount of food at the start of the light phase and were 
sectioned 6 hours afterwards, while HF-AL animals were sectioned 3 hours after start 
of the light phase; which might have influenced expression patterns of genes that 
display a diurnal pattern, such as Bmal, Cry1, Elovl3 and Elovl6. Indeed, we found a 
significant up-regulation of the circadian clock regulator Bmal in HF-DR mice (data not 
shown). However, we found the expression of Cry1 to be increased, while it is expected 
Figure 6 Confirmation of 
microarray results by real-time 
qRT-PCR. The expression of 
Acaca (A), Acly (B), Fasn (C), 
Sqle (D), Srebf1 (E), Elovl3 (F), 
and Elovl6 (G) in HF-DR and HF-
AL mice was analysed by qRT-
PCR (left) using stable reference 
genes Canx, B2m, Sil1, and 
Rps15. Data obtained with 
microarray are shown for 
comparison (right). Data 
represent the mean ± S.E.M. of 
12 mice, in which the mean 
expression of HF-AL mice is set 
to 1.0. *P<0.05; ***P<0.001. 
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to be stable within the time frame just mentioned (1). Accordingly, the expression level 
of Elovl3 is increased instead of decreased, as would be expected if the difference was 
due to the circadian rhythm of this gene (2). Finally, the increase in expression of Elovl6 
is well beyond the increase in expression that is normally seen during this time frame in 
the light phase (a 2-fold increase that is normally seen, compared to a 47.2-fold 
increased observed in this study) (8). It seems, therefore, unlikely that the differences 
observed in the expression of metabolic genes, which is the focus of this study, are 
primarily due to the differences in feeding and sectioning time.   
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Srebf1 and Srebf2 are expected to play a major role in the adaptation to a high-fat 
diet in HF-DR animals 
Srebf1 and -2, play an important role in the regulation of lipid metabolism, and were 
both higher expressed in HF-DR mice. Although Srebf1 did not belong to the list of 
genes with the strongest P-values (Table 3), the same list contains various genes that 
are under transcriptional control of both Srebf isoforms, such as Elovl6, Acly and Acaca 
(38). SREBPs (the human annotation of Srebfs) are known as crucial cellular molecules 
that mediate adaptive metabolic responses to changing dietary exposures (57). Nuclear 
translocation of SREBPs is regulated by intracellular fatty acid and sterol levels. When 
cellular sterols are abundant, SREBPs are inactive in the endoplasmic reticulum 
membrane. Upon sterol depletion, SREBPs are cleaved by regulated proteolysis to 
release the mature transcription factor domain, which translocates to the nucleus. 
SREBPs then bind promoter sterol-regulatory elements (SREs) to activate genes 
involved in the biosynthesis and uptake of cholesterol and fatty acids (3). The 
expression of Ppara and Pparg, two other key regulators of lipid metabolism, is not 
significantly altered between HF-DR and HF-AL, implying the significance of both 
Srebfs in upregulating lipid metabolism in our study. 
Consistently to the upregulation of both Srebfs, cholesterol synthesis appeared to be 
significantly changed in HF-DR mice (Fig. 5), in fact, 20 of the 22 genes that are 
involved in this metabolic process were upregulated by our treatment. At first sight it 
might appear strange for HF-DR mice to increase the rate of cholesterol and fatty acid 
synthesis. The HF-AL mice consumed 3.94 kcal from fat per day; this was 2.76 kcal for 
Figure 7 Mitochondrial density in WAT of  t=0, 
HF-AL, and HF-DR mice. Mitochondrial density 
was measured by the mitochondrial DNA copy 
number versus nuclear DNA and measured with 
qRT-PCR. Data represent the mean ± S.E.M. of 12 
mice, of which the mtDNA/nDNA ratio of HF-AL 
mice was set to 1.0. ***P<0.001. 
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HF-DR mice, while a chow-fed mouse eats about 1.08 kcal form fat per day (5). 
Second, mice on a standard chow diet receive no cholesterol, while HF-DR mice do 
consume cholesterol; although to a lesser extent compared to HF-AL mice. It can, 
therefore, be assumed that both HF-DR and HF-AL mice received enough energy from 
fat. Similar results on Srebfs functioning and upregulation of energy metabolism have, 
however, earlier been observed in dietary restricted animals. At first, high-fat diets are, 
known to induce expression of Srebf1 in the liver (36), and studies in both mice and 
humans showed that the expression of SREBPs is downregulated in obese versus lean 
subjects (39, 41, 56). These authors subsequently hypothesize that the downregulation 
of Srebfs correlates with the dedifferentiation of adipocytes in obesity, while enhanced 
differentiation of adipocytes is rather known as a characteristic of dietary restriction 
(15). Second, it was shown that re-feeding after fasting stimulates the expression of 
Srebf1 (35), which implies that the dietary restricted animals in our study are still (6 
hours after feeding) in a post-prandial state. A result that is consistent to a study by 
Bruss et al. (4), who noticed that dietary restriction elevates fatty acid synthesis in mice 
until 4 to 6 hours after food provision compared to normal fed mice as measured by 
their respiratory exchange ratio. Our study confirms this finding and implicates an 
important role for Srebf1 and Srebf2 in this metabolic adaptation.  
Finally, upregulation of metabolic rate has earlier been observed in ‘normal’ low-fat 
dietary restriction studies in mice (15), as well as in dietary restricted nematodes (17) 
and flies (18). The main difference with these studies is, however, that our results 
primarily point in the direction of lipid metabolism, implying that mice are capable of 
adjusting their metabolism specifically to their diet. As a result, HF-DR mice seem to be 
better equipped to deal with the excess of amount of fat in their diet, compared to the 
HF-AL mice. Several aspects of the micro array results fit within this theory. The 
upregulation of, for example, mitochondrial fatty acid β-oxidation (Fig. 5), in which acyl-
CoA molecules are oxidized to generate acetyl-CoA that can subsequently be used in 
the citric acid cycle, enables HF-DR animals to synthesize ATP during scarcity of 
pyruvate. Pdk1 that was also upregulated by HF-DR complements in this process by 
protecting carbohydrate stores in muscle (46) and, in this way, stimulating cells to shift 
to fat utilization and spare carbohydrate stores. Finally, the upregulation of Stard4 and 
Stard5 could make the metabolism of cholesterol more efficient by regulating the 
transfer of cholesterol to different cellular compartments. Apart from that, by binding, 
transporting, and positioning dietary cholesterol, STARD4 protein increases cholesteryl 
ester formation; and is therefore, postulated to play a role in the determination of serum 
total cholesterol and LDL cholesterol (51), which were found to be significantly 
decreased in serum of HF-DR mice (Fig. 3). 
 
HF-DR significantly enhanced mitochondrial function and density in WAT 
The mitochondrion serves a critical function in the maintenance of cellular energy 
stores, thermogenesis, and apoptosis. Proper control of mitochondrial function is, 
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therefore, of major importance for cell survival and the maintenance of metabolic 
health. In our list of strongly regulated genes we identified several genes that are 
involved in mitochondrial function (Table 3). The expression patterns of these genes 
pointed towards an improved mitochondrial function. To further confirm this finding, we 
analysed our complete set of regulated genes for genes that are better established to 
play a key role in the regulation of mitochondrial function (Table 4). In the first place we 
aimed at genes involved in the process of mitochondrial biogenesis. Mitochondrial 
biogenesis is mainly determined by genes that promote the formation of elements of 
the respiratory chain and the maintenance of mitochondrial DNA. Ppargc1a, Ppargc1b 
and Esrra are known as the key transcriptional regulators within this process and were 
all significantly upregulated in HF-DR animals. Nrf1, Gabpa and Tfam that work as the 
direct effectors of Ppargc1a and stimulated mitochondrial biogenesis (53) were 
consistently upregulated in these animals. In addition, we found a significant increase in 
the expression of CoxIV and CoxVb that are under transcriptional control of Nrf1 and 
Gabpa and serve a direct function in the formation of the cytochrome oxidase subunits 
(24).  
Second, we looked at genes involved in mitochondrial dynamics, which can be 
characterized by the degree of fission and fusion of mitochondria. Fission and fusion 
refers to the formation and breakdown of tubules between mitochondria, which plays an 
important role in the regulation of mitochondrial morphology. Dysregulation of genes 
involved in fission and fusion relates to the development of various disorders, such as 
diabetes (68). In mammals, fission is primarily regulated by Dnml1 and Fis1, which are 
both upregulated by HF-DR, although the regulation of Fis1 is only marginally 
significant. Fusion of mitochondrial tubules is mediated by Mfn1 and OPA1, which are 
both significantly upregulated in HF-DR mice. OPA1 is specifically involved in the fusion 
of the mitochondrial inner membrane and was found to be cleaved and activated by 
OMA1, which is also significantly upregulated in our data set. Finally, we also found a 
significant upregulation in the expression of Stoml2 and Dhodh that play a role in stress 
induced fusion and the transcriptional regulation of fission respectively. Under normal 
conditions, fission and fusion proteins are expressed in response to the mitochondrial 
activity of the cell. Artificial overexpression of one of either fission or fusion proteins 
disrupts the balance and disturbs normal cell function (68). Fis1 overexpression in liver 
cells, for example, causes mitochondrial fragmentation and impaired glucose stimulated 
insulin secretion; while overexpression of Mfn1 causes similar perturbations of the 
metabolism-secretion coupling of glucose (43). Regarding the improved health status of 
HF-DR mice, we hypothesize that the upregulation of both fission and fusion proteins 
relates to the observed improvement of mitochondrial function.  
Fission and fusion proteins are, additionally, involved in the regulation of apoptosis by 
the elimination of damaged mitochondria by autophagy. Selective autophagy of 
mitochondria, or mitophagy, has extensively been described in yeast, where it is known 
to play an important role in the determination of cell survival or cell death after oxidative 
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stress (22). In short, damaged, aged or excess mitochondria are a risk factor for the 
cell, and proper elimination of such organelles is important to maintain optimal cellular 
homeostasis. To also investigate the end stage of mitochondrial function we analysed a 
number of genes involved in mitochondrial autophagy. In mammals, mitophagy is 
regulated by Bnip3, Bnip3l, and Park2 (40, 69), of which the latter two were significantly 
upregulated in HF-DR mice. Finally we analysed the expression of mTor, a 
serine/threonine protein kinase transcription factor that responds to nutrient starvation, 
oxidative stress and availability of growth factors. In fact, nutrient starvation and 
oxidative stress inhibit mTor transcription, which stimulates autophagy and apoptosis 
(20). mTor appeared to be significantly higher expressed in HF-DR animals, which 
implies a decreased prevalence of oxidative damage and apoptosis. The downstream 
effectors of mTor, Ulk1 and Ulk2 that initiate apoptosis in the absence of mTor were 
either not regulated or significantly downregulated.  
It should be noted that dietary restriction is often related to downregulation of mTor 
(25). An increase in autophagy is in this case seen as strategy to survive low nutrient 
concentrations by recycling their own cell content. In our study, however the restriction 
of the high-fat diet still provides the animals with an amount of calories that is similar to 
the amount of calories that mice consume on a standard low-fat rodent diet: the HF-DR 
mice received 9.2 kcal/day, while an ‘average’ male C57BL6/J mouse eats around 10.8 
kcal/day (5). It can, therefore, be hypothesised that the HF-DR mice received sufficient 
nutrients and therefore did not need to switch to salvage pathways such as autophagy.  
To summarise, microarray analysis provided us with a convincing amount of evidence 
for the upregulation of mitochondrial function in HF-DR mice. The increase in the ratio 
of mitochondrial DNA in WAT of HF-DR mice, which can be seen as an estimation of 
the mitochondrial density (27), further confirms our findings regarding the upregulation 
of mitochondrial genes. Although the promotion of mitochondrial biogenesis induced by 
caloric restriction was recently re-evaluated in an extensive restriction study in rats, in 
which no changes were found in the amount of mitochondrial proteins in restricted 
animals (14), improvements of mitochondrial function in WAT were earlier observed in 
other restricted animals and is thought to be related to the beneficial effects of 
restriction (15, 37), in which our study is the first to report effects on mitochondrial 
function in mice restricted on a high-fat diet.  
 
Conclusions  
The results of our study prove that dietary restriction can reverse the adverse effects of 
an, initial unhealthy, high-fat diet. Our treatment had a large influence on gene 
expression in WAT. An in-depth study on genes with the strongest P-values revealed a 
major role for genes involved in lipid metabolism and mitochondrial functioning. It is 
hypothesized that the restriction procedure has forced the metabolism of mice towards 
the utilization of especially lipids in order to effectively make use of the diet, spare 
carbohydrates and to create a stable energy balance. The effective use of fat seems to 
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protect HF-DR mice from the increase in serum cholesterol and leptin levels that were 
found in HF-AL mice, as well as from the decrease in mitochondrial density in WAT, 
and decrease in glucose sensitivity and serum adiponectin levels.  
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Abstract 
 
Indirect calorimetry (InCa) can potentially be used to non-invasively assess metabolic 
and age-related flexibility. To assess the use of InCa for this purpose, we tested the 
sensitivity and response stability over time of three InCa-based treatments in old versus 
adult mice. Diurnal patterns of respiratory exchange ratio were followed for 24 hours 
under standard conditions (Treatment 1), but the results were not stable between test 
periods. As a challenge, fasted mice received glucose to test switch-effectiveness from 
fat to glucose oxidation (Treatment 2). No differences between groups were observed, 
although old mice showed higher adiposity and lower white adipose tissue 
mitochondrial density, indicative of age-impaired metabolic health. Lastly, adaptation to 
a challenge of oxygen restriction (OxR, 14.5 % O2) was assessed as a novel approach 
(Treatment 3). This treatment stably detected significant differences: old mice did not 
maintain reduced oxygen consumption under OxR during both test periods, while adult 
mice did. Further biochemical and gene expression analyses showed that OxR affected 
glucose and lactate homeostasis in liver and WAT of adult mice, supporting the 
observed differences in oxygen consumption.  
In conclusion, InCa analysis of the response to OxR in mice is a sensitive and 
reproducible treatment to non-invasively measure age-impaired metabolic health.   
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Introduction 
 
Health can be defined as the ability to adequately respond to physiological stress – that 
is, to be flexible and display homeostatic robustness (20). Metabolic flexibility is the 
capacity of an organism to adequately respond to changes in the environment, such as 
changes in nutritional input, energetic demand, or environmental changes like oxygen 
limitation. Metabolic flexibility can, therefore, be used as a measure for health. 
A major disadvantage of many methods that assess health status is necessity of 
invasive procedures, which induce stress and modify physiological status. Blood 
sampling and injection have a pronounced effect on both blood glucose levels and body 
temperature in mice (25). Even simple routine procedures, such as lifting by the tail and 
restraining by hand, can have a significant influence on stress markers, such as plasma 
corticosterone levels, heart rate, and body temperature (38). Therefore, stress does not 
only affect whole body metabolism, but also increases variability of experimental data 
and reduces the quality and reproducibility of data obtained. Non-invasive techniques 
might overcome these drawbacks. 
Indirect calorimetry (InCa) is commonly used as a non-invasive method to assess 
metabolism without disrupting an animal’s normal behavior. In InCa the levels of O2 
consumption and CO2 production are measured and used to calculate whole body 
energy expenditure (EE) and respiratory exchange ratio (RER), which reflects substrate 
use (23).  
Deviations from the normal diurnal pattern of RER and EE can indicate health 
problems. In humans, for example, the absence of a clear day and night rhythm relates 
to an increased risk of Type 2 diabetes and cardiovascular diseases (3, 39). In mice, 
deviations from the normal circadian rhythm relate to decreased longevity (35), and 
increased body weight (1, 46). Alternatively, feeding a high-fat diet disturbs the 
expression of regulatory genes of the diurnal clock (4). 
Next to the assessment of diurnal patterns under standard, free-feeding conditions, 
InCa also facilitates the incorporation of challenge tests. Challenge tests have major 
advantages above static physiological measurements, because they also assess the 
ability to adequately respond thus enlarging the effects of an experimental procedure 
(55). Indeed, nutritional (28) and environmental challenges (32) within InCa have been 
used efficiently to sensitively test metabolic health.  
To conclude, analysis of metabolic health by InCa is promising and has numerous 
potential applications. The objective of this study was, therefore, to further establish 
InCa as a way to measure age-impaired metabolic health in mice and to identify the 
most sensitive and reproducible treatment. We compared three treatments and 
validated their reproducibility over time in two groups of apparently healthy male 
C57BL/6J mice that differed in age (adult vs. old). Treatment 1 was used to assess the 
natural diurnal pattern of RER. Treatments 2 and 3 were used to assess the response 
to a nutritional and environmental challenge. With treatment 2, we assessed metabolic 
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switch-flexibility of fasted mice in response to glucose consumption. With treatment 3, 
we used a novel approach to measure metabolic flexibility; mice were challenged by 
exposure to low oxygen conditions (oxygen restriction, OxR, 14.5 % O2) and their 
adaptive response was tested. The level of 14.5% oxygen is comparable to the 
situation at high altitude (around 10,000 ft.) and in certain airplanes, or the situation in 
obesity related disorders such as obstructive sleep apnea (18). The mild restriction in 
oxygen availability, therefore, resembles a condition that we can encounter in normal 
daily life. Moreover, pilot studies showed that this oxygen reduction is enough to apply 
a certain pressure on mouse physiology and to alter metabolism. Each treatment was 
tested twice with at least 10 weeks in between to examine the reproducibility of the 
treatment.  
 
Materials and methods 
 
Animals and experimental manipulations 
The Animal Welfare Committee of Wageningen University, Wageningen, The 
Netherlands approved the experimental protocols (males: DEC2009061, females: 
DEC2011014). Eighteen male C57BL/6JOlaHsd mice (Harlan Laboratories, Horst, The 
Netherlands) were individually housed and maintained under environmentally controlled 
conditions (21 ± 1 ºC, 12 h/12 h light–dark cycle, 45% ± 10% humidity) with ad libitum 
access to feed and water. Mice received a pelletized diet (2016 Teklad Global 16% 
Protein Rodent Diet, Harlan) with 22% energy from protein, 12% energy from fat, and 
66% energy from carbohydrates from weaning until the end of the study to exclude 
possible nutritional interference (34). Mice arrived at 8 weeks of age, at two different 
time-points - mice for the ‘old’ group arrived 62 weeks before the mice of the ‘adult’ 
group. After the mice for the ‘adult’ group arrived, all mice were housed in the same 
room and could adapt for two weeks. At the start of the study (t=0), the adult mice 
(n=12) were 10 weeks of age and the old mice (n=6) were 72 weeks of age. 
Bodyweight was determined weekly. Feed intake was determined weekly between 
week -2 and week 5, between week 8 and 11, and in the last week of the study by 
weighing the amount of feed in each cage at the start and at the end of the week. InCa 
treatment 1 and 2 were applied in weeks 0 and 13. Treatment 3 was applied in weeks 4 
and 15. Mice were sacrificed in week 18. All analyses were done for 12 adult mice and 
6 old mice, except where indicated. Treatment 3 was also applied to 6 adult (13 weeks) 
and 6 old (75 weeks) female C57BL/6JRcc mice.  
At the end of the study, all mice received two grams of feed at the start of the dark 
phase and were sacrificed in random order 19 to 21 hours afterwards. Half of the adult 
mice were exposed to OxR for six hours prior to section, whereas the other 6 adult 
mice remained under ambient conditions. At the time point of sacrifice, mice were 
anesthetized by inhalation of 5% isoflurane with either 14.5% oxygen (OxR groups) or 
ambient air (ambient group) as a carrier. Blood was sampled after decapitation and 
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collected in Mini collect serum tubes (Greiner Bio-one, Longwood, USA), and 
centrifuged for 10 min at 3000 g and 4 °C to obtain serum. Serum samples were 
aliquoted and stored at –80 °C. After blood collection, gonadal white adipose tissue 
(WAT) and liver tissue were dissected, weighted, and snap frozen in liquid nitrogen and 
stored at –80 °C.  
 
Indirect calorimetry (normal and low oxygen conditions) 
The PhenoMaster Indirect Calorimetry System (TSE Systems, Bad Homburg, 
Germany) is equipped for simultaneous measurements of a reference cage and 12 
individual mice in type II macrolon cages, using a constant flow rate of 0.40 L/min and a 
sample flow rate of 0.38 L/min, as published (27). The system was supplemented with 
a Workhorse hypoxia pump (b-Cat B.V., Tiel, the Netherlands) that stably decreases air 
oxygen concentration to 14.5%. When inflow air was switched from ambient air to OxR, 
or vice versa, 30 minutes were needed before measurements were stable (see suppl. 
fig. 1 for an example of the measurements with empty cages). Air samples are 
analyzed with a high-speed Siemens Ultramat/Oxymat 6 O2 / CO2 analyzer (TSE) that 
can sensitively and accurately measure O2 in a range between 0% and 100% and CO2 
in a range between 0% and 1.5%. Here, the measuring range for O2 was set between 
0.0% and 21.5% and for CO2 between 0.0% and 1.0%. The analyzer was calibrated 
with two gas mixtures: one with 0.000% O2 and 1.007% CO2, and the second with 
20.949% O2 and 0.000% CO2 (Linde Gas, Schiedam, Netherlands). For all InCa 
measurements, mice remained in their home cage, with cage lids being replaced by 
airtight PhenoMaster cage lids. Mice were adapted in the Phenomaster system for at 
least 24h before the start of each measurement (see below). Rates of oxygen 
consumption (VO2, ml/h) and carbon dioxide production (VCO2, ml/h) were calculated 
by TSE software, using the reference cage as measurement of (adjusted) oxygen and 
carbon dioxide inflow, and used to calculate the respiratory exchange ratio (RER = 
VCO2/VO2) and energy expenditure (EE= (3.941*VO2+1.106*VCO2)/1000 in kcal/h). 
Physical activity is measured in the indirect calorimetry system with a frame containing 
8 infrared beams at the long side (X-frame) of the animal cage and 6 infrared beams at 
the short side (Y-frame) of the cage. Physical activity was recorded for 8 animals 
simultaneously and expressed as total beam breaks (both X and Y) per minute. 
Diurnal pattern of RER (Treatment 1). 
Feed and water were provided ad libitum. InCa parameters and feed intake were 
measured for 24 hr. Mean RER values were calculated over 24 hours and distinctly 
over the light and dark phase. 
Response to glucose administration (Treatment 2).  
Mice received a restricted amount of feed (2 gram per animal) at the start of the dark 
phase (18.00h). After the start of the following light phase, in a fasted state, all animals 
received a single glucose pellet (2g / kg BW). The time point when all glucose was 
consumed (within 1 to 3 minutes) was taken as time point t=0. Mice were followed for 
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120 minutes afterwards and the RERs of individual animals were used to calculate the 
incremental area under the curve.  
Response to OxR challenge (Treatment 3). 
Mice received 2 gram of feed at the start of the dark phase. After start of the light 
phase, the oxygen level was decreased from ambient (20.8%) to 14.5% (OxR). After 30 
minutes, the oxygen level stabilized and measurements were recorded for six hours 
under OxR. Next, the oxygen level was normalized to ambient within 30 minutes and 
measurements were again recorded for another 2 hours under ambient conditions. The 
experiment was divided in blocks of 100 minutes: 100 minutes before OxR exposure; 0-
100 min, 100-200 min, and 200-300 minutes during OxR exposure; and 100 minutes 
after OxR. Blocks were compared within each animal group. 
 
Analysis of serum and tissue parameters 
Liver (40-60 mg per sample) and WAT (80-120 mg per sample) were homogenized in 
liquid nitrogen and dissolved in 1 ml TRIS-HCl buffer (50 mM, pH 7.4) with an 
automated Pellet Mixer (VWR International B.V., Amsterdam, the Netherlands). The 
tissue homogenates were centrifuged at 12,000 g at 4⁰C for 5 minutes and 
supernatants were transferred to new precooled tubes and kept on ice. Total protein 
concentration was determined with the RC DC protein assay (Biorad), using Bovine 
Serum Albumin Fraction V dilutions (Roche Diagnostics GmbH, Mannheim, Germany) 
as standard. The tissue homogenates were subsequently stored at -80 ⁰C until 
determination of lactate and citrate synthase activity levels. 
Lactate levels in serum, WAT, and liver were determined using the Lactate Assay Kit II 
(Biovision, Mountain View, USA). Preparation of the samples was carried out according 
to the manufacturer’s protocol. Serum, liver, and WAT samples were 30x, 4x, and 2x 
diluted in assay buffer, respectively. Lactate concentrations were calculated based on 
the linear regression curve of a serial diluted lactate standard (provided by the kit). The 
lactate concentration in homogenized WAT and liver was corrected for the amount of 
total protein in each sample. 
Glucose levels in blood were determined with a Freestyle blood glucose system (Abbott 
Diabetes Care, Hoofddorp, the Netherlands) according to the manufacturer’s 
instructions. 
Tissue homogenates were diluted to 1 mg/ml protein for liver and 0.15 mg/ml for WAT 
to measure the citrate synthase activity level with the Citrate Synthase Assay Kit 
(Sigma Aldrich) according to the manufacturer’s instructions (although for WAT, 16 µL 
of sample was used; and for liver and WAT, absorbance was measured for 60 
minutes). Activity levels were calculated from the linear slope (15
th
 to 60
th
 minute) of the 
absorbance curves. 
Hepatic glycogen was detected with iodine. Liver samples were grinded in liquid 
nitrogen and homogenized in 1 µl of 7% perchloric acid per mg tissue. Samples were 
centrifuged for 15 minutes at 4⁰C and 1000 g and the resulting supernatant was left for 
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1.5 hours at -80⁰C after which 1 ml (per 300 µl HClO4) petroleum ether was added. 
Subsequent vortexing resulted into a separation into two layers of which the lower 
phase was used for further analysis: 10 µl sample was incubated for 10 minutes in a 
96-wells plate with 260 µl reagent containing 0.89M calcium chloride, 1.32mM iodine, 
and 11.4 mM potassium iodide. Absorption was measured at 460 nm. Glycogen 
concentrations were calculated based on the linear regression curve of a serial diluted 
glycogen standard. 
The ratio of mitochondrial DNA to nuclear DNA in WAT was determined by qRT-PCR 
as described previously (19) with the following modification: total DNA was extracted 
from homogenized eWAT by digestion with Proteinase K in a lysis buffer (50 mM Tris-
HCL, pH 7.5, 0.5% SDS and 12.5 mM EDTA, pH 8.0). After overnight incubation at 
56°C, Proteinase K was inactivated by a 10-minutes incubation at 70°C. Samples were 
then incubated with 40 µg/ml RNAse A (Sigma-Aldrich) for 1h at 37°C. After 
centrifugation, the aqueous phase was mixed and extracted with an equal amount of 
phenol-chloroform-isoamylacohol and twice with chloroform. DNA was precipitated by 
96% ethanol and sodium acetate (3M, pH 5.2). DNA was washed with 750 µl of cold 
70% ethanol, air-dried and re-suspended in 10 µl of RNAse DNAse free water. DNA 
concentration was adjusted to 65 ng/µl with RNAse DNAse free water. 
RNA isolations and cDNA synthesis from liver and WAT were performed as described 
(57). qRT-PCR was performed as previously described (56). Ribosomal protein S15 
(Rps15) and endoplasmic reticulum chaperone SIL1 homolog (Sil1) were used as 
reference genes. The primer sequences and PCR annealing temperatures for each 
gene are provided in table 1. Analyses of gene expression, and glucose, glycogen, 
protein and lactate levels were only performed in adult mice. 
 
Table 1 Primer sequences and PCR annealing temperatures used for qRT-PCR. 
Hk1, hexokinase 1; Hk2, hexokinase 2; Ldha, lactate dehydrogenase A; Pdk1, pyruvate dehydrogenase 
kinase 1; Pklr, pyruvate kinase; Rps15, ribosomal protein S15; Sil1, endoplasmic reticulum chaperone 
SIL1 homolog; Slc16a1, solute carrier family 16 (lactate importer). Genes denoted with an asterisk were 
used as reference genes for normalization. 
 
Statistical analyses 
Data are expressed as mean ± SEM; statistical analyses were performed using 
GraphPad Prism version 5.03 (Graphpad, San Diego, USA). P-values < 0.05 were 
considered statistically significant and denoted as follows: p<0.05 (*), p<0.01 (**), and 
p<0.001 (***). Pdk1 and Pklr expression levels in WAT were not normally distributed 
Gene  Forward primer 5’ – 3’    Reverse primer 5’ – 3’ PCR temp. 
Hk1 ATCTGTATGCCATGCGGCTCTCT TGAAATCCCCCTTTTCTGAGCCGT 60.0ºC 
Hk2 GACCAGAGCATCCTCCTCAAGTG CTTCATAGCCACAAGTCATCATAGTCC 58.0ºC 
Ldha CACGCTGCTTCTCCTCGCCAGT GGCACAAGCCATGCCAACAGCAC 62.0ºC 
Pdk1 TGAAGCAGTTCCTGGACTTCGGGTC TGTCGGGGAGGAGGCTGATTTCT  62.0ºC 
Pklr TGGCGGACACCTTCCTGGAACA TCTGCATGGTACTCATGGGAGCCA 60.0ºC 
Rps15* CGGAGATGGTGGGTAGCATGG ACGGGTTTGTAGGTGATGGAGAAC 62.0ºC 
Sil1* GGCCGCCTTTTCCAGCAATC CGGGGAGAGGCTGGTTTGTG 62.0ºC 
Slc16a1 GGCCACCACTTTTAGGCCGC AGTCGATAGTTGATGCCCATGCCA 62.0ºC 
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and were log-transformed. Measurements at single time points between 2 independent 
groups were analyzed by independent Student’s t-tests. To compare the different 
periods before, during and after OxR within each group, blocks of 100 minutes were 
analyzed by one-way repeated measures ANOVA and subsequent Bonferroni Posthoc 
analysis. Oxygen consumption during OxR was also analyzed with ANCOVA using 
SPSS Statistics for Windows, version 19 (IBM Corp., Armonk, USA), in which body 
weight was used as confounding factor. 
 
Results 
 
Old and adult mice differ in body weight, body composition, and mitochondrial 
density in WAT. 
To assess health status of adult and old mice, differences in BW, body composition, 
and mitochondrial density in liver and WAT were analyzed. Decreased WAT 
mitochondrial density is associated with impaired metabolic health (e.g. (10)). Mean 
BW of old mice was significantly greater during the complete course of the study 
compared with adult mice (fig. 1A, solid lines).  
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Figure 1 Body weight, feed intake, adiposity, and mitochondrial density in WAT and liver of ADULT 
and OLD mice. Adult mice (n=12, 10 weeks old at start of the experiment) and old mice (n=6, 72 weeks at 
start of the experiment) were individually housed and received ad libitum chow diet. In week 18, at the start 
of the dark phase, mice received a restricted amount (2 gr.) of feed, and tissues were harvested in the 
following light phase. Individual body weight (solid lines) and feed intake (dashed lines) (A) were followed 
during the complete period of study. Gonadal fat pad weight is analyzed as absolute values (B) and relatively 
to the animal’s body weight (C). Mitochondrial density in WAT was determined by the ratio of mitochondrial 
DNA over nuclear DNA (D) and by citrate synthase activity levels (E). Citrate synthase activity levels were 
also determined in liver (F). 
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The absolute (fig. 1B) and relative (fig. 1C) gonadal fat pad weights at the end of the 
study were significantly larger in old mice. Overall, feed intake was not significantly 
different between groups; only in weeks 5 and 8 old mice consumed more feed 
compared with adult mice (fig. 1A, dashed lines). Old mice had a significant lower ratio 
of mitochondrial DNA to nuclear DNA in WAT than adult mice, which indicates a 
decrease in mitochondrial density (fig. 1D). This is supported by a significantly lower 
citrate synthase (CS) activity level in WAT of old mice, which is also considered a 
marker for tissue mitochondrial density (fig. 1E). In contrast, hepatic CS activity level 
was not significantly different between both groups of mice (fig. 1F).  
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Figure 2 TREATMENT 1 - Mean RER and feed intake of ADULT and OLD mice under free-feeding 
conditions. RERs of adult (n=12; 10 weeks old in week 0) and old (n=6; 72 weeks old in week 0) mice 
were recorded for 24 hours after a 24h adaptation in the indirect calorimetry system in week 0 (A) and 
week 13 (D), during which they had ad libitum access to feed and water. For both measurements, mean 
RER was calculated over the complete 24 hours, as well as over the complete light and dark phase 
(B=week 0, and E=week 13). Feed intake was measured continuously during the calorimetric recordings 
and is presented as the % of feed intake in the dark phase (C=week 0, and F= week 13).  
 
Old mice showed an impaired diurnal pattern of RER and food intake in week 0, 
although these differences disappeared in week 13 
In week 0, adult and old mice displayed a different diurnal RER pattern (fig. 2A); the 
mean RER of old mice was significantly lower during the complete 24 hours and during 
the dark phase, compared with the mean RER of adult mice in both time frames (fig. 
2B). Consistently, old mice consumed a smaller percentage of their feed during the 
dark phase versus adult mice (fig. 2C). In week 13, however, the difference between 
both groups had disappeared (fig. 2D), and both old and adult mice consumed a similar 
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percentage of feed during the dark phase (fig. 2F) and did not differ in mean values of 
RER (fig. 2E). During calorimetric measurements, adult mice consumed 3.52±0.29 (wk. 
0) and 2.74±0.15 (wk. 13) gram over 24 hours, whereas old mice consumed 2.85±0.42 
(wk. 0) and 3.53±0.38 (wk. 13) gram over 24 hours. 
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Figure 3 TREATMENT 2 - Respiratory response to a glucose bolus in fasted ADULT and OLD 
mice. Adult (n=12, 10 weeks old in week 0) and old (n=6, 72 weeks old in week 0) mice were fasted in 
the indirect calorimetry system (restricted feed (2 gr.) at the start of the dark phase) and received a 
glucose pellet (2 gr/kg BW) after start of the following light phase. RER was recorded for 2 hours after 
voluntary consumption of the glucose pellet in week 0 (A) and week 13 (E). T=0 represents the time 
point when the glucose pellet was fully consumed (within 1-3 minutes after provision). RER after 
glucose consumption was analyzed as the incremental area under the curve (iAUC) (B=week 0, and F= 
week 13), as the highest individual RER peak after glucose consumption (C=week 0, and G= week 13), 
and as the time needed to reach the RER peak (D=week 0, and H= week 13).  
 
Physical activity follows the same pattern as the RER; in week 0, old mice lack a clear 
day- and night rhythm, whereas this was present in adult mice (suppl. fig. 3A). In week 
13, old and adult mice do not differ in their activity pattern (suppl. fig. 3B). It should be 
noted that the activity measurements in week 0 were partially hampered by the 
available nesting material in the animal cages. This resulted in an overall 
underestimation of activity. We solved this for the remaining measurements by slightly 
reducing the available nesting material to a level that it did not interfere with beam 
break measures. Old mice have a higher energy expenditure than adult mice in both 
measurements (suppl. fig 4A+B).  
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Figure 4 TREATMENT 3 - Respiratory response to oxygen restriction in fasted ADULT and OLD 
mice. Adult (n=12, 14 weeks old in week 4) and old (n=6, 76 weeks old in week 4) mice were fasted in 
the indirect calorimetry system (restricted feed (2 gr.) at the start of the dark phase) and were exposed 
to oxygen restriction after the start of the following light phase. Oxygen consumption was recorded for 2 
hours before, 6 hours during, and 2 hours after exposure to oxygen restriction in week 4 (A) and week 
15 (C). Oxygen consumption was analyzed within each animal group as the total area under the curve 
(AUC) in blocks of 100 minutes: 100 minutes before exposure; 0 to 100 min, 100 to 200 min, and 200 to 
300 minutes during exposure; and 100 minutes after exposure (B=week 4, and D= week 15). Bars with 
different letters are statistically different. 
 
Adult and old mice do not differ significantly in the response to glucose 
consumption 
For treatment 2 and 3, mice were fasted by providing them with a restricted amount of 
food (2gr) at the start of the dark phase. Mice generally eat the restricted amount of 
food during the first part of the dark phase. With this method we ascertain that all mice 
are in fasting state before the start of the light phase, and we can control timing and 
quantity of feed intake before mice are challenged with glucose or OxR. Both adult and 
old mice, indeed, showed a mean RER between 0.69 and 0.72 at least one hour before 
glucose consumption, which indicates fasting. After glucose consumption, mean RER 
increased to approximately 0.83 and decreased after approximately 45 minutes (fig. 3A 
and 3E). The response to glucose administration was analyzed by the incremental area 
under the curve (iAUC) of individual RER curves over 120 minutes after glucose 
consumption. The mean iAUC was not significantly different (fig. 3B and 3F) indicating 
a similar glucose tolerance. Furthermore, adult and old mice showed similar RER peak 
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values and a similar time needed to reach the RER peak in both week 0 (fig. 3C and 
3D) and week 13 (fig. 3G and 3H).  
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In week 0, old mice are, on average, more active before and after glucose consumption 
than aged mice; whereas both groups do not differ in physical activity in week 13 
(suppl. fig. 3C+D). In week 0, adult mice have higher EE levels before and after glucose 
consumption compared with old mice, whereas the opposite pattern was observed in 
week 13 (suppl. fig 4E+F). 
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Exposure to OxR only decreases oxygen consumption in adult mice  
Because old adult mice differ in body weight we decided to only analyze oxygen 
consumption before, during and after OxR within each animal group. OxR significantly 
decreased oxygen consumption in both adult and old mice during the first 100 minutes 
of exposure (fig. 4). In adult mice, the drop in oxygen consumption continued during the 
complete period of OxR, even after returning back to normoxia. In old mice, on the 
Figure 6 Parameters of lactate and glucose 
metabolism in liver tissue of adult mice that 
were either exposed to OxR or NORMAL air. 
Mice (28 weeks old) were fasted (restricted 
feed (2 gr.) at the start of the dark phase) and 
placed in normal (n=6) or oxygen restriction 
(n=6) conditions for 6 hours prior to tissue 
harvest. Liver tissue was homogenized to 
determine lactate (A) and glycogen (B) levels. 
Total mRNA was isolated to measure the 
expression of genes involved in glucose and 
lactate metabolism (C), which is expressed as 
the fold change of mice that were exposed to 
oxygen restriction over mice that remained 
under normal conditions. Hepatic Pdk1 
expression was below detection level.  
n.d., not determined; Pdk1, pyruvate 
dehydrogenase kinase 1; Hk1, hexokinase 1; 
Hk2, hexokinase 2; Pklr, pyruvate kinase; Ldha, 
lactate dehydrogenase A; Slc16a1, solute 
carrier family 16 (lactate importer). 
 
Figure 5 Serum lactate and blood glucose levels of 
adult mice that were either exposed to OxR or 
NORMAL air.  Adult mice (28 weeks old) were fasted 
(restricted feed (2 gr.) at the start of the dark phase) 
and placed in normal (n=6) or oxygen restriction (n=6) 
conditions for 6 hours prior to blood collection. Blood 
glucose levels were determined directly after the 
exposure to oxygen restriction (B). Whole blood was 
then used to separate serum, in which lactate levels 
were determined (A).  
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contrary, the decrease in oxygen consumption disappeared after the first 100 minutes 
of OxR (fig. 4). Similar patterns were observed in week 15, supporting the 
reproducibility of the treatment. RER values remained stable and within the 
physiological range during the exposure (suppl. fig. 2A+B). Although OxR decreases 
physical activity in both groups of mice, old and adult mice do not differ in physical 
activity (suppl. fig. 3E+F). The levels of EE follow the same pattern as the level of 
oxygen consumption during and after exposure to OxR (suppl. fig 4E+F).  
To analyze differences in oxygen consumption during OxR between old and adult mice 
we used ANCOVA to correct for the difference in body weight (2, 52). ANCOVA 
showed that, when corrected for body weight, old and adult mice do not differ in 
average oxygen consumption during OxR (wk4: p=0.53 and wk15: p=0.84). Body 
weight on itself also did not account for the difference between old an adult mice (wk4: 
p=0.08 and wk15: p=0.20). VO2 during OxR rather depends on the combination of both 
age and body weight. Furthermore, we analyzed body weight and oxygen consumption 
during OxR within each group with linear regression. We did not find a correlation 
between body weight and oxygen consumption during OxR in neither of the groups 
(Week 4: p=0.22, R
2
=0.14 for adult mice and p=0.11, R
2
=0.52 for old mice; Week 15: 
p=0.99, R
2
<0.00 for adult mice and p=0.17, R
2
=0.42 for old mice). The OxR challenge 
was also applied to female mice and, as in males, we observed sustained decreased 
oxygen consumption in adult, but not in old mice (data not shown).  
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Figure 7 Parameters of lactate and glucose metabolism in WAT of adult mice that were either 
exposed to OxR or NORMAL air. Mice (28 weeks old) were fasted (restricted feed (2 gr.) during the 
dark phase) and placed in normal (n=6) or oxygen restriction (n=6) conditions for 6 hours prior to tissue 
harvest. WAT was homogenized to determine lactate levels (A). Total mRNA was isolated to measure 
the expression of genes involved in glucose and lactate metabolism (B), which is expressed as the fold 
change of mice that were exposed to oxygen restriction over mice that remained under normal 
conditions. Pdk1, pyruvate dehydrogenase kinase 1; Hk1, hexokinase 1; Hk2, hexokinase 2; Pklr, 
pyruvate kinase; Ldha, lactate dehydrogenase A 
 
OxR altered glucose and lactate metabolism 
The physiological mechanisms involved in the adaptation in oxygen consumption were 
further analyzed in the adult mice. Blood glucose and serum and WAT lactate levels 
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were significantly increased by OxR (fig. 5A+B and fig 7A). Hepatic lactate 
concentrations, however, were not significantly altered by OxR (fig. 6A), suggesting an 
increase in the lactate clearance rate in liver by gluconeogenesis. To investigate this in 
more detail, hepatic glycogen levels and expression levels of genes involved in glucose 
and lactate metabolism were studied in WAT and liver tissue of adult mice that were 
either exposed to OxR or normal air. Hepatic glycogen levels were unaltered by the 
exposure to OxR (fig. 6B). OxR significantly decreased the expression of hexokinase 1 
in WAT (fig. 7B) and significantly increased the expression of the lactate importer 
Slc16a1 (Mct1) in liver tissue (fig. 6C), which suggests an increase in gluconeogenesis 
in liver tissue. The other genes that were measured in liver and WAT were not 
significantly different between groups (fig. 6C and 7B). Hepatic Pdk1 mRNA was below 
detection level in both groups of mice.  
 
Discussion 
 
Three different InCa-based treatments to measure age-dependent metabolic health 
were compared and examined for stability over time. The OxR challenge appeared to 
be most stable and sensitive to identify differences between adult and old mice. The 
observed changes in oxygen consumption were supported by gene expression and 
biochemical analysis in adult mice. 
 
Old mice show a decrease in metabolic health 
Aging affects metabolic health and correlates with an increase in bodyweight and risk 
factors for cardiovascular diseases and type 2 diabetes (15). Old mice indeed had a 
higher body weight and adiposity compared with adult mice and showed decreased 
mitochondrial density in WAT. In support, the expression of nuclear-encoded 
mitochondrial genes involved in oxidative phosphorylation, lipid metabolism and 
biosynthesis was previously shown to decrease with age in mice WAT (30). 
Furthermore, obese as well as insulin resistant rodents and humans show decreased 
WAT mitochondrial density (7, 10, 12, 19, 26, 29, 41, 49, 51), which suggests that the 
old mice display decreased adipose tissue health and associated decreased metabolic 
health. Next to WAT, the liver plays an important role in the maintenance of metabolic 
homeostasis. The mitochondrial density in liver tissue was, however, not affected by 
the aging process. The liver might be less susceptible to changes in mitochondrial 
density, as was previously seen in a dietary intervention with resveratrol (33).  
 
The diurnal pattern of RER can indicate metabolic health but depends on feeding 
behavior  
The mammalian circadian rhythm is affected by both aging (14) and obesity (37). 
Therefore, we expected to find differences in the pattern of RER between old and adult 
mice that would remain over time. Old versus adult mice indeed showed a disturbed 
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pattern of RER in week 0; they lacked a clear day- and night-rhythm and their mean 
RER was lower during the dark phase, compared with adult mice. These differences in 
RER are probably due to a difference in feeding pattern between both groups. Old mice 
consumed significantly less feed during the dark phase. The observed difference in the 
diurnal pattern of RER between adult and old mice is consistent with the disturbed 
pattern of EE and physical activity levels of old mice in week 0 and is expected to be a 
reliable observation. The measurements in week 0 showed that the old mice have a 
disturbed diurnal pattern, which is a common characteristic of aging (59).  
In week 13, surprisingly, the pattern of RER appeared to be normalized to the values of 
adult mice. The change in the pattern of RER between weeks 0 and 13 is reflected by a 
change in feeding behavior of the old mice. Old mice had, in fact, increased feed intake 
in the dark phase to a similar level as adult mice, which suggests that the old mice have 
adapted their behavior to that of adult mice. Behavioral adaptation of old to adult mice 
might have been facilitated by sensory contact between mice. Although mice were 
individually housed, the transparent cages with a wire bar lid enable mice to 
communicate by smell, hearing and sight (54). Cages of both age groups were placed 
mixed and in random order on the same shelf. Sensory contact with an unfamiliar male 
mouse can cause dramatic changes in physiology and behavior, such as changes in 
heart rate, body temperature, and physical activity (45), which might explain the 
behavioral changes in old mice during the course of the study. The change in behavior 
that we observed in the old mice during the course of the study might be comparable to 
the behavioral changes that are seen in intergenerational programs in humans, in 
which generations are brought together in, for example, day care activities to support 
both young and old. Elderly people, who had the opportunity to engage in joined 
activities with children on a daily base, reported to feel “energized and vitalized by 
interactions with children” (58).  
Our results show that care should be taken to draw conclusions on the health status of 
mice solely based on InCa measurements under free-feeding conditions. In particular 
factors that influence feeding behavior, such as the influence of sensory contact 
between mice. 
 
Old and adult mice show similar responses to glucose administration 
We expected that old mice would be less glucose tolerant, causing a delayed and 
blunted response in RER, as was shown recently for old mice using a standard glucose 
tolerance test (47). Moreover, it was shown that re-feeding in the InCa system leads to 
different responses in RER between mice with a different health status (28), indicating 
the value of the InCa system to distinguish between dietary groups based on the 
response to nutrient intake. We, however, observed no differences between old and 
adult mice in either of the two test periods, which indicates similar glucose tolerance.  
The absence of differences in the response to glucose consumption may, in the first 
place, be due to the C57BL/6JOlaHsd strain that we used. This strain is known to have 
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an improved glucose tolerance compared with other BL/6J strains (24). Alternatively, a 
different method of glucose administration or a higher dose of glucose might have 
revealed differences in the RER response. Here, mice received pelleted glucose to 
avoid disturbances in respiratory exchange caused by opening of the calorimetric cage, 
or by stress of handling, injection, or oral gavage. Flachs, et al. (22), however, showed 
that a large dose of dissolved glucose does result in differences in RER between two 
dietary groups. Although, the increase in RER is comparable in both studies, we cannot 
exclude that a standard caloric load, which was based on a regular oral glucose 
tolerance test, is insufficient to pick up differences in glucose uptake and oxidation with 
the InCa system. Also we cannot exclude that the absence of a difference in RER 
response in our study is due to the use of liquid versus pelleted glucose, since the latter 
speeds up gastric emptying, which could increase the response in RER. Finally, it is 
possible that glucose is partly converted to glycogen, which is not reflected in changes 
in RER. Old and adult mice might differ in the degree of the conversion. It seems, 
however, unlikely that this difference will complete mask a difference in (RER) 
response. For future research it will be interesting to directly link InCa measurements 
for glucose tolerance to conventional oral glucose tolerance tests.  
 
Adult versus old mice consume less oxygen during and after exposure to OxR  
Oxygen restriction (14.5% O2) in the InCa system is a novel approach to investigate 
parameters of metabolic health in mice and is based on the assumption that flexibility of 
cellular oxygen utilization depends on metabolic health status (6). Adequate oxygen 
delivery is essential for cell survival and normal metabolic function. When oxygen is 
restricted, metabolic adaptations are needed to assure sufficient ATP production and 
prevent development of oxidative stress. 
In vitro studies have shown that extreme OxR increases glycolytic ATP (and lactate) 
production and reduces mitochondrial fatty acid oxidation (48), causing a decrease in 
cellular oxygen consumption (44). Next to an increase in glycolysis, hypoxia stimulates 
gluconeogenesis in hepatocytes (9) to clear lactate from the blood. The majority of in 
vivo studies confirm the results of in vitro studies. Long term exposure to OxR causes 
an increase in the expression of genes involved in angiogenesis and glycolysis, and a 
decrease in the expression of hepatic genes involved in lipid metabolism in mice (5, 
17), and an increase in glucose transport (50) and hexokinase activity (13) in rat heart. 
On whole body level, OxR decreases oxygen consumption and energy expenditure in 
both rodents and humans (40, 42, 43), which reflects the decrease in mitochondrial 
activity that is seen in in vitro studies.  
Our results show that OxR indeed decreased oxygen consumption during, but also 
after the exposure in adult mice, whereas old mice only sustained this lower level 
during the first 100 minutes of exposure. This was also seen when we repeated the 
measurements in week 15, showing treatment reproducibility.  
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The reduction in oxygen consumption can partly be explained by the reduction in 
physical activity that was seen during OxR. The unit ‘beam breaks/ minute’ that was 
used to describe physical activity represents the sum of total beam breaks in x-axis and 
y-axis in the horizontal plane. Infrared beam interruptions may, however, miss out on 
the more subtle types of activity (21), making them less suitable to calculate activity-
induced EE (AEE) in relation to total energy expenditure (TEE). Since we cannot 
accurately calculate AEE, we used an alternative approach that estimates AEE by 
comparing TEE with (resting metabolic rate) RMR (AEE = TEE - RMR). If we use our 
available data from treatment 1, we see that AEE contributes to 17.7 % of TEE. Based 
on published data and modeling, it was calculated that AEE contributes to roughly 
13.5% of TEE (53). The reduction in EE during OxR is 31.8% compared to TEE. Based 
on both calculations of AEE it seems unlikely that the reduction in EE and VO2 during 
OxR only depends on a reduction in AEE. We rather think that old and adult mice differ 
in the response to OxR because of a difference in metabolic adaptation.  
To further analyze metabolic adaptation to OxR in adult mice we analyzed circulating 
lactate levels, which were found to be significantly increased by the exposure to OxR. 
The increase in serum lactate suggests an overall increase in anaerobic glycolysis 
leading to lactate production. An increase in ATP production by glycolysis might partly 
explain the decrease in oxygen consumption during OxR. The liver showed only a slight 
(non-significant) increase in glycolytic enzymes, which suggests that other tissues 
might be involved in production of lactate. OxR, indeed, increased lactate levels in 
WAT, supporting the metabolic changes seen in hypoxia exposed cells (36) or 
reprogrammed cancer cells (31). However, no major changes in gene expression were 
found in this tissue. Hexokinase 1 was down-regulated, whereas the expression of 
hexokinase 2, pyruvate kinase and lactate dehydrogenase were unaltered by OxR. 
Apparently, the mild 6 hr. OxR did not result in major differences in gene expression 
levels in vivo. The increase in WAT lactate levels might be due to changes in glycolytic 
enzymes at protein level. Alternatively, the degree of fasting that was induced 
preceding and during OxR might in part overrule or delay metabolic switching. 
Hepatic lactate levels were not altered by OxR, which suggests that the liver is involved 
in lactate clearance - that is, uptake of lactate from the bloodstream and subsequent 
conversion to glucose, which can be released to provide glucose to other tissues. 
Indeed, we observed upregulation of the hepatic lactate importer (Slc16a1) supporting 
increased hypoxia-mediated hepatic gluconeogenesis (9) and an increase in blood 
glucose levels. Furthermore, we did not find a decrease in glycogen levels between 
both groups, which indicates that the increase in blood glucose levels is not caused by 
hepatic glycogenolysis but rather suggests increased hepatic gluconeogenesis from 
lactate. The resulting glucose is expected to be partly secreted into the blood stream 
and partly stored as glycogen, causing the increase in blood glucose levels and the 
slight, although non-significant, increase in hepatic glycogen levels in mice that were 
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exposed to OxR. Blood glucose levels were under both conditions slightly higher than 
expected; this is most likely due to the use of isoflurane prior to decapitation (11, 16). 
The continuation of decreased oxygen consumption of adult mice after their return to 
normoxia supports functional down-regulation of metabolism. The decrease in oxygen 
consumption after the exposure to OxR - when the oxygen level is restored to normal 
values - is accompanied with a slight increase in RER in this time period (suppl. fig. 2). 
RER possibly increases because the overload of blood glucose (that was induced by 
OxR) is cleared from the blood and stored, as the mice are still in a fasted state. For 
future research it might be interesting to focus on the molecular background of the 
recovery to normal metabolism after exposure to OxR. It is tempting to speculate that 
autophagy has a role in the functional metabolic adaptation to OxR and, thereby, 
facilitates the lowering of oxygen demand. Autophagy can provide cells with 
‘emergency’ substrates and is induced by hypoxia and impaired in aging (8). 
 
A challenge concept is more valuable to test metabolic health with InCa 
In our study, implementation of a challenge (glucose and OxR) produced more reliable 
and stable results between measurements, compared with measurements under free-
feeding conditions (RER diurnal pattern). Similar drawbacks of InCa under free-feeding 
conditions were previously described by Even and Nadkarni (21), who concluded that 
feed intake should be totally controlled and activity precisely measured.  
The exposure to OxR appeared to be more sensitive to identify differences between old 
and adult mice, compared with the administration of glucose. Our results were 
confirmed in female mice and could be further strengthened by validation in other 
models. OxR combined with InCa measurements is a promising novel concept to non-
invasively assess physiological health status. 
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Supplemental figure 1 Measurements under normoxic and hypoxic conditions in empty cages of 
the indirect calorimetry system. In our indirect calorimetry system the air composition in the animal 
cages (in grey, each cage individually plotted) is compared to the air composition of an empty reference 
cage (in black). The delta O2 and CO2 are used to calculate O2 consumption and CO2 production by the 
software. In this example all ANIMAL CAGES were empty in order to check the stability of air 
composition in individual cages and the comparability of the animal cages with the REFERENCE 
CAGE. This clearly shows stability during hypoxic conditions, similar to normoxic conditions. 
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Supplemental figure 2 Average RER before, during and after the exposure to OxR (treatment 3) 
of ADULT and OLD mice in WEEK 4 and WEEK 15. Adult (n=12, 14 weeks old in week 4) and old 
(n=6, 76 weeks old in week 4) mice were fasted in the indirect calorimetry system by providing them 
with a restricted amount (2 gr.) of feed at the start of the dark phase and were exposed to oxygen 
restriction after the start of the following light phase. RER was recorded for 2 hours before, 6 hours 
during, and 2 hours after exposure to oxygen restriction in week 4 (A) and week 15 (B). 
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Supplemental figure 3 Average activity of ADULT and OLD mice during TREATMENT 1, 2 and 3. 
For treatment 1 and 2, activity of adult (n=8; 10 weeks old in week 0) and old (n=6; 72 weeks old in 
week 0) mice was recorded in the indirect calorimetry system for, respectively, 24 and 3 hours after the 
24h adaptation in week 0 (A+C) and week 13 (B+D). For treatment 1, mice had ad libitum access to 
feed and water. For treatment 2, mice were fasted (restricted feed (2 gr.) at the start of the dark phase) 
and received a glucose pellet (2 gr/kg BW) after start of the following light phase. T=0 represents the 
time point when the glucose pellet was fully consumed (within 1-3 minutes after provision). For 
Treatment 3, adult (n=8, 14 weeks old in week 4) and old (n=6, 76 weeks old in week 4) mice were 
fasted in the indirect calorimetry system (restricted feed (2 gr.) at the start of the dark phase) and were 
exposed to oxygen restriction after the start of the following light phase. Activity was recorded for 2 
hours before, 6 hours during, and 2 hours after exposure to oxygen restriction in week 4 (E) and week 
15 (F). 
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Supplemental figure 4 Average energy expenditure of ADULT and OLD mice during TREATMENT 
1, 2 and 3. For Treatment 1 and 2, energy expenditure of adult (n=12; 10 weeks old in week 0) and old 
(n=6; 72 weeks old in week 0) mice was recorded for, respectively, 24 and 3 hours after a 24h 
adaptation in the indirect calorimetry system in week 0 (A+C) and week 13 (B+D). For Treatment 1, 
mice had ad libitum access to feed and water. For Treatment 2, mice were fasted (restricted feed (2 gr.) 
at the start of the dark phase) and received a glucose pellet (2 gr/kg BW) after start of the following light 
phase. T=0 represents the time point when the glucose pellet was fully consumed (within 1-3 minutes 
after provision). For Treatment 3, adult (n=12, 14 weeks old in week 4) and old (n=6, 76 weeks old in 
week 4) mice were fasted in the indirect calorimetry system (restricted feed (2 gr.) at the start of the 
dark phase) and were exposed to oxygen restriction after the start of the following light phase. Energy 
expenditure was recorded for 2 hours before, 6 hours during, and 2 hours after exposure to oxygen 
restriction in week 4 (E) and week 15 (F). 
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Abstract  
 
Challenge tests stress homeostasis and may reveal deviations in health that remain 
masked under unchallenged conditions. Ideally, challenge tests are non-invasive and 
applicable in an early phase of an animal experiment. Oxygen restriction (OxR; based 
on ambient, mild normobaric hypoxia) is a non-invasive challenge test that measures 
the flexibility to adapt metabolism. Metabolic inflexibility is one of the hallmarks of the 
metabolic syndrome.  
To test whether OxR can be used to reveal early diet-induced health effects, we 
exposed mice to a low-fat (LF) or high-fat (HF) diet for only five days. The response to 
OxR was assessed by calorimetric measurements, followed by analysis of gene 
expression in liver and epididymal white adipose tissue (eWAT), and serum markers – 
for e.g. protein glycation and oxidation. 
Although HF feeding increased body weight, HF and LF mice did not differ in indirect 
calorimetric values under normoxic conditions and in a fasting state. Exposure to OxR, 
however, increased oxygen consumption and lipid oxidation in HF mice vs. LF mice. 
Furthermore, OxR induced gluconeogenesis and an antioxidant response in liver of HF 
mice, whereas it induced de novo lipogenesis and an antioxidant response in eWAT of 
LF mice; indicating that HF and LF mice differed in their adaptation to OxR. OxR also 
increased serum markers of protein glycation and oxidation in HF mice, whereas these 
changes were absent in LF mice. 
Cumulatively, OxR is a promising new method to test food products on potential 
beneficial effects for human health.   
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Introduction  
 
Challenge tests, such as the oral glucose tolerance test, are an important tool to reveal 
early diet-induced health effects (55). Early dietary effects are typically masked by 
homeostasis under normal conditions. By challenging homeostasis, however, subtle 
changes in health status can be revealed. The response to fasting and refeeding, for 
example, shows subtle changes in carbohydrate use between mice fed different high-
fat diets or between mice that differ in adiponectin expression, whereas normal indirect 
calorimetric measurements do not differentiate between these groups (2, 22). Metabolic 
challenge tests are preferably non-invasive and determine the flexibility to switch 
between different metabolic substrates in an early phase of a nutritional intervention. 
Early detection of changes in metabolic flexibility can shorten animal studies and 
reduces age-related variation between animals. More importantly, early diet-induced 
changes can be predictive for diet-induced changes at the long-term. Consumption of a 
high-fat diet, for example, induces changes in gene expression in mice white adipose 
tissue (WAT) after 5 days that are sustained until 12 weeks of feeding (57).  
Oxygen restriction (OxR) was recently described as a new challenge test to reveal 
differences in metabolic health between adult and old mice (14). The challenge with 
OxR that was used in this study was based on mild ambient, normobaric hypoxia and 
was performed in the indirect calorimetry (InCa) system. OxR affects whole body 
metabolism (33, 40), and it is hypothesised that only animals that exhibit metabolic 
flexibility can adapt in an adequate way. Metabolic flexibility is, for this purpose, defined 
as the capacity to adequately respond to the environment, being either altered 
nutritional input, energetic demand, or environmental changes like oxygen limitation. 
The flexibility to adapt to OxR can be assessed at whole body level from respiratory 
output and at tissue and circulation level from the expression of different molecular 
markers.  
Metabolic adaptations to OxR are extensively described. It is widely accepted that OxR 
induces a switch from oxidative to (anaerobic) glycolytic ATP production (32, 48) to 
reduce oxygen consumption and prevent the formation of reactive oxygen species. 
Local hypoxia in adipose tissue that occurs in obesity can, indeed, lead to chronic and 
low-grade inflammation when oxygen supply does not match oxygen demand (58, 59). 
Furthermore, OxR decreases insulin sensitivity (44) and increases lipolysis (60) in 
adipocytes. Previously, we showed that OxR reduces oxygen consumption and 
increases blood glucose and lactate levels in adult mice. Serum lactate levels of adult 
mice exposed to OxR were almost 20% higher than serum lactate levels of adult mice 
that remained under normoxic conditions, which indicates an increase in glucose 
utilization through the glycolytic pathway. The changes in oxygen consumption were, 
however, absent in old mice suggesting a reduction in metabolic flexibility (14). The use 
of OxR as a challenge test to investigate the effect of food components on (mouse) 
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health status is promising because of its non-invasive nature and the similarities with 
obesity-related-disorders, such as sleep apnoea (12).  
InCa measurements can be used to investigate energy expenditure (EE) and 
respiratory energy ratio (RER) under normal, free-feeding conditions, but also to 
investigate the response to a nutritional or environmental challenge, such as fasting 
and re-feeding (22) or changes in housing temperature (11). RER and EE in mice 
during free-feeding conditions directly correlate to the composition of the diet consumed 
(20). Compared to mice fed a standard diet, mice that consume a high-fat diet generally 
have a low diurnal RER and a high EE because of the increase in fat oxidation (e.g. 
34). The consumption of a high-fat diet can, furthermore, increase diet induced 
thermogenesis by brown adipose tissue (3). Basal metabolic rate – that is, when mice 
are fasted and housed under thermoneutral conditions – is, however, not influenced by 
consumption of a high-fat diet (17). Here, we tested whether OxR in the InCa system 
can be used in an early phase of an animal study to identify differences between 
dietary groups, which are not observed under a normoxic conditions.  
For this study, we therefore measured the response to OxR of mice that were either fed 
a semi-purified, standardized LF or HF diet for five days. The HF diet that was used in 
this study is known to increase weight gain, insulin resistance and circulating leptin 
levels, and decrease circulating adiponectin levels in C57BL/6J mice after several 
weeks of ad libitum feeding (20, 57). We expected that the mice on the LF and the HF 
diets would not differ in indirect calorimetric values under normoxic conditions. OxR is, 
on the other hand, expected to reveal differences in indirect calorimetric values of HF 
and LF mice. The adaptation to OxR was further investigated by analysis of gene 
expression patterns in liver and WAT and by assessment of serum markers of protein 
glycation and oxidation.  
 
Materials and methods 
 
Animals and experimental manipulations 
Forty-eight male C57BL/6JOlaHsd mice were used for this study (Harlan Laboratories, 
Horst, The Netherlands). The experimental protocol was approved by the Animal 
Welfare Committee of Wageningen University, Wageningen, The Netherlands 
(DEC2012035). Mice arrived at 10 weeks of age and were individually housed and 
maintained under environmentally controlled conditions (20 - 22.5 ºC, 12 h/12 h light–
dark cycle, 40 - 55% humidity) and had ad libitum access to feed and water. The study 
consisted of a three week adaptation phase and a 5 day experimental phase – a 
schematic overview of the study can be found in supplemental figure 1. During the 
adaptation phase, mice received the purified low-fat BIOCLAIMS standard diet, which 
contains 10% energy from fat (for a detailed description of the diet, see (21)). For the 
experimental phase mice were stratified by body weight and allocated to the HF or LF 
group. The experimental phase lasted for five days, during which mice were housed in 
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the indirect calorimetry system. The HF diet had the same ingredients as the LF diet, 
but carbohydrate - wheat starch - was partly replaced by fat (70% sunflower oil, 18% 
coconut oil, and 12% flaxseed oil) to 40% energy from fat (21). Feed intake and body 
weights were monitored on a weekly basis during the adaptation phase, and after the 5 
days of either LF or HF feeding. In the InCa system, feed intake was recorded real-time 
during the 5 experimental days. At the end of the experimental phase, 12 mice of each 
group were exposed to OxR (LFo and HFo) in the indirect calorimetry system (see 
below), while the remaining 12 mice of each group remained under normoxic conditions 
(LFn and HFn). LFo and HFo mice were killed directly after the exposure to OxR; LFn 
and HFn mice were killed at the same time point. 
 
Indirect calorimetry (normal and oxygen restriction conditions) 
Indirect calorimetry was measured with a PhenoMaster System (TSE Systems, Bad 
Homburg, Germany) equipped for simultaneous measurements of oxygen consumption 
and carbon dioxide production of 12 individual mice as published (20). The system is 
supplemented with a Workhorse hypoxia pump (b-Cat B.V., Tiel, the Netherlands), 
which filters oxygen out of normal room air and stably decreases the oxygen 
concentration from 20.9% to 12%, as published (14). For all calorimetric 
measurements, mice remained in their home cage, while the cage lids were replaced 
by air tight PhenoMaster cage lids, which guarantee a stable air flow through the animal 
cage and enables air sampling for calorimetric measurements every 13 minutes during 
the measurements under normal conditions and every 11 minutes during the 
measurements under OxR. Rates of oxygen consumption (VO2, ml/h) and carbon 
dioxide production (VCO2, ml/h) were calculated and used by the TSE software to 
calculate the respiratory exchange ratio (RER=VCO2/VO2). The percentage of energy 
derived from glucose and fat oxidation was calculated from average RER values during 
OxR of individual LF and HF fed mice (39).  
 
Measurements under normoxic conditions 
Mice were adapted in the Phenomaster system for at least 24h before the start of the 
measurements. After those 24h, both groups of mice (LF and HF) received a fresh 
batch of feed after which the actual measurements started. O2 consumption, CO2 
production and feed intake were measured for the following 5 days. The average VO2, 
RER and physical activity were calculated for each mouse individually over the 2
nd
, 3
rd
, 
4
th
 and 5
th
 day of HF or LF feeding. Data obtained during day 1 were discarded since 
the introduction of a fresh batch of feed generally causes a slight over-consumption in 
mice. 
 
Measurements under oxygen restriction 
After the five days of HF or LF feeding, mice remained in the indirect calorimetry 
system for the measurements under OxR or normal conditions – a detailed scheme of 
78   l   CHAPTER 4 
 
the exposure can be found in supplemental figure 1. At the start of the dark phase, all 
feed was removed and mice received a restricted amount of feed - 1.8 gram for the LF 
diet and 1.5 gram for the HF diet - to ensure identical caloric intake. The restricted 
amount of feed is generally consumed within 6 hours after start of the dark phase, 
which means that all mice are in a fasted state (RER<0.8) at least one hour before the 
start of the light phase. The two hours preceding exposure to OxR were used to 
analyse VO2, RER, and physical activity during fasting and normoxic conditions. One 
hour after the start of the light phase (when mice were still in a fasted state) the oxygen 
level was decreased from 20.9% to 12% within 30 minutes as described previously 
(14). After 30 minutes, oxygen level is stabilized and measurements were recorded for 
six hours under OxR. 
 
Tissue and blood collection (at time of section) 
Mice were decapitated directly after the exposure to the OxR (LFo and HFo) or normal 
air (LFn and HFn). Blood was collected in Mini collect serum tubes (Greiner Bio-one, 
Longwood, USA), and centrifuged for 10 minutes at 3000 g and 4°C to obtain serum. 
Serum samples were aliquoted and stored at -80°C. Glucose concentration was 
measured in whole blood with a Freestyle blood glucose system (Abbott Diabetes Care, 
Hoofddorp, the Netherlands) according to the manufacturer’s instructions. After blood 
collection, gonadal WAT and liver tissue were dissected and snap frozen in liquid 
nitrogen and stored at –80 °C. The right epididymal fat depot was weighted directly 
after dissection and was used as an indicator of whole body adiposity.  
 
Serum glycation and oxidation markers 
Serum glycation and oxidation markers were analysed by stable isotopic dilution 
analysis liquid chromatography with tandem mass spectrometric detection (LC-
MS/MS), as described (51), recently revised for additional analytes (43). Analytes 
determined were: early glycation adduct Nε-fructosyl-lysine (FL); advanced glycation 
endproducts (AGEs) - Nε-(carboxymethyl)lysine (CML), Nε-(1-carboxyethyl)lysine 
(CEL) and methylglyoxal-derived hydroimidazolone (MG-H1); oxidation markers - N-
formylkynurenine (NFK), dityrosine (DT) and protein carbonyl glutamic γ-semialdehyde 
(GSA); protein nitration marker 3-nitrotyrosine (3-NT); and related amino acids, lys, arg, 
tyr and trp. Glycation, oxidation and nitration adducts of serum protein were determined 
after exhaustive enzymatic hydrolysis by incubation with pepsin, pronase E and finally 
aminopeptidase with prolidase under argon. Antioxidant and pH conditions in pre-
analytical processing prevented artifactual formation or loss of analytes. Serum (25 µl) 
was diluted to 500 µl with water and washed by 4 cycles of 10-fold concentration and 
dilution in water over a 10 kDa cut-off microspin filter at 4 ⁰C. The final washed protein 
concentrate (50 µl) was delipidated by extraction with water-saturated ether and 
assayed for protein concentration by the Bradford method. An aliquot of protein (100 
µg) was digested for analysis. Analytes were detected by electrospray positive 
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ionisation multiple reaction monitoring LC-MS/MS and quantified by stable isotopic 
dilution analysis. Serum protein content of glycation, oxidation and nitration adducts is 
reported as mmol/mol related to amino acid.  
 
RNA isolation, cDNA synthesis and Quantitative real-time reverse transcription-
polymerase chain reaction (qRT-PCR) 
RNA isolation from WAT was performed as described previously (56). Briefly, WAT was 
homogenized in liquid nitrogen using a cooled mortar and pestle. Total RNA was 
isolated using TRIzol reagent, chloroform, and isoamyl alcohol (PCI) (Invitrogen, Breda, 
The Netherlands) followed by purification with RNeasy columns (Qiagen, Venlo, The 
Netherlands) using the instructions of the manufacturer. RNA concentration and purity 
were measured using the Nanodrop (IsoGen Life Science, Maarsen, The Netherlands). 
RNA quality was additionally checked on the Experion automated electrophoresis 
system (Bio-Rad, Veenendaal, The Netherlands) using Experion StdSense chips (Bio-
Rad). 
RNA isolation from liver was performed with RNeasy columns (Qiagen) according to 
the manufacturer’s protocol. 
qRT-PCR was performed as previously described (56). Data were normalized against 
the geometrical mean of the reference genes ribosomal protein S15 (Rps15), and beta-
2 microglobulin (B2m), which were confirmed for their stable gene expression levels 
(geNorm, Ghent University Hospital, Ghent, Belgium). Primers were designed using 
NCBI Primer-Blast (NCBI Website). The primer sequences and PCR annealing 
temperatures for each gene are summarized in supplemental table 1.  
 
Statistical analyses 
Data are expressed as mean ± SEM. Statistical analyses were performed using 
GraphPad Prism version 5.04 (Graphpad, San Diego, USA) and SPSS Statistics for 
Windows, version 19 (IBM Corp., Armonk, USA). Data were checked for normality 
using the D’Agostino and Pearson omnibus normality test. Test results that were not 
normally distributed were log-transformed. Measurements at single time points between 
2 independent groups (body and WAT weight, average values of time course data: 
RER, VO2 and physical activity, feed intake, serum glycation and oxidation markers and 
qRT-PCR results) were analysed by independent Students’ t-tests.  
Time course data (RER, VO2, and physical activity during OxR) were analysed with 2-
way-ANOVA and Bonferoni Posthoc analysis (factor 1=diet, factor 2=time).  
VO2 during OxR was also analysed with ANCOVA, in which body weight was used as 
confounding factor. The correlation between oxygen consumption and body weight was 
further analysed with linear regression. 
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Results 
 
5 days high-fat feeding increased body weight and did not alter eWAT weight nor 
fasting blood glucose levels  
The consumption of the HF diet increased energy intake in HF mice compared to LF 
mice, which led to a significant increase in body weight in HF mice (phenotypical data 
are presented in table 1). Epididymal WAT (eWAT) weight and fasting blood glucose 
levels were unaltered by the period of HF feeding. Since calorimetric analyses are only 
based on mice that were exposed to OxR, phenotypical data were also compared 
between these subgroups of mice (LFo and HFo). LFo and HFo mice did not differ in 
body weight or eWAT weight. 
 
Table 1 Phenotypical data of mice fed semisynthetic LF or  
HF diet over a period of 5 days 
 LF (n=24) HF (n=24) 
Initial body weight (g) 25.54 ± 0.20 25.62 ± 0.20 
Final body weight (g) 27.66 ± 0.32 28.62 ± 0.31 * 
Total body weight gain (g) 2.15 ± 0.19 2.99 ± 0.23 ** 
eWAT weight (g) 0.29 ± 0.07 0.30 ± 0.07  
eWAT weight (%/BW) 1.03 ± 0.04 1.04 ± 0.04 
Energy intake (kcal/day) 13.97 ± 0.30 15.62 ± 0.35 *** 
Fasting glucose (mM) 6.43 ± 0.20 6.86 ± 0.27 
 LFo (n=12) HFo (n=12) 
Initial body weight (g) 25.54 ± 0.18 25.56 ± 0.20 
Final body weight (g) 27.28 ± 0.54 28.53 ± 0.36 
Total body weight gain (g) 1.74 ± 0.24  2.96 ± 0.35 
eWAT weight (g) 0.28 ± 0.02  0.30 ± 0.02 
eWAT weight (%/BW) 1.00 ± 0.06 1.04 ± 0.05 
Data are expressed as mean ± SEM for the full group of animals (top)  
and subset of mice exposed to OxR (bottom). eWAT weight resembles  
the weight of the right epididymal fat depot. Asterisks denote significant  
differences from control (LF) values. 
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Figure 1 Oxygen consumption, RER and physical activity under normoxic conditions of LF and HF 
mice. Oxygen consumption (a), RER (b) and physical activity (c) under normal, free-feeding conditions 
were averaged over the last 4 days of the 5 days of high- or low-fat feeding. The 2 hours before the 
exposure to OxR - when mice were in a fasted state - were used to analyse VO2, RER and physical 
activity under normal, although fasted, conditions. 
OxR AND EARLY HIGH-FAT DIET-INDUCED CHANGES IN METABOLISM   l   81 
 
4  
Fasting under normal conditions eliminated differences in RER and VO2 between 
HF and LF mice 
VO2 and RER during ad libitum conditions were significantly different between HF and 
LF mice (fig. 1a+b); HF feeding increased VO2 (92.1 ml/h in LF vs. 96.3 ml/h in HF) and 
decreased RER (0.946 in LF vs. 0.856 in HF ), which indicates increased fat oxidation. 
When mice were in a fasted state - prior to the exposure to OxR - differences in VO2 
and RER between HF and LF fed mice disappeared (fig. 1a+b). The absence of 
differences of VO2, RER and physical activity enabled us to distinguish the effect of 
OxR on each of these measurements and to establish whether dietary background 
influences the response to OxR. LF and HF mice did not differ in physical activity, 
neither when fasted nor in non-fasted state (fig. 1c).  
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Figure 2 Oxygen 
consumption, RER and 
physical activity during OxR 
of LF and HF fed mice. 
Oxygen consumption (a), RER 
(b) and physical activity (c) 
during 6 hours of OxR after 5 
days of low- or high-fat feeding. 
Mice were fasted prior to the 
exposure to OxR. 
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Exposure to OxR revealed differences between fasted HF and LF mice  
HF mice showed a significantly higher oxygen consumption during OxR compared with 
LF mice (fig. 2a), whereas their RER was significantly reduced (fig. 2b). LF and HF 
mice did not differ in physical activity during the exposure to OxR (fig. 2c). Levels of 
VO2, RER, and physical activity were significantly reduced by OxR compared to levels 
under normoxic fasted conditions for both dietary groups (suppl. table 2).  
HF mice had a significantly lower glucose oxidation rate during OxR, which is 
accompanied by a significant higher rate of fat oxidation (fig. 3a). OxR increased blood 
glucose levels, although no differences were found between HF and LF mice (fig. 3b). 
Since oxygen consumption and energy expenditure during indirect calorimetry are more 
complicated to interpret when animals differ in body weight (5, 6, 53), we also analysed 
average oxygen consumption of LF and HF mice in relation to body weight. Oxygen 
consumption significantly correlated to body weight during both normoxic conditions 
(fig. 4a) and during OxR (fig. 4b). Although the subgroups of LF and HF mice that were 
exposed to OxR did not differ significantly in body weight, the difference in average 
oxygen consumption during OxR between LF and HF mice disappeared when 
correcting for body weight with ANCOVA (fig. 4c). To further understand the effect of 
body weight on oxygen consumption during OxR (VO2,OxR) we also analysed its 
correlation with oxygen consumption during normoxic conditions (VO2,norm). The relation 
between VO2,OxR and VO2,norm shows to what extend the physiological status - including 
body weight - can predict oxygen consumption during OxR. In other words, in this 
analysis not only body weight is taken into account but all other factors that influence 
the level of oxygen consumption. Interestingly, in LF mice VO2,OxR strongly correlates 
with VO2,norm (fig. 4d). In HF mice VO2,OxR does not correlate with VO2,norm, which 
suggests that other factors, apart from body weight, play a role in the adaptation to 
OxR.  
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Figure 3 Energy from glucose and fat oxidation and blood glucose levels of LF and HF mice 
during and after OxR. The percentage of energy derived from glucose (a, left axis) or fat oxidation (a, 
right axis) were derived from average RER values during OxR of individual LF and HF fed mice. Blood 
glucose levels (b) were measured directly after the exposure to OxR.  
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OxR increased protein oxidation and glycation adducts in serum of HF mice 
Serum proteins can be oxidized or glycated by reactions with free radicals and 
saccharides, respectively. Changes in the level of protein oxidation and glycation 
adducts in serum can either result from changes in the level of total body oxidative and 
glycation damage or changes in clearance of the adducts from the circulation by protein 
turn-over or renal clearance (52). Since LF and HF mice differed in glucose oxidation 
rate and oxygen consumption during OxR, we investigated serum levels of several 
markers for protein oxidation and glycation (fig. 5). Dityrosine and 3-nitrotyrosine 
residues of serum protein were significantly increased upon OxR in HF mice but 
unchanged by exposure to OxR in LF mice. AGE adduct, MG-H1 and CML, residue 
contents of serum protein tended towards increase by OxR in HF mice but failed to 
reach statistical significance (p=0.054 and p=0.074, resp.), whereas their levels 
remained unaltered by OxR in LF mice. Glycation and oxidation adduct residue 
contents of serum protein were not changed by LF or HF feeding under normoxic 
conditions whereas the protein nitration adduct, 3-nitrotyrosine, residue content of 
serum protein was decreased in HF mice compared with LF mice.  
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Figure 4 Oxygen consumption of LF and HF mice during OxR and correction for body weight. 
Oxygen consumption levels during normoxia (VO2,norm; a) and OxR (VO2,OxR; b) positively correlated 
with body weight. HF mice have a significantly higher oxygen consumption level during the 6 hours of 
OxR, but not when corrected for body weight (c). Oxygen consumption levels during OxR (VO2,OxR) 
were positively correlated with oxygen consumption levels during normoxia (VO2,OxR) in LF mice, but 
not in HF mice (d). 
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OxR induced an antioxidant response, gluconeogenesis, and de novo 
lipogenesis in liver of HF mice 
Altered oxygen levels can affect redox balance and glucose and lipid metabolism. We 
therefore investigated hepatic transcript levels encoding proteins involved in the 
response to oxidative stress and the formation of cytosolic NADPH and transcripts 
involved in glucose and lipid metabolism in LF and HF mice that were either exposed to 
OxR or remained under normoxic conditions. An integrated schematic overview of the 
function of each gene of interest is shown for the response to oxidative stress (fig. 6a), 
and gluconeogenesis and de novo lipogenesis (DNL; fig. 6b).  
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Figure 5 Serum markers for protein glycation and oxidation of LF and HF mice after OxR. 
Different markers for protein glycation and oxidation were analysed in serum of LF and HF mice that 
were sacrificed immediately after the exposure to OxR. 
 
In HF mice, all key enzymes involved in gluconeogenesis were significantly upregulated 
by the exposure to OxR; except for solute carrier family 2 (Slc2a2), which expression 
was unaltered by OxR, and phosphoenolpyruvate carboxykinase 1 (Pck1), which 
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expression was only marginally (p=0.056) increased in HF mice (fig. 7c). Opposite to 
the increase in gluconeogenesis in HF mice, the expression of pyruvate kinase (Pklr) 
was also elevated by OxR, suggesting an increase in glycolysis. Furthermore, OxR 
induced an increase in the expression of superoxide dismutase 2 (Sod2) and 
uncoupling protein 2 (Ucp2), which are involved in the response to oxidative stress in 
HF mice. OxR also induced DNL, as shown by the increased expression of acetyl-
Coenzyme A carboxylase alpha (Acaca) and fatty acid synthase (Fasn). 
In LF mice, gene expression data does not indicate changes in gluconeogenesis (fig. 
7b). Only Pklr and solute carrier family 16 (Slc16a1) mRNA levels were found to be 
elevated by OxR, which suggest an increase in glycolysis and an increase in lactate 
import. The increase in the expression of stearoyl-Coenzyme A desaturase 1 (Scd1) 
suggests that OxR increased the formation of unsaturated fatty acids in LF mice. None 
of the genes involved in the response to oxidative stress were altered by OxR in LF 
mice. 
Under normoxic conditions, none of these genes were differentially expressed between 
LF and HF mice, except for malic enzyme (Me1) and Scd1, which both had a lower 
expression level in HF mice compared with LF mice (fig. 7a). Relative expression levels 
of all genes, which is the expression level corrected by the expression level of both 
reference genes, can be found in supplemental figure 2a. 
 
OxR induces an antioxidant response and alters mitochondrial activity and de 
novo lipogenesis in WAT of LF mice  
WAT is, next to the liver, also expected to play an important role in the adaptation to 
OxR. In LF mice, the response to oxidative stress was significantly upregulated by OxR 
in WAT (Sod2 and Ucp2; fig. 8b). Vascular endothelial growth factor A (Vegfa), which is 
a direct target of the hypoxia inducible factor 1 (Hif1a), was also significantly 
upregulated by OxR. OxR also had a strong effect on genes involved in DNL in LF 
mice: all 5 genes involved in DNL were found to be upregulated by OxR, of which all 
but one (Scd1) were significantly increased. Furthermore, OxR seemed to have altered 
mitochondrial activity in WAT of LF mice; the expression of citrate synthase (Cs), which 
is an important component of the citric acid cycle, was elevated, and the expression of 
pyruvate dehydrogenase kinase 1 (Pdk1), which phosphorylates and inhibits the 
pyruvate dehydrogenase complex and thus reduces the formation of acetyl-coA from 
pyruvate, was elevated. In HF mice no changes in gene expression levels in WAT were 
found (fig. 8c). 
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Figure 6 continued 
Sod1 (cytosolic) and Sod2 (mitochondrial) work as antioxidants by converting O
2-
 to H2O2. NADPH is formed 
during the conversion of malate to pyruvate, which is catalysed by Me1. Txnrd2 maintains thioredoxin in a reduced 
state. NADPH plays an important role in antioxidant defence by serving as the main electron donor for reductases, 
such as thioredoxin that is involved in the conversion of H2O2 to H2O. 
b. Gluconeogenesis and de novo lipogenesis (DNL). Gluconeogenesis occurs during fasting or when circulating 
lactate levels are elevated and only takes places in the liver. During gluconeogenesis, lactate is taken up from 
circulation by Slc16a1 (MCT1). Lactate is converted to pyruvate by Ldha. Pyruvate is transported into the 
mitochondrion and converted to oxaloacetate by Pcx. The conversion of pyruvate to acetyl-coA (by Pdh) is 
blocked by Pdk1. Oxaloacetate is converted to PEP by Pck1 (cytosolic) or Pck2 (mitochondrial). In the cytoplasm, 
PEP is converted into glucose and glucose can be transported out of hepatocytes by Slc2a2. The expression of 
Pklr, which converts PEP back to pyruvate, is blocked. Malate can also be converted back to pyruvate by Me1. 
DNL is the synthesis of fatty acids from non-lipid precursors and can occur in both liver and adipose tissue. For 
DNL, citrate is transported out of the mitochondrion and converted into acetyl-CoA by Acly. Acetyl-CoA can then 
be converted to long chain (unsaturated) fatty acids by subsequently Acaca, Fasn, Scd1, and Elovl6. Genes that 
are underlined were measured in this study. 
 
Figure 6 Schematic overview of the role 
and function of each gene of interest. 
a. Response to oxidative stress. An 
increase in mitochondrial activity generally 
leads to an increase in the formation of 
reactive oxygen species (ROS). Pgc1a 
(Ppargc1a) is a key regulator of 
mitochondrial activity and density and is 
inhibited by hypoxia inducible factor (Hif1a). 
Vegfa is a direct target gene of Hif1a and 
was used as a marker for Hif1a availability. 
Ucp2 decreases mitochondrial membrane 
potential and decreases mitochondrial 
activity. Pdk1 can also decrease 
mitochondrial function by limiting the 
formation of Acetyl-CoA, the major 
substrate for the TCA cycle. Cs is a major 
component of the TCA cycle and can 
enhance mitochondrial activity.  
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To further understand the changes in lipid and mitochondrial activity in LF mice, we 
studied the expression of Pnpla2 and Cpt1, two key enzymes in lipolysis and beta 
oxidation. Neither of the two genes was found to be regulated by OxR in LF and HF 
mice. Under normoxic conditions, the expression levels of Ucp2, Vegfa, Txrnd2 and 
Cpt1a were higher in HF mice compared with LF mice (fig. 8a). Relative expression 
levels of all genes can be found in supplemental figure 2b. 
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Figure 7 Gene expression in liver tissue of LF and HF mice that were either exposed to OxR or 
remained under normoxic conditions. Total mRNA was isolated to measure the expression of genes 
involved in antioxidant response, gluconeogenesis and de novo lipogenesis in liver tissue of LF and HF 
mice. Gene expression is calculated as the fold change of HF mice under normoxic conditions over LF 
mice under normoxic conditions (a); and of LF (b) and HF (c) mice that were exposed to oxygen 
restriction over the LF and HF mice that remained under normoxic conditions. Sod1, superoxide 
dismutase 1; Sod2, superoxide dismutase 2; Ucp2, uncoupling protein 2; Me1, malic enzyme; Pdk1, 
pyruvate dehydrogenase kinase 1; Pklr, pyruvate kinase; Pck1 phosphoenolpyruvate carboxykinase 1 
(Pepck); Ldha, lactate dehydrogenase A; Slc16a1, solute carrier family 16 (Mct1); Pcx, pyruvate 
carboxylase; Slc2a2, solute carrier family 2 (facilitated glucose transporter; Glut2); Acaca, acetyl-
Coenzyme A carboxylase alpha; Acly, ATP citrate lyase; Elovl6, ELOVL family member 6, elongation of 
long chain fatty acids; Fasn, fatty acid synthase; Scd1, stearoyl-Coenzyme A desaturase 1. 
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Figure 8 Gene expression in WAT of LF and HF mice that were either exposed to OxR or 
remained under normoxic conditions. Total mRNA was isolated to measure the expression of genes 
involved in antioxidant response, mitochondrial activity, lactate and lipid metabolism and de novo 
lipogenesis in eWAT of LF and HF mice. Gene expression is calculated as the fold change of HF mice 
under normoxic conditions over LF mice under normoxic conditions (a); and of LF (b) and HF (c) mice 
that were exposed to oxygen restriction over the LF and HF mice that remained under normoxic 
conditions. Sod1, superoxide dismutase 1; Sod2, superoxide dismutase 2; Ucp2, uncoupling protein 2; 
Txnrd2, thioredoxin reductase 2; Vegfa, vascular endothelial growth factor A; Cs, citrate synthase; 
Ppargrc1a peroxisome proliferative activated receptor gamma coactivator 1 alpha (Pgc1a); Pdk1, 
pyruvate dehydrogenase kinase 1; Ldha, lactate dehydrogenase A; Cpt1a, carnitine 
palmitoyltransferase 1a; Pnpla2, patatin-like phospholipase domain containing 2; Acaca, acetyl-
Coenzyme A carboxylase alpha; Acly, ATP citrate lyase; Elovl6, ELOVL family member 6, elongation of 
long chain fatty acids; Fasn, fatty acid synthase; Scd1, stearoyl-Coenzyme A desaturase 1. 
 
Discussion 
 
5 days high-fat feeding increased body weight 
HF versus LF mice had a higher energy intake and, as a result, a higher body weight 
after five days of feeding. The increase in body weight that was seen in our study is 
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predictive for the detrimental effects of long-term high-fat feeding (57). The absence of 
significant differences in blood glucose levels and adipose tissue weight makes it 
possible to compare the effect of OxR between both dietary backgrounds. 
 
Feeding a high-fat diet increased oxygen consumption and decreased RER; 
although no differences were present when mice were in a fasted state 
Whole body oxygen consumption depends on various factors, such as physical activity 
and body weight, but also metabolic rate and diet composition (20, 24). LF and HF mice 
did not differ in physical activity and HF mice had a higher caloric intake compared with 
LF mice. Diet composition can, specifically, determine the level of diet-induced 
thermogenesis (DIT). DIT depends on the activity of brown adipose tissue and its 
responsiveness to adrenergic stimulation and can be measured by the increase in 
norepinephrine-induced oxygen consumption (3). High-fat feeding is known to increase 
DIT, and therefore, oxygen consumption in mice (17). Diurnal RER, on the other hand, 
highly depends on the food quotient (FQ) of the diet. The FQ of the LF diet was 0.93 
and the FQ of the HF diet was 0.85 (calculations based on Livesey et al. (29)). 
Therefore, and as expected, HF mice had a higher oxygen consumption and a lower 
RER, compared with LF mice during free-feeding conditions. When fasted, however, 
the effect of dietary history is diminished and HF and LF mice did not differ in RER and 
oxygen consumption. This result is consistent with a human study (8), which also 
showed that fasting RER correlates with insulin resistance, but was not significantly 
different between subjects with different habitual dietary intakes. The absence of an 
effect of dietary background on fasting RER and oxygen consumption values facilitates 
comparison of the response to OxR between both groups. 
 
LF and HF mice differed in their adaption to OxR  
The level of OxR mimics mild ambient hypoxia that occurs at moderate-high altitude (± 
4000 m.), in certain airplanes, and on a systemic level, during obstructive sleep apnoea 
(12, 36). The exposure to OxR had a strong effect on whole body metabolism: it 
significantly decreased physical activity and oxygen consumption in both HF and LF 
mice. The decrease in physical activity is likely partly responsible for the reduction in 
oxygen consumption during OxR. A metabolic switch from mitochondrial oxidative to 
glycolytic ATP production may also contribute to the decreased oxygen consumption, 
as has been shown before (14, 35). A switch to glycolytic ATP production also explains 
the increase in blood glucose levels that were induced by OxR in both groups of mice. 
OxR is known to increase blood glucose and insulin levels (12, 38, 45), which is 
presumably caused by the conversion of lactate to glucose in liver tissue (10) or by - or 
in combination with - a reduction in insulin and glucose sensitivity that is frequently 
observed after exposure to OxR (30, 37, 45). 
Although both groups of mice showed clear changes in blood glucose levels, oxygen 
consumption, RER and physical activity before and during OxR; also clear differences 
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existed in the adaptation to OxR. LF and HF mice did, on the other hand, not differ in 
physical activity during OxR; differences in indirect calorimetric values are, therefore, 
likely to be caused by differences in metabolic adaptation. 
HF mice had, in fact, lower RERs during OxR, which directly relates to a decrease in 
the level of whole body glucose oxidation in HF mice compared with LF mice. The 
switch from fatty acid oxidation to glucose oxidation is expected to be favourable during 
periods of low oxygen availability because glucose oxidation utilizes less oxygen 
compared to fat oxidation (23). HF mice, indeed, consumed more oxygen during OxR 
compared with LF mice, whereas no significant differences were present between both 
groups prior to the exposure. Although, it should be noted that - when taking the heat 
equivalents of oxygen of both carbohydrate and fat into account (29) - a switch from 
100% fat oxidation to 100% carbohydrate oxidation results in a decrease of 
approximately 7% in oxygen consumption, which means that the switch from lipid to 
glucose oxidation during OxR that was seen in LF mice, only accounts for a small 
proportion to the decrease in whole body oxygen consumption. Larger differences in 
oxygen consumption could be achieved by an increase in anaerobic glycolysis, by 
increased metabolic efficiency and/or by induction of autophagy dependent 
metabolism. The latter has been shown to contribute to adaptation to hypoxia in 
rodents (18) and humans (31). These changes will not necessarily affect RER, but can 
be visualized using oxygen consumption. 
The differences in indirect calorimetry during OxR between HF and LF mice may 
indicate a decrease in metabolic flexibility in HF mice. Ex vivo studies, indeed, showed 
that the flexibility to switch from fat to glucose oxidation reflects the donor's metabolic 
characteristics, such as the percentage of body fat and serum free fatty acid levels (54). 
Five days of high-fat feeding might be sufficient to elicit differences in metabolic status 
that can be revealed by a challenge with OxR. 
 
 
OxR induced an increase in several markers for protein glycation and oxidation 
in serum of HF mice 
Oxygen restriction can result in increased glycolytic flux, as well as increased oxidative 
stress. An increased glycolytic flux may be due to a switch from fat to glucose oxidation 
and by a switch from oxidative ATP production to anaerobic ATP production (50). 
Although, ATP production via anaerobic glycolysis is only effective if lactate clearance 
does not match lactate production. Increased oxidative stress may be caused by an 
increased production of reactive oxygen species (ROS). Indeed, ambient hypoxia can 
lead to the production of mitochondrial ROS, with the level of ROS production 
depending on basal metabolism and the degree and duration of hypoxia (50). Hypoxia 
also leads to increased flux through anaerobic glycolysis with increased formation of 
methylglyoxal and related AGE formation – although this may be countered by hypoxia-
induced increased expression of the protective enzyme, glyoxalase 1 (49). ROS are 
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thought to contribute to increased serum markers of oxidative damage and reactive 
dicarbonyl metabolites, such as glyoxal and methylglyoxal, and increased serum 
markers of AGEs (52). To assess possible effects of the level of OxR, that was 
imposed here, on glycolytic flux and oxidative stress, we examined protein adducts as 
serum markers of glycation and oxidative stress. The consumption of a HF diet on itself 
did not lead to differences in the serum markers of interest, except for 3-nitrotyrosine – 
one of the serum markers for oxidative stress and nitric oxide availability (42). Serum 
protein 3-NT residue content was decreased in HF mice compared with LF mice under 
normoxic conditions. This likely relates to decreased nitric oxide bioavailability (15). 
Serum protein 3-nitrotyrosine and dityrosine residue content were significantly 
increased upon OxR under HF diet conditions, but not under LF diet conditions. This 
suggests hypoxia mediated mitochondrial ROS production due to limited oxygen 
availability. The increase in 3-nitrotyrosine and dityrosine in HF mice may be explained 
by the higher oxygen consumption during OxR, which will result in a higher apparent 
hypoxia in HF mice compared with LF mice. Alternatively, this may be explained by a 
relative larger switch to glycolytic metabolism. Taken together, our data suggest that 
OxR increases oxidative stress in particular under HF conditions.  
 
OxR induced gluconeogenesis, de novo lipogenesis, and an antioxidant 
response in liver tissue of HF mice  
Exposure to a similar level of ambient normobaric hypoxia leads to an almost three-fold 
reduction in oxygen saturation in mouse liver tissue (45). OxR may, therefore, result in 
an increase in glycolytic flux and peripheral lactate production and clearance by the 
liver (10). OxR can, furthermore, induce an increase in oxidative stress at tissue level, 
which leads to an increase in the expression of genes involved in oxidative stress. 
Finally, OxR might also induce hepatic de novo lipogenesis (DNL). Hepatic DNL is 
increased in obesity (16) and decreased during caloric restriction (47), and is therefore 
considered as a relevant marker for metabolic health. Long-term exposure to OxR 
increases the expression of genes involved in DNL (4) and therefore resembles the 
effects seen in obesity. The combination of short-term HF feeding and exposure to OxR 
that we used in this study might, consequently, have a synergistic effect on DNL gene 
expression.  
Before we discuss the changes in gene expression level that are induced by OxR in LF 
and HF mice, we will first focus on the changes in gene expression induced by HF 
feeding on itself – under normoxic conditions. Five days of HF feeding appeared to 
have a minor effect on the genes that were analysed in this study, with only two genes 
being significantly regulated. The decreased expression of Malic enzyme (Me1) 
suggests a lower conversion of cytoplasmic malate to pyruvate in HF mice as part of 
fatty acid synthesis from glycolytic intermediates, which is expected because of the 
lower amount of carbohydrates and higher amount of lipids in the HF diet. The 
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decrease in stearoyl-Coenzyme A desaturase 1 (Scd1) is likely due to the large amount 
of unsaturated fatty acids in the HF diet. 
The hepatic response to OxR in LF mice seems quite straight forward. Both pyruvate 
kinase (Pklr), which is involved in the last step of the glycolytic pathway and is 
stimulated by shortage of ATP; and lactate dehydrogenase (Ldha), which converts 
pyruvate to lactate during anaerobic glycolysis, were upregulated by OxR. The increase 
in hepatic glycolysis in LF mice might contribute to the decrease in oxygen 
consumption that was observed during OxR. LF mice do not show changes in the 
genes involved in hepatic gluconeogenesis, suggesting that lactate levels are below 
threshold values. From the 5 DNL genes that were analysed, only Scd1 was 
significantly induced by OxR in LF mice. Furthermore, none of the genes that respond 
to oxidative stress were altered, suggesting that oxygen supply in liver tissue matched 
the oxygen demand. 
The hepatic response to OxR in HF mice, on the other hand, appeared to be more 
complicated. HF mice showed a strong and consistent upregulation of genes involved 
in gluconeogenesis, suggesting that the liver is stimulated to clear lactate from the 
blood. Next to the increase in gluconeogenesis, we also see an increase in the 
expression of Pklr, suggesting that glycolysis is also upregulated. Upregulation of both 
gluconeogenesis and glycolysis would lead to an apparent, energy-costly pyruvate-
malate-phosphoenolpyruvate (PEP) cycling (also see figure 6a). Under normal 
conditions, insulin stimulates Pklr , but inhibits simultaneously pyruvate carboxylase 
(Pcx) and PEP carboxykinase (Pck) but this regulation seems to be disturbed during 
OxR in HF mice. Another possibility could be that the pyruvate-malate-PEP cycling is 
interrupted by the direct conversion of malate to pyruvate by cytoplasmic malic enzyme 
(Me1), which leads to cytosolic NADPH production. NADPH plays an important role in 
antioxidant defence by serving as the main electron donor for reductases, such as 
thioredoxin that is involved in the conversion of ROS to water (1). In support of this, 
intermittent hypoxia was also shown to induce the expression of hepatic Me1 in obese 
mice (28). 
OxR, indeed, induced a strong antioxidant gene expression response in liver tissue of 
HF mice, suggesting that oxygen availability did not match oxygen demand in these 
mice. This is supported by the increase in serum markers for oxidative stress 
specifically in HF mice. It is possible that oxygen demand in HF mice is increased by an 
insufficient reduction of fatty acid beta oxidation. Indeed, HF mice showed a higher 
whole body lipid oxidation rate compared with LF mice. Fatty acid beta oxidation is 
possibly higher in HF mice to ensure sufficient ATP production for gluconeogenesis. 
Finally, HF mice also showed an increase in hepatic DNL, based on the increase in the 
expression of acetyl-Coenzyme A carboxylase alpha (Acaca) and fatty acid synthase 
(Fasn). Hepatic DNL is associated with obesity and promotes lipotoxicity, insulin 
resistance and non-alcoholic fatty liver disease (41).  
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OxR induces an antioxidant response and DNL in WAT of LF mice  
WAT can rapidly expand during periods of high caloric intake. When tissue expansion 
exceeds vascularization, parts of the tissue will become hypoxic, which is suggested to 
lead to inflammation and the formation of ROS (46). Tissue hypoxia can be counter-
acted by transcriptional activation via Hif1a, leading to an increase in the antioxidant 
response and vascularization. Ambient OxR might induce similar responses in WAT to 
prevent hypoxia at tissue level. Hypertrophic WAT is expected to be the first tissue to 
experience problems in oxygen supply and availability during low oxygen conditions. 
Although LF and HF mice did not differ in epididymal WAT tissue mass, both groups 
differed in the expression of genes involved in the response to oxidative stress during 
OxR. In HF mice, no changes were found in the expression of any of the genes of 
interest. In LF mice, however, we found a consistent upregulation of genes involved in 
the response to oxidative stress. Controversially, we also found an upregulation in the 
expression of citrate synthase, which plays an important role in the citric acid cycle and 
is expected to increase mitochondrial activity. OxR did, however, not alter the 
expression of Pnpla2 and Cpt1a, which suggests that the difference in antioxidant 
response by OxR between HF and LF mice is not caused by a difference in WAT 
lipolysis or fatty acid beta oxidation. It should be noted that three of the genes involved 
in the response to oxidative stress - Vegfa, Ucp2 and Txnrd2 - were already 
upregulated in HF mice compared to LF mice under normoxic conditions, which 
indicates that HF mice were already involved in WAT adaptation prior to the exposure 
to OxR. Physiological adaptation of WAT during high-fat feeding facilitates fat storage 
without decreasing the oxygenation of the cells. The exposure to OxR was possibly not 
severe enough to overcome or further strengthen the preconditioning by high-fat 
feeding; the increase in gene expression caused by high-fat feeding might prevent mice 
to further increase gene expression during OxR. It was, indeed, recently shown that 
high-fat feeding in mice increased metabolic health parameters such as plasma leptin 
and the expression of tumour necrosis factor (Tnf) in WAT; exposure to ambient 
hypoxia did, however, increase leptin and Tnf in lean mice but not in obese mice (45). 
Furthermore, it was recently shown that mice with a larger potential for WAT 
remodelling had, when exposed to ambient hypoxia, a larger degree of tissue hypoxia 
and higher expression of angiogenesis-related genes in WAT (26). These findings 
result from genetic differences of the two mouse strains used. Diet might, however, also 
influence the potential for WAT remodelling.  
Next to the increase in genes involved in oxidative stress, OxR also induced a 
consistent increase in DNL in WAT of LF mice. An increase in DNL in adipose tissue is 
associated with a healthy phenotype in mice, eg. during caloric restriction (13), whereas 
a decrease in WAT DNL is associated with obesity and type 2 diabetes (16). Induction 
of DNL by OxR may increase WAT palmitoleate production (7), which might serve to 
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improve insulin sensitivity in response to the increase in blood glucose levels that was 
observed during OxR.  
 
OxR is a promising challenge test to investigate early diet-induced changes in 
metabolism. 
In this study we show that, after only 5 days of HF or LF feeding, mice differ in their 
adaptation to OxR. The adaptation in HF mice is possibly less effective because of the 
higher level of oxygen consumption that was observed and the increase in protein 
glycation and oxidation adducts in serum. The apparent difference in the adaptation to 
OxR between HF and LF mice is emphasised by the changes in genes expression that 
were induced by OxR. OxR, in fact, induced an almost reverse pattern of gene 
expression in LF versus HF mice: while the majority of hepatic genes was upregulated 
by OxR in HF mice, these genes remained unaffected in LF mice. In contrast, the 
majority of genes that were upregulated by OxR in eWAT of LF mice, remained 
unaffected in HF mice. Next to the metabolic changes that were induced by OxR in 
mice, OxR is also known to affect human metabolism. Similar levels of OxR lead, for 
example, to significant changes in oxygen saturation and CO2 production in humans (9, 
19). Although conflicting results were shown for the effect of hypoxia on blood glucose 
levels in humans (27, 37); acute hypoxia does alter glucose utilization in humans (25, 
37). OxR as a challenge test might be suitable to be included in future dietary studies 
for early, sensitive detection of changes in metabolic health in animal models but might 
also be considered to be used in human studies.  
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Supplemental figure 1 Schematic overview of the study design and exposure to OxR. The 
complete study lasted for three weeks. 48 male mice arrived at 10 weeks of age. After three weeks on 
the low-fat diet, mice were stratified and individually housed in the indirect calorimetry system. Mice 
could adapt to the InCa system for 24h after which 24 mice received a fresh batch of LF diet and 24 
mice switched to the high-fat diet. After 5 days of HF- or LF feeding, mice were exposed to OxR or 
remained under normal air conditions for 6 hours. Mice were fasted by providing them a restricted 
amount of feed at the start of the dark phase (18.00h) preceding the OxR or normoxic challenge. The 
restricted amount of feed is generally consumed within 6 hours (around 0.00h). Around 5.00h, all mice 
were in a fasted state (RER<0.8). For the LFo and HFo mice, oxygen is decreased from 20.9% to 12% 
from 7.00h to 7.30h. LFn and HFn mice remained under normoxic conditions. Indirect calorimetry values 
during OxR or normoxia were then recorded from 7.30h to 13.30h, after which mice were immediately 
sacrificed. 
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Supplemental figure 2 Relative gene expression in liver tissue and WAT of LF and HF mice that 
were either exposed to OxR or normoxic air. Gene expression in liver (a) and WAT (b) was 
calculated relatively to the geometric mean of the reference genes.  
Sod1, superoxide dismutase 1; Sod2, superoxide dismutase 2; Ucp2, uncoupling protein 2; Slc2a2, 
solute carrier family 2 (facilitated glucose transporter; Glut2); Pdk1, pyruvate dehydrogenase kinase 1; 
Pklr, pyruvate kinase; Pck1 phosphoenolpyruvate carboxykinase 1 (Pepck); Ldha, lactate 
dehydrogenase A; Slc16a1, solute carrier family 16 (Mct1); Pcx, pyruvate carboxylase; Me1, malic 
enzyme; Txnrd2, thioredoxin reductase 2; Vegfa, vascular endothelial growth factor A; Ppargrc1a 
peroxisome proliferative activated receptor gamma coactivator 1 alpha (Pgc1a); Cs, citrate synthase; 
Cpt1a, carnitine palmitoyltransferase 1a; Pnpla2, patatin-like phospholipase domain containing 2; 
Acaca, acetyl-Coenzyme A carboxylase alpha; Acly, ATP citrate lyase; Elovl6, ELOVL family member 6, 
elongation of long chain fatty acids; Fasn, fatty acid synthase; Scd1, stearoyl-Coenzyme A desaturase 
1. 
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Supplemental table 1 Primer sequences and PCR annealing temperatures for qRT-
PCR 
Genes denoted with an asterisk were used as reference genes for normalization. 
 
 
 
Supplemental table 2 Average oxygen consumption, RER and physical activity levels 
of LF and HF mice during OxR and normoxic conditions in the indirect calorimetry 
system 
 
 
 
 
 
 
Data are expressed as mean ± SEM, n=12 mice per group. Asterisks denote significant differences from 
control (normoxic) values. All measurements were performed during fasting conditions. 
Gene  Forward primer 5’ – 3’ Reverse primer 5’ – 3’ PCR temp. 
Acaca GTTGAAGGCACAGTGAAGGCTTAC ATGGCGACTTCTGGGTTGGC 58.0ºC 
Acly TGGGCTTCATTGGGCACTACC TGGGCTTCATTGGGCACTACC 62.0ºC 
B2m* CCCCACTGAGACTGATACATACGC AGAAACTGGATTTGTAATTAAGCAGGTTC 60.0ºC 
Cpt1a CTGAGACAGACTCACACCGC GTGGAGCCTACGGTTGTTCT 58.0ºC 
Cs ACAGTGAAAGCAACTTCGCC GTCAATGGCTCCGATACTGC 58.0ºC 
Elovl6 GGCACTAAGACCGCAAGGCA GCTACGTGTTCTCTGCGCCT 62.0ºC 
Fasn AGTTAGAGCAGGACAAGCCCAAG TTCAGTGAGGCGTAGTAGACAGTG 58.0ºC 
Ldha CACGCTGCTTCTCCTCGCCAGT GGCACAAGCCATGCCAACAGCAC 62.0ºC 
Me1 GAGGTCATATCTCAGCAAGTGTCAG AATCAGGTAGGATCTGGTCATAATTAGTG 56.0ºC 
Pck1 ACTGTTGGCTGGCTCTCACTG TCTCAAAGTCCTCTTCCGACATCC 58.0ºC 
Pcx AGGGCGGAGCTAACATCTAC GGCTTCATCAGCTTTCTGCC 60.0ºC 
Pdk1 TGAAGCAGTTCCTGGACTTCGGGTC TGTCGGGGAGGAGGCTGATTTCT  62.0ºC 
Pklr TGGCGGACACCTTCCTGGAACA TCTGCATGGTACTCATGGGAGCCA 60.0ºC 
Pnpla2 CCAGTTCAACCTTCGCAATCTCTAC GCATGTTGGAAAGGGTGGTCATC 58.0ºC 
Ppargc1a CCCTGCCATTGTTAAGACC TGCTGCTGTTCCTGTTTTC 60.0ºC 
Rps15* CGGAGATGGTGGGTAGCATGG ACGGGTTTGTAGGTGATGGAGAAC 62.0ºC 
Scd1 TCATGGTCCTGCTGCACTTGG CTGTGGCTCCAGAGGCGATG 58.0ºC 
Slc2a2 TTGTCATCGCCCTCTGCTTCC GTGGTTCCTCCTGGTCGGTTC 58.0ºC 
Slc16a1 GGCCACCACTTTTAGGCCGC AGTCGATAGTTGATGCCCATGCCA 62.0ºC 
Sod1 TCGGCTTCTCGTCTTGCTCTC GTTCACCGCTTGCCTTCTGC 60.0ºC 
Sod2 TTCTGGACAAACCTGAGCCCTAAG GCAGCAATCTGTAAGCGACCTTG 60.0ºC 
Txnrd2 TGGCTGACTATGTGGAACCT ACTTGACTTTCCTGTCCTGC 62.5ºC 
Ucp2 AGTTCCGCCCTCGGTGTCGT TTGTGTCCGGACCGCAGGAGA 58.0ºC 
Vegfa AAGCCAGCACATAGGAGAGATGAG TCTTTGGTCTGCATTCACATCTGC 60.0ºC 
 normoxic OxR 
VO2 LF 83.9 ± 3.71 63.6 ± 1.50 *** 
RER LF 0.76 ± 0.01  0.73 ± 0.01 * 
Physical activity LF 16.28 ± 2.00 6.17 ± 1.03 *** 
VO2 HF 87.8 ± 2.61 67.7 ± 1.29 *** 
RER HF 0.75 ± 0.00  0.70 ± 0.01 *** 
Physical activity HF 16.31 ± 1.14 5.96 ± 0.70 *** 
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Abstract 
 
Poly-unsaturated fatty acids (PUFAs) are considered to be healthier than saturated 
fatty acids (SFAs), but others postulate that especially the ratio of omega-6 to omega-3 
PUFAs (n6/n3 ratio) determines health. Health can be determined with biomarkers, but 
functional health status is likely better reflected by challenge tests that assess 
metabolic flexibility. The aim of this study was to determine the effect of high-fat diets 
with different fatty acid compositions, but similar n6/n3 ratio, on metabolic flexibility. 
Therefore, adult male mice received isocaloric high-fat diets with either predominantly 
PUFAs (HFpu diet) or predominantly SFAs (HFs diet) but similar n6/n3 ratio for six 
months, during and after which several biomarkers for health were measured. 
Metabolic flexibility was assessed by the response to an oral glucose tolerance test, 
fasting and re-feeding test and oxygen restriction test (OxR; normobaric hypoxia). The 
latter two are non-invasive, indirect calorimetry-based tests that measure the adaptive 
capacity of the body as a whole. We found that the HFs diet increased mean adipocyte 
size and ectopic lipid storage in liver and muscle, but did not cause differences in body 
weight, total adiposity, adipose tissue health, serum adipokines, whole body energy 
balance, or circadian rhythm. HFs mice were, furthermore, less flexible in their 
response to both fasting- re-feeding and OxR, while glucose tolerance was 
indistinguishable.  
To conclude, the HFs versus the HFpu diet increased ectopic fat storage and mean 
adipocyte size and reduced metabolic flexibility in male mice. This study underscores 
the physiological relevance of indirect calorimetry-based challenge tests.   
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Introduction 
 
Excessive dietary fat intake is positively associated with weight gain and the 
development of metabolic diseases (4), such as insulin resistance, cardiovascular 
diseases, and type 2 diabetes. Metabolic diseases are often associated with a 
decrease in metabolic flexibility. Metabolic flexibility can be considered as the ability to 
switch between carbohydrate oxidation and fat oxidation (61) and is e.g. apparent in 
type 2 diabetics, who fail to adequately switch to glucose oxidation upon glucose 
consumption. Metabolic flexibility can, however, also be seen in a broader sense, in 
which it is defined as the capability to maintain homeostasis during a nutritional or 
environmental challenge (70). Such a challenge can consist of administration of a 
single nutrient, such as glucose (2, 27) or lipid (64), or a combination of nutrients like in 
a meal test (20, 36). Alternatively, it can consist of exposure to an environmental 
challenge, such as oxygen restriction (OxR), in which a major determinant for aerobic 
fuel oxidation – oxygen – is limited (15, 16). An adequate response to the challenge, 
ultimately, requires substrate switching, which is impaired when metabolic flexibility 
declines. Metabolic inflexibility arises from deficiencies in the handling of incoming and 
circulating nutrients by one or several of the organs that play a major role in 
metabolism, such as the liver, skeletal muscle, adipose tissue, brain and pancreas (62). 
Detection of metabolic inflexibility would, thus, benefit from a multiple level approach, in 
which different organs or metabolic systems are challenged. 
Next to the amount of dietary fat, the composition and type of fat affect the 
development of metabolic disease and metabolic inflexibility. Saturated fatty acids 
(SFAs) increase fasting insulin levels, weight gain, circulating leptin levels, liver 
triacylglycerols, mean adipocyte size and adipose tissue inflammation, and decrease 
adiponectin levels, compared to poly-unsaturated fatty acids (PUFAs) (5, 10, 19, 21, 
40, 43, 44, 66). Furthermore, the proportion of fatty acids to each other seems to 
determine health effects (21). Among the SFAs, for example, medium chain SFAs 
protect against the detrimental effects of long chain SFAs in both humans and rodents 
(60, 73); and among the PUFAs, omega-3 PUFAs (n-3 PUFAs) were shown to be more 
beneficial for rodent health status than omega-6 PUFAs (n-6 PUFAs) (23, 51, 65) that 
appear to have pro-inflammatory properties (72). It has, indeed, been suggested that 
especially the ratio of n-6 PUFAs to n-3 PUFAs (n6/n3 ratio) determines the 
pathogenesis of metabolic diseases, rather than the absolute amounts of n-3 PUFAs 
and n-6 PUFAs (59). The influence of the fatty acid composition of the diet on metabolic 
flexibility, however, remains largely unknown. In this study we, therefore, investigate the 
effect of two isocaloric high-fat (HF) diets that differ in fatty acid composition on 
metabolic health and metabolic flexibility in mice. The first diet (HFpu diet) is a 
standardized HF diet that is used in several previous studies (15, 33, 35, 71) and 
mainly contains PUFAs in the fat fraction. The second diet (HFs diet) is identical to the 
HFpu diet, except for the fat fraction, which mainly contained saturated fatty acids from 
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palm oil. Palm oil is the dominant fat constituent of most experimental rodent HF diets 
and is increasingly prevalent in human food products. Although the HFpu diet contains 
much more PUFAs, the ratio of n-6 FAs to n-3 FAs was kept similar between both diets. 
Metabolic flexibility was measured with one invasive challenge test: the oral glucose 
tolerance test (OGTT), which monitors the homeostatic blood glucose clearance in 
response to a glucose challenge; and two non-invasive challenge tests that were 
monitored with indirect calorimetry instead of blood sampling. Indirect calorimetry-
based challenge tests are suitable to asses metabolic flexibility because indirect 
calorimetry directly displays the extent and time course of substrate switching. For this 
study we used a nutritional challenge: a fasting and re-feeding challenge, and an 
environmental challenge with mild reduction in the availability of oxygen (OxR: [O2] = 
12% vs 21 % in normoxia). Using food as a challenge will target a wider range of 
processes than during an OGTT and, therefore, provides a broader reflection of 
metabolic sensitivity. OxR forces the use of metabolic pathways that facilitate 
adaptation to decreased oxygen availability and thus directly targets flexibility. Body 
weight, adiposity, liver and adipose tissue health, and circulating hormone and 
adipokine levels were also monitored during the course of the experiment to evaluate 
metabolic health status. 
 
Materials and methods 
 
Animals and experimental manipulations 
Thirty male C57BL/6JOlaHsd mice were used for this study (Harlan Laboratories, 
Horst, The Netherlands). The experimental protocol was approved by the Animal 
Welfare Committee of Wageningen University, Wageningen, The Netherlands 
(DEC2012088). Mice arrived at 10 weeks of age and were individually housed and 
maintained under environmentally controlled conditions (21 ± 1ºC, 12 h/12 h light–dark 
cycle, 50 ± 10% humidity) and had ad libitum access to feed and water. The study 
consisted of a three week adaptation phase and an experimental phase of 27 weeks 
(wk1 - wk27). During the adaptation phase, mice received the purified low-fat 
BIOCLAIMS standard diet, which contains 10% energy from fat (35). For the 
experimental phase, mice were stratified by body weight and allocated to the HFpu or 
HFs group. Both high-fat diets contained 40% energy from fat, but differed in the 
composition of the fat component. The control diet is the BIOCLAIMS purified 
standardized HF diet (HFpu diet), with 70% (w/w) sunflower oil, 18% coconut oil and 
12% flax seed oil (71). The HFs diet contains 98.1% palm oil and 1.9% flax seed oil (for 
a detailed description of both diets, see table 1). The HFs diet thus contained more 
saturated and long chain fatty acids, and less medium chain and n-3 fatty acids than 
the HFpu diet. The HFs contained the minimal requirements for n-3 fatty acids (50) and 
the ratio of n6/n3 fatty acids was kept similar between both diets. Body weight, body 
composition - by using an EchoMRI™ Whole Body Composition Analyser (EchoMRI™, 
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Houston, USA) - and feed intake were monitored on a weekly basis. Mice received a 
fresh batch of feed at the start of each week and feed intake was determined from 
week 5 onwards by weighing the amount of feed at the start and at the end of each 
week. Three mice of each dietary group were sacrificed after 5 days of HF-feeding to 
analyse liver steatosis at the start of the experiment. The remaining 12 mice per dietary 
group continued until the end of the experiment; although, 1 mouse of the HFpu group 
died before the end of the experiment for reasons unrelated to the dietary intervention 
and was excluded from all analyses.  
 
Table 1 Diet composition of HFpu and HFs 
Ingredients (g kg-1) HFpu HFs 
Casein 267 267 
Wheat starch 172.5 172.5 
Maltodextrin 100 100 
Glucose 50 50 
Sucrose 100 100 
Coconut oil 37.8 0 
Sunflower oil 147 0 
Flaxseed 25.2 4 
Palm oil 0 206 
Cholesterol 97 mg 97 mg 
Cellulose 50 50 
Mineral mixture 35 35 
Vitamin mixture 10 10 
Choline bitartrate 2.5 2.5 
L-Cysteine 3 3 
Energy (kJ g-1)  19.7 19.7 
Energy (% of total energy content)   
Carbohydrate 36.8 36.8 
Fat 40.2 40.2 
Protein 23.0 23.0 
Fatty acid profile (g kg-1)   
Caprylic acid (C8:0) 2.8 0 
Capric acid (C10:0) 2.3 0 
Lauric acid (C12:0) 16.9 0.2 
Myristic acid (C14:0) 6.4 2.1 
Palmitic acid (C16:0) 13.1 89.8 
Stearic acid (C18:0) 8.5 9.0 
Oleic acid (C18:1 n-9) 35.5 76.1 
Linoleic acid (C18:2 n-6) 100.9 19.3 
α-Linolenic acid (C18:3 n-3) 13.5 2.5 
Fatty acid profile (% of total energy content)   
Saturated fatty acids 9.6 19.4 
Medium chain fatty acids (C6:0 –C12:0) 4.2 0 
Long chain fatty acids (C14:0- C18:0) 5.4 19.3 
Mono-unsaturated fatty acids 6.8 14.6 
Poly-unsaturated fatty acids 21.9 4.2 
Omega 3 fatty acids 2.6 0.5 
Omega 6 fatty acids 19.3 3.7 
Ratio n-6/n-3 fatty acids 7.5 7.6 
The macronutrient content of the HFs diet was matched to the macronutrient content of the HFpu diet, 
which is a standardized high-fat diet that we also used in previous studies (35). Diets only differ in the 
amount and type of dietary oil that was added to obtain two isocaloric diets with 40 energy % from fat. 
The fatty acid profile of the used dietary oils was derived from the USDA National Nutrient Database for 
Standard Reference (68).  
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Indirect calorimetry was performed in weeks 5 and 20. OGTTs were performed in week 
22; the response to fasting and re-feeding and the response to OxR was measured in 
week 25. Mice were sacrificed in week 27 by decapitation to prevent effects of 
anaesthesia on metabolic parameters (9, 11), after which blood was collected in Mini 
collect serum tubes (Greiner Bio-one, Longwood, USA), and centrifuged for 10 minutes 
at 3000 g and 4°C to obtain serum. Serum samples were aliquoted and stored at -80°C. 
Glucose concentration was measured in whole blood with a Freestyle blood glucose 
system (Abbott Diabetes Care, Hoofddorp, the Netherlands) according to the 
manufacturer’s instructions. After blood collection, liver tissue, the left epididymal WAT 
(eWAT) depot and the acromion trapezius muscle, which is situated between the 
shoulder blades and underneath the brown adipose depot, were dissected and snap 
frozen in liquid nitrogen and stored at –80 °C. The right eWAT depot was weighted and 
stored in Dulbecco’s Phosphate Buffered Saline (PBS; Gibco, Paisley, UK) with 3.7% 
formaldehyde (Merck KGaA Darmstadt, Germany) (pH=7.40) at 4⁰C. 
 
WAT and liver histology and mitochondrial density 
The caudal part (one third of the complete tissue) of the right eWAT depot was fixed in 
PBS with 3.7% formaldehyde (pH=7.40) at 4⁰C for 24 hours with moderate shaking, 
and then washed in PBS for 2 hours with moderate shaking and stored in PBS with 
0.1% sodium azide for several days at 4⁰C until further use. Fixed tissues were 
embedded in paraffin and sectioned at 5 µm. Adipocyte size and the amount of crown-
like structures (CLS) in eWAT were determined as published (6) with adaptations as 
described (32, 33) in 8 mice per dietary group (randomly selected) and used as an 
indication of adipose tissue health (55). Briefly, macrophages were stained with a 
monoclonal anti-MAC2 antibody (diluted 1:5000, overnight incubation at 4 °C; 
Cedarlane Laboratories Limited, Burlington, Canada). Next, sections were rinsed in 
PBS and incubated for 60 min at room temperature with a secondary goat anti-rat 
biotinylated antibody (diluted 1:200; Vector laboratories, Burlingame, CA, USA), rinsed 
again with PBS, and incubated for 60 min at room temperatures with Vectastain Elite 
ABC reagent (dilution 1:1000; Vector laboratories). After rinsing with PBS, the sections 
were incubated for 2 minutes at room temperature with 3,3′-diaminobenzidine solution 
(dilution 1:200; Vector laboratories). To determine adipocyte size, sections were 
stained with haematoxylin QS (Vector laboratories). To determine adipocyte size, we 
used sections from three distant layers of the adipose depot (with 150 µm in between 
layers). Within each layer, approximately 5 pictures were taken with a Zeiss Axioscope 
2 microscope equipped with an axioCamMRc 5 digital camera (Zeiss Inc., Jena, 
Germany). All adipocytes in each picture were manually encircled with the Axiovision 
software (Carl Zeiss, version 4.8) to determine the surface area of at least 400 
adipocytes per mouse. The number of CLS was scored manually per 1000 adipocytes 
per mouse in the similar distant areas as the sections that were used to determine 
adipocyte size. All analyses were performed blinded to dietary background.  
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Mitochondrial density in eWAT was determined as indicator of WAT health. The ratio of 
mitochondrial DNA to nuclear DNA was measured with reverse transcription 
quantitative real-time PCR (RT-qPCR) as published (42) and with modifications as 
described (16). Briefly, total DNA was extracted from homogenized eWAT by digestion 
with Proteinase K (Sigma-Aldrich) in a lysis buffer (50 mM Tris-HCL, pH 7.5, 0.5% SDS 
and 12.5 mM EDTA, pH 8.0) and RNAse A (Sigma-Aldrich). Samples were then 
centrifuged, after which the aqueous phase was mixed and extracted with phenol-
chloroform-isoamylacohol and twice with chloroform. DNA was precipitated by 96% 
ethanol and sodium acetate (3M, pH 5.2), washed with cold 70% ethanol, air-dried and 
re-suspended in 10 µl of RNAse DNAse free water. Quality and quantity of DNA in each 
sample was analysed with the Nanodrop (IsoGen Life Science, Maarssen, The 
Netherlands) and each sample was diluted to the same DNA concentration of 100 ng 
µL-1.  
 
Serum and tissue analyses 
Serum insulin, leptin and adiponectin levels were determined with the Bio-Plex Pro 
Mouse Diabetes Assay (Bio-Rad, Veenendaal, The Netherlands) according to the 
instructions of the manufacturer with the Bio-Plex 200 system (Bio-Rad) and used as 
indicators of adipose tissue health. Serum aspartate transaminase and alanine 
transaminase levels were determined with the AST and ALT enzymatic assay kit (Bioo 
Scientific Corporation, Austin, USA) according to the instructions of the manufacturer. 
Triacylglycerol levels were determined with the Triglycerides Liquicolor Kit (Human, 
Wiesbaden, Germany) according to the instructions of the manufacturer and as 
published (30). Approximately 20 mg of liver or muscle tissue was grinded to a powder 
in liquid nitrogen. Grinded tissue was dissolved in homogenisation buffer (10 mM TRIS-
HCl, 2mM EDTA, 250 mM sucrose, pH 7.5) to a concentration of 40 mg tissue/ ml 
buffer. Tissue homogenates were homogenized with an automated pellet mixer (VWR, 
Boxmeer, The Netherlands) for at least one minute and by pulling the homogenate 
through a 25 gauge needle at least three times until all tissue was fully dissolved.  
 
Oral glucose tolerance test (OGTT) 
On the day of the OGTT, food was removed 1.5 hour after start of the light phase. Mice 
remained without food for the following 5 hours, after which blood glucose was 
measured via a tail cut with the Freestyle blood glucose system (Abott Diabetes Care) 
and 2 g glucose /kg bodyweight was given by oral gavage. Fifteen, 30, 60, 90, and 120 
min following glucose administration, glucose concentration was determined using the 
Freestyle blood glucose system. Glucose tolerance was analysed with individual time 
course data of blood glucose levels and the individual incremental area under the curve 
(iAUC). 
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Indirect calorimetry 
Oxygen consumption and carbon dioxide production were measured with an open 
indirect calorimetry system (TSE Systems, Bad Homburg, Germany) that is equipped 
for simultaneous measurements of 12 individual mice, as published (34). Mice could 
adapt to the indirect calorimetry system for 24 hours, after which the actual 
measurement started and O2 consumption and CO2 production were recorded every 
thirteen minutes. Energy expenditure (EE), respiratory exchange ratio (RER) and 
physical activity were determined as described previously (16).  
To measure the response to fasting and re-feeding, mice received 1.5 gram of their 
own feed at the start of the dark phase (18.00h) in the indirect calorimetry system. All 
feed was consumed within the first 6 hours of the dark phase, after which RER starts to 
decline. Between 6.00h and 14.00h of the following light phase mice are in a fasted 
state (RER<0.75). At 14.00h, mice regained ad libitum access to the HFpu diet (HFpu 
mice) or HFs diet (HFs mice). RER values of each mouse were averaged during the 
period of fasting (from 23.00h to 6.00h), during the period when mice are fasted (from 
6.00h to 14.00h) and during the period of re-feeding (from 14.00h to 22.00h). The 
maximal RER-value during re-feeding was calculated as the average of the three 
highest consecutive RER values representing a time span of 26 minutes during the 
complete period of re-feeding and was used for comparison with the food quotient of 
both diets. Food quotients were calculated with the heat equivalents of CO2 of each 
component of the diet (3). Heat equivalents of the individual dietary oils were derived 
from Livesey and Elia (45). The percentage of energy from glucose oxidation was 
derived from average RER values of individual mice with the table of Peronnet (52).  
Indirect calorimetry during OxR was performed as described (15, 16). For the exposure 
to OxR we used the same fasting regime as during the response to fasting and re-
feeding (mice received 1.5 gram of feed at the start of the dark phase). One hour after 
start of the following light phase, oxygen concentration in each animal cage was 
decreased to 12% and O2 consumption and CO2 production were recorded every 
thirteen minutes for the following 6 hours. The day previous to the exposure to OxR, 
mice were kept in the indirect calorimetry system under the same (fasting) conditions 
and during the same time period of the day but under normoxic conditions, which 
means that in the analysis to the response to OxR, mice served as their own control. 
Blood glucose was measured directly after the exposure to OxR or normal air via a tail 
cut and with the Freestyle blood glucose system. 
 
Statistics 
Data are expressed as mean ± SEM. All analyses are based on the data of the 11 
HFpu mice and 12 HFs mice; except for the analysis of adipocyte size and WAT CLS, 
which is based on 8 mice per group. Statistical analyses were performed using 
GraphPad Prism version 5.04 (Graphpad, San Diego, USA). Data were checked for 
normality using the D’Agostino and Pearson omnibus normality test. Test results that 
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were not normally distributed were log-transformed or analysed with a non-parametric 
test (feed intake in the indirect calorimetry system wk20). Measurements at single time 
points between 2 independent groups were analysed by independent Students’ t-tests 
(all data in Table 2 and Figure 2, the iAUC of the OGTT and the RER peak during re-
feeding).  
Comparisons between two groups that were repeated over time (all data in Table 3, 
Figure 1 and Figure 5, glucose levels during the OGTT, RER during fasting and re-
feeding) were analysed with two-way repeated measures ANOVA (factor 1=diet, factor 
2=time) and Bonferroni post-hoc analysis. P-values smaller than 0.05 were considered 
to be statistically significant. 
 
Results  
 
The HFs diet mainly affected mean adipocyte size in eWAT and ectopic lipid 
storage in liver and skeletal muscle  
After 27 weeks of feeding mice with isocaloric HF diets differing only in fatty acid 
composition, we detected no differences in BW, adiposity (fig. 1), cumulative feed 
intake, WAT mitochondrial density, serum glucose, insulin, leptin, or adiponectin levels 
(table 2) between HFpu and HFs mice. Of note, both groups of mice had relatively high 
fasting insulin levels that are well above levels that are usually seen in high-fat fed male 
C57BL/6J mice (around 0.11 nmol L-1 after 18 weeks of feeding (49)).  
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Figure 1 Body weight and total adiposity during 27 weeks of HF feeding. Body weight (solid lines) 
and total adiposity (dotted lines) were determined on a weekly basis during the 27 weeks of HFpu and 
HFs feeding. Total adiposity is expressed as the percentage of total body fat over body weight.  
 
Adipocytes in eWAT were significantly larger in HFs mice compared to HFpu mice (fig. 
2A and B), whereas no difference in the number of crown-like structures in eWAT was 
observed (fig. 2C). Moreover, the mice that consumed the HFs diet had significantly 
higher triacylglycerol levels in liver and muscle (table 2), which indicates increased 
ectopic lipid storage. Consistently, serum aspartate transaminase and alanine 
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transaminase levels, markers for liver damage, were both significantly increased in HFs 
mice compared with HFpu mice (table 2). To obtain an impression of the extent of liver 
steatosis in week 27 compared to the situation at the start of the intervention, hepatic 
lipids were stained with Oil-red-O after either 5 days or 27 weeks of high-fat feeding in 
a limited number of mice per group (suppl. fig. 1). Both the number and size of hepatic 
lipid droplets strongly increased over time.  
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Substrate oxidation and energy expenditure under non-challenged conditions do 
not explain the increase in adipocyte size and ectopic lipid storage 
Energy expenditure, physical activity and the respiratory exchange ratio under non-
challenged conditions were measured with indirect calorimetry in week 5 and week 20 
of HF feeding (table 3). We also analysed diurnal (or circadian) rhythm, since it is 
known that a disturbance in circadian rhythm relates to metabolic dysfunction (57). To 
ensure accurate measurement of EE, RER and physical activity, we also analysed 24h 
feed and water intake in the indirect calorimetry system and compared that with the 
feed intake in the home cage in the same week and also between dietary groups. A 
drop in feed intake might indicate stress and disturbs the measurement of diurnal RER. 
EE and physical activity can also be affected by stress. Diurnal feed and water intake in 
the indirect calorimetry system were not significantly different between both dietary 
groups (table 3).  
 
Figure 2 Mean adipocyte size and 
prevalence of crown-like structures in 
eWAT after 27 weeks of HF feeding. 
Representative images (A) of the 
haematoxylin stainings that were used to 
determine the average adipocyte surface 
area (B) in eWAT of HFpu and HFs mice. 
The bar in each picture represents a 
distance of 100 µm. The number of CLS (C) 
was determined with a MAC-2 macrophage 
staining in eWAT. * P< 0.05 HFs mice vs. 
HFpu mice. 
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Table 2 Phenotypical data of mice fed the HFpu or HFs diet for 27 weeks 
 HFpu HFs p-value 
Cumulative feed intake (kg) 0.350 ± 0.007 0.339 ± 0.005 n.s. 
Serum insulin (nmol L-1) 2.36 ± 0.17 1.92 ± 0.20 n.s. 
Serum glucose (mmol L-1) 6.90 ± 0.19 7.16 ± 0.15 n.s. 
Serum leptin (nmol L-1) 6.13 ± 0.71 5.67 ± 0.94 n.s. 
Serum adiponectin (mg L-1) 15.5 ± 1.10 18.9 ± 1.35 n.s. 
Serum triacylglycerols (g L-1) 6.02 ± 0.29 6.69 ± 0.57 n.s. 
WAT mitochondrial density (ratio to HFpu) 1.00 ± 0.09 0.87 ± 0.07 n.s. 
eWAT weight (g) 0.795 ± 0.067  0.866 ± 0.036 n.s 
Liver triacylglycerol (mg g-1 liver) 52.7 ± 3.30 66.1 ± 3.02 0.007 
Muscle triacylglycerols (mg g-1 muscle) 17.9 ± 1.61 22.9 ± 1.67 0.045 
Serum aspartate transaminase activity (µmol s-1 L-1) 0.69 ± 0.06 1.07 ± 0.12 0.009 
Serum alanine transaminase activity (µmol s-1 L-1) 0.83 ± 0.06 1.51 ± 0.16 <0.001 
Data are expressed as mean ± SEM (n=11 for HFpu and n=12 for HFs). All parameters were measured 
after 27 weeks of HFpu or HFs feeding and when mice were in a fasted state. The cumulative feed 
intake is calculated from the total feed intake between week 4 and week 27. eWAT weight represents 
the weight of the right epididymal WAT depot only. n.s. non-significant. 
 
Feed intake in the indirect calorimetry system was, furthermore, not significantly 
different from feed intake in the home cage. Feed intake in the home cage was 2.98 ± 
0.05 for HFpu and 2.88 ± 0.05 for HFs in week 5 and 3.39 ± 0.08 for HFpu and 3.28 ± 
0.05 for HFs in week 20. HFpu mice had significantly higher physical activity levels 
compared with HFs mice. The increase in physical activity did, however, not result in a 
significant increase in energy expenditure. HFpu and HFs mice neither differed in 
diurnal RER in week 5 nor in week 20. Physical activity was significantly higher in week 
5 compared to week 20, whereas energy expenditure was higher in week 20 compared 
to week 5.  
 
Table 3 Indirect calorimetry measurements of HFpu and HFs mice in week 5 and week 
20 
 Week 5  Week 20  
 HFpu HFs  HFpu HFs sign. 
Respiratory exchange ratio 0.832 ± 0.008 0.812 ± 0.011  0.836 ± 0.007 0.829 ± 0.008 n.s. 
Energy expenditure (J s-1) 0.583 ± 0.008 0.575 ± 0.009  0.684 ± 0.018 0.678 ± 0.013 §§§§ 
Activity (total beam breaks 
(x1000)) 
36.4 ± 2.94 26.5 ± 2.03  25.8 ± 2.89 19.7 ± 1.37 §§§, 
ŦŦ 
% of activity in the DP 70.0 ± 3.46 67.1 ± 1.57  64.9 ± 3.57 66.5 ± 1.44 n.s. 
Feed intake (g) 2.77 ± 0.10 2.61 ± 0.24  3.14 ± 0.13 2.95 ± 0.22 n.s. 
% of FI in the DP 70.4 ± 2.12 66.1 ± 5.74  63.8 ± 3.30 68.5 ± 2.94 n.s. 
Water intake (ml) 1.74 ± 0.16 1.45 ± 0.20  2.25 ± 0.21 1.84 ± 0.14 §§ 
Data are expressed as mean ± SEM (n=11 for HFpu and n=12 for HFs). Indirect calorimetry 
measurements during normal, free-feeding conditions were performed after 5 and after 20 weeks of 
feeding the HFpu or HFs diet. Data were recorded and averaged over 24 hours. Feed intake (FI) and 
physical activity are also expressed as the percentage in the dark phase (DP) to give insight into the 
diurnal pattern. § indicates a significant effect of time (§§ P<0.01, §§§ P<0.001 and §§§§ P<0.0001).  
Ŧ indicates a significant effect of the diet (ŦŦ P<0.01). n.s. non-significant. 
 
Finally, we analysed the diurnal pattern with the percentage of physical activity and the 
percentage of feed intake in the dark phase. Both HFpu and HFs mice were more 
active and consumed more feed during the dark phase in both measurements 
(p<0.0001 for all 4 comparisons) as expected for nocturnal animals. HFpu and HFs 
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mice did not differ in the percentage of physical activity or the percentage of feed intake 
in the dark phase, which shows that they have similar diurnal patterns. 
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Assessment of metabolic flexibility 
One of the major aims of this study was to investigate functional implications of 
changes in health status by assessing metabolic flexibility. The first test that we used 
was a standardized OGTT. The two isocaloric HF diets showed a comparable glucose 
tolerance after 22 weeks of feeding (Figures 3A and B).  
Metabolic flexibility was also assessed with a fasting and re-feeding test. HFpu and 
HFs mice had low RER values when fasted, which indicates preferential whole body fat 
oxidation. During re-feeding, RER increased, which indicates a combination of both fat 
and carbohydrate oxidation on whole body level (fig. 4A). HFpu and HFs mice did not 
differ in mean RER during fasting (from 23.00h to 6.00h) or when they were in a fasted 
state (from 6.00h to 14.00h). During re-feeding (from 14.00h to 22.00h), however, HFpu 
mice showed a significantly larger increase in RER compared to HFs mice. 
Furthermore, the average RER over the complete period of re-feeding (fig. 4B) and 
maximal RER-value during re-feeding (fig. 4C) of HFpu mice matched the food quotient 
of the HFpu diet, which indicated that HFpu mice effectively alter their metabolism to 
use the nutrients that are available in the diet. In contrast, HFs mice did not increase 
RER levels above 0.815, which is significantly lower to the levels that were obtained in 
HFpu mice and is remarkably lower than the food quotient of the HFs diet. The 
reduction in the response to re-feeding in HFs mice indicates a reduction in metabolic 
flexibility. During re-feeding, mice had ad libitum access to feed, during which HFpu 
and HFs mice consumed a similar amount of feed (fig. 4C). 
Figure 3 Oral glucose tolerance 
test after 22 weeks of HF feeding. 
HFpu and HFs mice were fasted for 
5 hours at the start of the light 
phase, after which mice received 
glucose via oral gavage and blood 
glucose levels were monitored for 
the 2 hours afterwards (A), and 
expressed as iAUC (B). 
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Figure 4 RER during the fasting and re-feeding challenge after 25 weeks of HF feeding. HFpu and 
HFs mice were fasted and regained ad libitum access to their feed at 14.00h while RER was monitored 
continuously (A, the grey bar below the figure indicates the dark phase). RER values of individual mice 
were averaged when mice were fasting (from 23.00h to 6.00h), when mice were in a fasted state (from 
6.00h to 14.00h) and during re-feeding (from 14.00h to 22.00h) (B). The table (C) summarises the 
maximal RER-value during re-feeding based on three consecutive measures, the food quotients of the 
diets, and the feed intake during the 8 hours of re-feeding. ** P< 0.01 HFs mice vs. HFpu mice. 
 
Finally, metabolic flexibility was assessed using an exposure to OxR. HFpu and HFs 
mice did not differ in RER under normoxic conditions (fig. 5A). Exposure to OxR 
increased RER in HFpu mice compared to HFs mice (fig. 5B and C), which translates 
to an increase in the percentage of energy from full glucose oxidation (fig. 5D). An 
increase in glucose oxidation is considered advantageous during OxR since the 
oxidation of one mole of glucose requires less oxygen compared to the oxidation of one 
mole of fat. Furthermore, an increase in glucose oxidation can prevent the increase in 
blood glucose levels that is often seen during OxR (15). HFs mice seemed less flexible, 
based on the absence of a response to the reduction in oxygen availability. The 
analysis of blood glucose levels before and after exposure to OxR revealed a 
(statistical) interaction between the diet (HFpu and HFs) and oxygen level (OxR and 
normoxia) because HFpu and HFs responded differently to the exposure. Bonferroni 
post-hoc analysis revealed that HFs mice had higher blood glucose levels during OxR 
compared to HFpu mice (fig. 5E). 
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Figure 5 RER during the OxR challenge after 25 weeks of HF feeding. HFpu and HFs mice were 
fasted and exposed to normal air (A; 20.8% O2) or to oxygen restriction (B; 12.0% O2) for 6 hours. 
Asterisks (in B) indicate the individual time points at which the 2-way ANOVA post-hoc analysis 
revealed significant differences between HFpu and HFs mice. RER values of individual mice were 
averaged during the 6 hours in normal or hypoxic air (C) and used to estimate the percentage of energy 
from glucose oxidation (D). Blood glucose was measured directly after the exposure to OxR or normal 
air (E). * P<0.05 and ** P< 0.01 HFs mice vs. HFpu mice. 
 
Discussion 
 
We examined the effects of two isocaloric high-fat diets differing in fatty acid 
composition, but similar n6/n3 ratio, on metabolic flexibility and on different markers of 
metabolic health in adult male mice. The HFpu diet contained predominantly PUFAs, 
while the HFs diet mainly contained SFAs, supposedly being unhealthier. 
Unexpectedly, most biomarkers, including body weight, adiposity, WAT health, serum 
glucose, insulin and adipokine levels, and glucose tolerance did not differ between the 
two dietary groups. HFs mice, however, had bigger adipocytes, higher triacylglycerol 
levels in liver and skeletal muscle, higher serum alanine transaminase and aspartate 
transaminase levels, and a reduced physical activity level. Despite these relatively 
small phenotypical changes, HFs mice were less flexible in the response to the fasting 
and re-feeding challenge and the OxR challenge, which indicates a reduction in 
metabolic flexibility. 
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The ratio of n-6 to n-3 PUFAs might account for the small phenotypical 
differences between HFpu and HFs mice  
The HFpu and HFs diets primarily differ in the amount of long chain SFAs (5.4% in 
HFpu vs. 19.3% in HFs) and PUFAs (21.9% in HFpu vs. 4.2% in HFs). Excessive 
consumption of saturated fat leads to WAT expansion, WAT inflammation and inhibition 
of glucose and fat oxidation (reviewed by 40). Long chain SFAs (C14-C18), compared 
to medium chain SFAs (C6-C12), further increase weight gain and fat-mass gain (21, 
48). n-3 PUFAs, on the other hand, reduce weight gain (24), protect against 
cardiovascular diseases (12) and reduce inflammatory proteins (38). These effects 
seem to contrast our results. However, differences in weight gain, WAT inflammation, 
or adiposity are not always reported in studies in which the amount of SFAs is 
increased compared to other (unsaturated) fatty acids (19, 21, 43, 65). Moreover, 
studies in which the amount of n-3 PUFAs is increased compared to other (saturated or 
n-6) FAs do not always show improvements in body weight, liver lipids or inflammatory 
cytokines (1, 7, 25, 77). One explanation for the absence of major differences in the 
studied markers for metabolic health between HFpu and HFs mice may be that both 
diets have a similar n6/n3 PUFA ratio. It has been proposed that health effects of HF 
diets primarily depend on this ratio (59). A ten-fold increase in the n6/n3 ratio in 
isocaloric high-fat diets with similar SFA content, for example, increased hepatic lipid 
storage, even though feed intake was significantly higher in the low n6/n3 group (54). It 
was also shown that a 4-fold increase in the amount of SFAs did not increase body 
weight, WAT inflammation or adipocyte size when the n6/n3 ratio was kept equal 
between diets (21). However, there are also studies that show that the n6/n3 ratio does 
not influence body weight (76) or lipid peroxidation in liver (14), and it was suggested 
that the absolute mass of essential fatty acids, rather than the n6/n3 ratio, determines 
long-term health effects of a diet (75). Our study however, shows that body weight gain 
and WAT health are equally affected as long as the dietary n6/n3 ratio is kept similar. 
 
The HFs diet and HFpu diet differently affect lipid storage in WAT, muscle and 
liver  
After 27 weeks of high-fat feeding, HFs mice had bigger adipocytes and more ectopic 
lipid storage in muscle and liver than HFpu mice, which suggests that the type of 
dietary fat affects the allocation of fat storage. Adipocyte hypertrophy is known to 
indicate a reduced capacity to initiate hyperplasia (29). A certain reduction in the 
formation of new adipocytes increases fat storage in existing adipocytes, leading to 
further adipocyte enlargement. Large adipocytes are less sensitive to insulin than 
smaller adipocytes (reviewed by 28) and adipocyte size is positively associated with 
insulin resistance and Type 2 diabetes in both humans and rodents (56, 74). The failure 
to recruit new adipocytes does not only increase adipocyte hypertrophy but also 
increases ectopic fat storage (29). Ectopic fat deposition, or steatosis, can lead to cell 
dysfunction and cell death (69) and is strongly associated with insulin resistance (46). 
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n-3 PUFAs are known to prevent both adipocyte hypertrophy and obesity-related 
adipose remodelling (37), which might explain the increase in adipocyte size, and 
possibly related ectopic lipid storage, in HFs vs. HFpu mice. The increase in ectopic 
lipid accumulation in HFs mice might, on the other hand, also result from increased lipid 
uptake, increased fatty acid synthesis, or reduced fat oxidation in liver and muscle 
tissue (58), which are also affected by dietary fat composition (18, 43, 47). The dietary 
fatty acid composition, thus, seems to alter the allocation of fat storage, even though 
total adiposity remains equal between both groups. The increase in ectopic lipid 
storage is expected to lead to differences in metabolic health and metabolic flexibility.  
 
The changes in the response to fasting and re-feeding and oxygen restriction in 
HFs mice indicate impairment of carbohydrate metabolism  
Despite the significant changes in adipocyte size and ectopic lipid storage, HFs and 
HFpu mice did not differ in in their response to the OGTT. The stress response that is 
induced by oral gavage or blood sampling (63, 67) may potentially have masked any 
differences in the response. It is, however, more likely that HFs and HFpu mice simply 
had a similar glucose tolerance, because both diets provide a similar glycaemic load. 
Next to the OGTT, metabolic flexibility was analysed with two non-invasive tests in the 
indirect calorimetry system. Under unchallenged conditions, HFpu and HFs mice did 
not differ in mean diurnal RER; furthermore, diurnal RER values matched the food 
quotient of the diet consumed, which means that under free-feeding conditions, 
macronutrient oxidation matches macronutrient availability. Fasting RER values were 
also similar between HFs and HFpu mice, indicating that mice do not differ in the 
flexibility to switch to the mobilization and oxidation of stored lipids (26). When mice 
were, however, challenged to switch from a fasting to a fed state, it became apparent 
that HFs mice made less efficient use of the carbohydrates in the diet. Also during the 
challenge with OxR, HFpu mice reached higher RER values than HFs mice, which 
indicates a higher level of glucose oxidation. The increase in RER during OxR was also 
observed in low-fat versus high-fat fed mice (15) and was accompanied by a reduction 
in oxygen consumption in low-fat versus high-fat fed mice. A metabolic switch from fat 
to glucose oxidation can lead to a small reduction in oxygen consumption (45), which is 
considered favourable during low-oxygen conditions. Mice that are less flexible, e.g. 
because of HF-feeding, proved to be less effective in this adaptation (15), which was 
also seen here in HFs versus HFpu mice. Both indirect calorimetry-based challenge 
tests, thus, show that HFs mice have a reduced capacity to increase glucose oxidation. 
The mechanistic background behind this reduction in metabolic flexibility needs further 
investigation. The type of dietary fat does, unlike the amount of fat (8), not affect 
intestinal absorption of carbohydrates (53); the difference in diet composition, therefore, 
does not account for the difference in substrate oxidation after re-feeding. HFs mice 
might, however, be less flexible because of a reduced mitochondrial capacity to oxidize 
carbohydrates. Chronic HF feeding is known to disturb β-oxidation, leading to increased 
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accumulation of β-oxidative intermediates and reduced glucose oxidation: a condition 
that is referred to as ‘mitochondrial overload’ (41). Saturated fatty acids are oxidized 
more slowly than unsaturated fatty acids (10, 39), but it is as yet unclear whether the 
changes in the rate of oxidation also increase incomplete FA oxidation. Alternatively, 
HFs mice might be more prone to use glucose for hepatic de novo lipogenesis (DNL) 
instead of using it for mitochondrial oxidation. Hepatic DNL is positively associated with 
obesity and other metabolic disorders (17), where it increases ectopic lipid storage (13). 
Furthermore, hepatic DNL was observed as a response to OxR in mice in high-fat fed 
mice (15).  
 
 
Conclusions 
A diet high in SFAs versus a diet high in PUFAs, but similar n6/n3 ratio, did not affect 
many parameters of metabolic health in male mice, but led to an increase in mean 
adipocyte size in eWAT, ectopic lipid accumulation in liver and skeletal muscle, and to 
liver damage. Both indirect calorimetry-based challenge tests showed that HFs mice 
were less flexible in the switch from fat to carbohydrate use, which indicates a reduction 
in metabolic flexibility.  
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Supplemental figure 1 Hepatic lipid droplets after 5 days and 
27 weeks of HF feeding. Representative images of the Oil-red-O 
stainings in liver after 5 days and 27 weeks of HFpu or HFs 
feeding. Pictures were used to visualise the extent of hepatic 
steatosis at the end of the study. The bar in each picture 
represents a distance of 100 µm.  
 
Methodology:  
Liver tissue was immediately frozen after dissection, after which 
part of the left lobe was removed and sectioned at 7 µm with a 
cryostat (Leica Microsystems, Nussloch GmbH, Germany). 
Sections were made in four equally distant (distance: 56 μm) parts 
of the left lobe to achieve representative sections. Sections were, 
then, left at room temperature for 30 minutes and were  fixed in 
3.7% buffered formalin and stained with Oil-red-O (Sigma-Aldrich, 
St Louis, MO, USA) as published (22) and with modifications as 
described (31). Oil-red-O stainings were performed for 3 mice per 
group (randomly selected). 
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Abstract 
 
Oxygen availability can be limited during expansion of white adipose tissue (WAT) in 
obesity. Little is known on the adaptation of WAT to mild oxygen restriction (OxR). 
Therefore, we studied metabolic adaptation to acute OxR in fasted, diet-induced 
moderately obese mice that were exposed to mild hypoxic (12% O2) or normoxic 
(20.9% O2) conditions for 6 hours.  
Adaptation to OxR was assessed by determination of amino acid and (acyl)carnitine 
levels in serum and in WAT, and by whole genome gene expression analysis of WAT. 
Adaptation was also assessed during OxR with indirect calorimetry.  
We found that OxR reduced mitochondrial oxidation at whole-body level, as shown by a 
reduction in whole-body oxygen consumption and an increase in serum long-chain 
acylcarnitine levels. WAT did not seem to contribute to this serum profile since only 
short-chain acylcarnitines were increased in WAT and gene expression analysis 
indicated an increase in mitochondrial oxidation, based on coordinate down-regulation 
of Sirt4, Gpam and Chchd3/Minos3. In addition, OxR did not induce oxidative stress in 
WAT, but increased molecular pathways involved in cell growth and proliferation. OxR 
increased levels of the amino acids tyrosine, lysine, and ornithine in serum, and of 
leucine/isoleucine in WAT.  
This study shows that OxR limits oxidative phosphorylation at whole-body level, but in 
WAT compensatory mechanisms seem to operate. The down-regulation of the 
mitochondria-related genes Sirt4, Gpam, and Chchd3 may be considered as a 
biomarker profile for WAT mitochondrial reprogramming in response to acute exposure 
to limited oxygen availability. 
 
 
WAT ADAPTATION TO ACUTE OxR   l   125 
 
 
6  
Introduction 
 
Oxygen restriction (OxR) was recently introduced as a challenge test to investigate 
metabolic flexibility in mice (11, 12) and is based on short-term exposure to ambient 
hypoxia. OxR reduces whole-body oxygen consumption and increases serum glucose 
and lactate levels in rodents (11, 12, 31). In vitro studies consistently show that, when 
cells are exposed to hypoxic air, the level of anaerobic glycolysis increases (reviewed 
by 41), leading to increased lactate formation and reduced cellular oxygen consumption 
(34). The metabolic response to mild ambient hypoxia ([O2]=12%) in vivo, as applied in 
the OxR challenge, however, depends on the metabolic flexibility of the body as a 
whole. Each organ reacts in a specific way that matches the oxygen demand, functional 
capacity and metabolic function of the organ. The liver, for example, decreases sterol 
metabolism to spare oxygen and increases gluconeogenesis to clear lactate from 
circulation (4, 9, 11). The heart responds to chronic hypoxia by increasing cardiac 
hypertrophy and stroke volume (13). Not much is known about the adaptation of white 
adipose tissue (WAT) to OxR, even though WAT plays a major role in the maintenance 
of metabolic health and is known to be the primary organ that is sensitive to tissue 
hypoxia in obesity (35). Knowledge on the metabolic response of WAT to short term 
OxR will contribute to understanding its role in metabolic flexibility and in the 
interpretation of WAT focused metabolic flexibility assessment. The only study that, to 
our knowledge, investigated the effect of OxR on energy metabolism in WAT in vivo 
used a chronic exposure to OxR in lean mice (45), assessing long term metabolic 
adaptation, rather than a short term exposure as applied here, where the primary 
response is assessed. Also, the effect of short-term OxR on mitochondrial function in 
WAT in vivo remains largely unknown, whereas these organelles are expected to be 
essential for metabolic adaptation to OxR considering their role in energy production 
and their reliance on oxygen availability. In vitro studies, indeed, show that 
mitochondrial function is inhibited during acute hypoxic exposure, leading to a reduction 
in oxygen consumption and to cell death (34). Furthermore, it was shown that acute 
hypoxia in vivo, as for example seen in perinatal hypoxia, causes an increase in 
circulating acylcarnitines, whereas free carnitine (or L-carnitine) levels decrease (2, 3, 
42). Free carnitines are essential cofactors for mitochondrial transport and 
mitochondrial fatty acid (FA) oxidation, whereas acylcarnitines are intermediates of FA 
oxidation. High plasma levels of acylcarnitines indicate incomplete FA oxidation (24, 25, 
32), which indicates that OxR also affects mitochondrial function in vivo.  
Here, we determined the effect of acute, normobaric OxR on whole body energy 
metabolism and aimed to elucidate the role of WAT in the response to OxR. In this 
study, we used moderately obese mice that were fed a semi-purified high-fat diet that 
mainly contains unsaturated fatty acids to induce WAT expansion without increased 
WAT inflammation (43). The metabolic response to OxR at whole body level was 
assessed by determination of oxygen consumption and respiratory exchange ratio 
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(RER) using indirect calorimetry (InCa) and by determination of blood glucose and 
serum adiponectin levels. Liquid chromatography–mass spectrometry was used to 
analyse free carnitine, acylcarnitines and amino acids levels in both serum and WAT. 
Finally, we employed whole-genome gene expression analysis of WAT and measured 
tissue lactate levels and aconitase functionality. 
 
Materials and methods 
 
Animals and experimental manipulations 
The experimental protocol for animal handling was approved by the Animal Welfare 
Committee of Wageningen University, Wageningen, The Netherlands (DEC2012088). 
Twenty-four male C57BL/6JOlaHsd mice were used for this study (Harlan Laboratories, 
Horst, The Netherlands). Mice arrived at 10 weeks of age and were individually housed 
and maintained under environmentally controlled conditions (21 ± 1ºC, 12 h/12 h light–
dark cycle, 50 ± 10% humidity) and had ad libitum access to feed and water. During the 
first three weeks of the study, mice could adapt to the new environment and received 
the purified low-fat BIOCLAIMS standard diet, which contains 10% energy from fat (19). 
Thereafter, mice received the purified BIOCLAIMS high-fat diet, which contains 40% 
energy from fat (11, 48) for the remaining 6 weeks of the study. Body weight and body 
composition - by using an EchoMRI Whole Body Composition Analyser (EchoMRI, 
Houston, FL, USA) - were monitored on a weekly basis. At the end of the study, mice 
were randomly allocated to the oxygen restriction (OxR mice) or the normoxia (Norm 
mice) treatment (12 mice per group). Mice were directly sacrificed after the exposure to 
OxR or normoxic air by decapitation to prevent effects of anaesthesia on metabolic 
parameters (5, 8), after which blood was collected in Mini collect serum tubes (Greiner 
Bio-one, Longwood, FL, USA). Glucose concentration was measured in whole blood 
with a Freestyle blood glucose system (Abbott Diabetes Care, Hoofddorp, the 
Netherlands) according to the manufacturer’s instructions. After blood collection, the left 
epididymal WAT (eWAT) depot was dissected, snap frozen in liquid nitrogen and stored 
at –80 °C. Serum tubes were centrifuged for 10 minutes at 3000 g and 4°C to obtain 
serum, which was aliquoted and stored at -80°C. 
 
Indirect calorimetry during OxR or normal air 
Indirect calorimetry (TSE Systems, Bad Homburg, Germany) during oxygen restriction 
was performed as described (11, 12). In short, mice could adapt to the InCa system for 
24 hours, all feed was removed at start of the dark phase and mice received a 
restricted amount of feed (1.5 gram) to ensure a fasting state at the start of the 
following light phase. One hour after start of the light phase, oxygen concentration in 
each animal cage was decreased from 20.9% to 12% (for OxR mice) and VO2 and 
VCO2 were recorded every thirteen minutes for the following 6 hours. Norm mice were 
treated in the same manner, but remained under normoxic conditions. 
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Serum and tissue analyses 
Serum adiponectin levels were determined with the Bio-Plex Pro Mouse Diabetes 
Assay (Bio-Rad, Veenendaal, The Netherlands), according to the instructions of the 
manufacturer, with the Bio-Plex 200 system (Bio-Rad). Serum and WAT acylcarnitine 
and amino acid levels were determined with ultra high performance liquid 
chromatography–mass spectrometry (UltiMate3000 RSLC, Thermo Scientific, 
Sunnyvale, CA, USA; QTRAP 5500, AB-Sciex, Framingham, MA, USA) according to a 
published method (36). Acylcarnitines and amino acids were separated with a HILIC 
Kinetex column, 50x2.1 mm, 1.7 µm (Phenomenex Inc., Ca, USA) at 25°C using 
gradient elution: eluent A, 90/10 (v/v) acetonitrile/buffer; eluent B, 90/10 (v/v) 
water/buffer; ammonium formate (20 mM, pH 4.0) as the buffer. Elution began with 
100% eluent B at a flow rate of 0.5 mL/min, decreased to 25% A in 8.5 minutes, 
returned to 100% D in 0.5 min and stayed at 100% D for 0.5 minutes. The total run time 
was 9.5 min. Metabolites were identified by multiple reaction monitoring. Serum and 
WAT samples were treated with methanol and 0.1% formic acid and an internal 
standard with labeled amino acids and acylcarnitines (Chromsystems Instruments and 
Chemicals GmbH, Gräfelfing, Germany) was added to each sample. The concentration 
of individual metabolites was calculated with the peak area of the metabolite of interest 
and the peak area of the corresponding internal standard. The amino acids leucine and 
isoleucine are detected together within one peak.  
The aconitase activity level is a marker for oxidative stress (14), and was measured as 
described (40). Briefly, WAT samples were ground in liquid nitrogen and homogenized 
in Tris-HCl (50 mM, pH 7.4) buffer with a digital ultrasonic sonifier (Branson Ultrasonic 
Corporation, Danbury, CT, USA). WAT citrate synthase activity and lactate levels were 
measured with the Citrate Synthase Assay Kit (Sigma Aldrich) and Lactate Assay Kit II 
(Biovision, Mountain View, USA), respectively, according to the manufacturer’s 
instructions and as published (12). To assure similar sample input for the aconitase, 
lactate, and citrate synthase assays, samples were diluted to the same total protein 
concentration, as determined with the RC DC protein assay (Biorad) using Bovine 
Serum Albumin Fraction V dilutions (Roche Diagnostics GmbH, Mannheim, Germany) 
as standard. 
 
RNA isolation and micro array hybridization 
Total RNA was isolated from eWAT using TRIzol reagent, chloroform, and isoamyl 
alcohol (PCI) (Invitrogen, Breda, The Netherlands) as described (46) followed by 
purification with RNeasy columns (Qiagen, Venlo, The Netherlands) using the 
instructions of the manufacturer. RNA concentration and purity were measured using 
the Nanodrop (IsoGen Life Science, Maarssen,The Netherlands) and the Experion 
automated electrophoresis system (Bio-Rad). For global transcriptome analysis, 8 × 60 
K Agilent whole-mouse genome microarrays (G4852A, Agilent Technologies Inc., 
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Santa Clara, CA, USA) were used according to the manufacturer’s protocol with a few 
modifications as described previously (17). All arrays are deposited in GEO under 
number GSE64238. Two arrays from the OxR group were, based on their aberrant MA 
plots, excluded for further analysis. In total, 33,845 of the 59,305 probes on the array 
had a fluorescent signal twice above the background signal and were statistically 
analysed. 
 
Statistics  
Data are expressed as mean ± SEM. All analyses are based on the data of 12 Norm 
mice and 12 OxR mice; except for the measurement of physical activity, which is based 
on 8 random selected mice per experimental group. Gene expression data is based on 
12 Norm mice and 10 OxR mice. Statistical analyses were performed using GraphPad 
Prism version 5.04 (Graphpad, San Diego, CA, USA). Statistical analyses of gene 
expression data were performed using GeneMaths XT version 2.12 (Applied Maths, 
Inc. Austin, TX, USA). Data were checked for normality using the D’Agostino and 
Pearson omnibus normality test. All data that were normally distributed were analysed 
by independent Students’ t-tests. Test results that were not normally distributed were 
analysed with a Mann-Whitney test (the case for free carnitine, C5, C5-1 and C5DC 
acylcarnitines in WAT). P-values smaller than 0.05 were considered to be statistically 
significant. 
 
Results 
 
Effects of OxR on whole body level 
Mice from the OxR and Norm group did not significantly differ in body weight or body 
composition prior to the exposure (Norm mice: BW 33.2 ± 1.11 g, total fat mass 9.35 ± 
0.83 g, lean mass 22.34 ± 0.36 g; OxR mice: BW 34.2 ± 0.80 g, total fat mass 10.40 ± 
0.54 g, lean mass 22.42 ± 0.24 g). The response to OxR was continuously monitored 
during the exposure to OxR or normoxic air with the InCa system. Average oxygen 
consumption (fig. 1A) and energy expenditure (fig. 1B) were significantly lower during 
the six hour exposure to OxR indicating an immediate reduction in metabolic rate. 
Average RER (fig. 1C), representing substrate usage, was marginally decreased by 
OxR, whereas no statistical significant differences were seen in physical activity (fig. 
1D).  
Blood glucose (fig. 2A) and serum adiponectin levels (fig. 2B), and serum free carnitine, 
acylcarnitine, and amino acid levels (table 1) were measured directly after the exposure 
to OxR or normoxic air. Blood glucose levels significantly increased by the exposure to 
OxR, whereas adiponectin levels remained unaffected. In serum, 18 of the 53 
metabolites that could be detected were significantly altered by OxR (for the complete 
list of measured metabolites in serum, see supplemental table 1). OxR decreased 
levels of free carnitine, did not alter any of the short-chain acylcarnitines (C4-C8), but 
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stably increased the level of several medium-chain (C10-C14) and long-chain (C16-
C20) acylcarnitines in serum. OxR also increased the serum level of the amino acids 
tyrosine, lysine, and ornithine. 
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Effects of OxR in WAT 
The effect of OxR on energy metabolism in WAT was, at first, studied by the 
determination of lactate and aconitase activity levels in WAT. The presence of lactate 
indicates increased anaerobic metabolism; WAT lactate levels were not altered by the 
exposure to OxR (fig. 2C). Decreased aconitase activity levels indicate increased 
oxidative stress (18). We also measured citrate synthase activity in WAT, as a marker 
for mitochondrial density. Changes in the level of mitochondrial density would interfere 
with the measurement of aconitase activity. We found that OxR did not alter 
mitochondrial density, as assessed by citrate synthase activity (fig. 2D), or ROS 
production, as assessed by aconitase activity (fig. 2E).  
Second, we measured the influence of OxR on (acyl)carnitine and amino acid levels in 
WAT (table 1). We found that 7 of the 59 metabolites that could be detected were 
significantly altered by OxR (for the complete list of measured metabolites in WAT, see 
supplemental table 1). OxR increased free carnitine levels, did not alter any of the long- 
or medium-chain acylcarnitines, but increased the levels of several short-chain 
acylcarnitines. OxR also increased the level of the amino acids leucine and isoleucine.  
We also studied the influence of OxR on WAT whole genome gene expression, to gain 
insight into the molecular background of the observed changes in WAT metabolism. 
We found that 82 micro-array probes were significantly regulated (p<0.01) by OxR. 
These 82 probes correspond to 78 unique genes that were categorised by function 
Figure 1 OxR decreases oxygen consumption 
and energy expenditure but does not alter 
RER or physical activity. Whole body oxygen 
consumption (A), energy expenditure (B), and 
RER (C) levels were averaged over the 6 hours 
of normoxia or OxR in 12 mice per group. 
Physical activity (D) was determined as total 
beam break during OxR or normoxia in 8 mice 
per group. Mice remained in a fasted state during 
the measurements. ***P < 0.001  
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(table 2). Forty-five of those genes had a known function (additional information of the 
genes with a known function can be found in supplemental table 2). The majority of 
those 45 genes is involved in cell growth and survival and most genes are regulated in 
the direction to stimulate cell proliferation and inhibit apoptosis.  
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The second class of regulated genes contains genes involved in transcription and 
translation, a process that is closely related to cell growth and survival. Consistently, 
most genes in the second class are regulated in the direction to stimulate transcription 
and translation. Zooming in on genes annotated to mitochondria, three genes were 
identified: Sirtuin 4 (Sirt4), glycerol-3-phosphate acyltransferase, mitochondrial (Gpam) 
and coiled-coil-helix-coiled-coil-helix domain containing 3 (Chchd3/ Minos).These 
genes play an important role in the regulation of fatty acid oxidation and mitochondrial 
structure and were all significantly down regulated by OxR. Since the metabolite 
analysis revealed an effect of OxR on acyl carnitines and amino acids, expression of 
genes encoding proteins with central functions in their metabolism were analysed (table 
3). However, none of these genes were significantly regulated by OxR.  
Finally, we also focussed on genes involved in the response to oxidative damage, 
which might increase when energy demand does not match oxygen availability. We 
found no changes in genes involved in antioxidant response (such as superoxide 
dismutase 1 or 2 or catalase) or genes involved in autophagy (such as general 
transcription factor 2 (P62) or microtubule-associated protein 1 (LC3)). We found no 
clear changes in genes involved in ER stress, such as activating transcription factor 6 
or protein phosphatase 1 r15a , except for Der1-like domain family 3 (Derl3). Derl3 is 
involved in the degradation of misfolded glycoproteins and was significantly down 
regulated by OxR (table 2). 
Figure 2 OxR increases blood glucose 
and WAT lactate levels but does not alter 
serum adiponectin or WAT aconitase 
activity. Blood glucose levels (A), serum 
adiponectin (B), WAT lactate (C) and WAT 
citrate synthase (D) and aconitase activity 
(E) levels were determined after the 6 hours 
of normoxia or OxR in 12 mice per group. 
WAT measurements were corrected for 
protein content of the tissue homogenate. 
*P < 0.05 
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Table 1 Overview of significantly regulated amino acids, acylcarnitines and 
free carnitine in serum and WAT  
Data are expressed as the fold change of the level in OxR mice compared with the level in  
Norm mice. n=12 mice per group.  
 
Table 2 Functional categorization of all 78 genes that were significantly regulated 
(p<0.01) after 6 hours of OxR in WAT 
Fold changes (OxR to Norm) are shown in parentheses behind each gene symbol. Additional 
information about the significantly regulated genes can be found in supplemental table 2. 
Metabolite  Name  
 Fold 
change 
p-value 
 Fold 
change 
p-value 
   SERUM  WAT 
Free carnitine 
C0 free carnitine  -1.26 0.003   1.50 0.012 
Short-chain acylcarnitines 
C3 propionylcarnitine   1.01 0.918   2.25 0.039 
C4DC methylmalonylcarnitine   - -   1.45 0.045 
C5 methylbutyrylcarnitine   1.04 0.586   2.60 0.004 
C5-1 methylcrotonylcarnitine   1.24 0.311  15.59 0.003 
C5DC glutarylcarnitine   - -   2.90 0.004 
Medium-chain acylcarnitines 
C10 decanoylcarnitine   1.36 0.003  -1.73 0.197 
C10-1 decenoylcarnitine   1.34 0.008  -1.11 0.598 
C12-1 dodecenoylcarnitine   2.40 <0.001  -1.70 0.184 
Long-chain acylcarnitines 
C16 palmitoylcarnitine   1.39 <0.001   1.13 0.579 
C16-1 palmitoleylcarnitine   1.55 <0.001  -1.46 0.315 
C16-2 hexadecadienoylcarnitine   1.41 <0.001  -1.82 0.143 
C16DC dicarboxypalmitoylcarnitine   1.26 0.003   1.31 0.087 
C18-1 oleylcarnitine   1.35 <0.001  -1.07 0.797 
C18-1OH 3-hydroxyoleoylcarnitine   1.27 0.047  -1.06 0.860 
C18-2 linoleylcarnitine   1.47 <0.001  -1.25 0.427 
C18-2OH 3-hydroxylinoleoylcarnitine   1.76 0.014  -1.07 0.821 
C18-3 linolenoylcarnitine   1.41 0.003  -1.29 0.444 
C20-3 eicosatrienoylcarnitine   1.52 0.002  -1.07 0.879 
C20-4 eicosatetraenoylcarnitine   1.29 0.023  -1.10 0.786 
Amino acids 
leu + ile leucine + isoleucine   1.15 0.223   2.06 0.029 
lys lysine   1.39 0.003   - - 
orn ornithine   2.54 0.002   1.47 0.732 
tyr tyrosine   1.26 0.036   1.43 0.18 
Function 
# of 
genes 
Gene symbol (and fold change) 
Cell growth & survival 11 Fam107a (1.4), Dusp9 (1.3), Haus7 (1.2), Nt5c2 (1.2), Hbegf (1.3), 
Prdm4 (1.2), Traf4 (-1.2), Tchp (-1.1), Cdip1 (-1.2), Rabgap (-1.2), 
Tubgcp4 (-1.2) 
Transcription & translation 6 Med24 (1.2), Tnks2 (1.2), Zfp319 (1.2), Hsf2 (-1.3), Zfp523 (-1.2),  
Hoxb3 (-1.2) 
Neuronal plasticity & transport 5 Synpo (1.3), Stau2 (1.3), Samd14 (1.3), Kifc2 (-1.2), Homer1 (-1.2) 
Immune response 4 Retnlg (1.6), Gpr65 (1.2), Podxl2 (1.2), Trim59 (1.3) 
Active and passive 
transmembrane transport 
4 Clca1 (1.4), Sec63 (1.2), Atp2b4 (-1.3), Vamp1 (-1.2) 
Redox homeostasis 3 Mt1 (1.4), Hspb7 (1.3), Pdia5 (1.2) 
Mitochondrial function 3 Gpam (-1.3), Chchd3 (-1.2), Sirt4 (-1.2) 
Signal transduction 3 Ms4a4a (1.3), Adrbk2 (-1.2), Pigc (-1.2) 
Blood pressure & angiogenesis 2 Ren2 (1.8), Apold1 (1.3) 
Diverse functions 3 Lhfp (1.2; lipoma formation), Derl3 (-1.3; degradation of misfolded 
ER proteins); Olfr1466 (-1.2; olfactory receptor) 
Unknown function 34  
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Discussion 
 
OxR reduces mitochondrial oxidation at whole body level 
OxR significantly decreased oxygen consumption and increased blood glucose levels, 
which is consistent with previous studies using the OxR challenge (11, 12). The 
increase in blood glucose levels probably indicates an increase in hepatic 
gluconeogenesis (4, 11). The decrease in oxygen consumption indicates a decrease in 
mitochondrial oxidative phosphorylation at whole-body level. A reduction in oxygen 
consumption can be achieved by a switch from aerobic (mitochondrial) to anaerobic 
glycolytic ATP production; however, also the small, although non-significant, decrease 
in physical activity might contribute to the reduction in oxygen consumption. 
Hypothermia is also known to play a role in the reduction of oxygen consumption in 
mice during hypoxia (15); however, body temperature was not assessed in our study.  
OxR, furthermore, increased serum levels of the amino acids lysine, ornithine and 
tyrosine. Elevations in circulating amino acid levels are strongly related to obesity (33), 
where it is expected to impair skeletal muscle glucose uptake and increase hepatic 
gluconeogenesis (26, 27). Interestingly, also during OxR, hepatic gluconeogenesis (4, 
11) and circulating glucose levels are increased. In contrast to the studies that focus on 
amino acid levels in obesity, in our study amino acid levels changed independently from 
dietary intake. The increase in amino acids that is seen in both obesity and OxR might, 
therefore, be seen as a regulator of glucose homeostasis, rather than solely a 
consequence of dietary intake.  
 
Table 3 Regulation of genes involved in carnitine and amino acid metabolism after 6 
hours of OxR in WAT  
Changes in gene expression are shown as the fold change of the level in OxR mice (n=10) compared to 
the level in Norm mice (n=12). n.d., not detected 
 
Gene 
symbol 
Gene name 
Fold 
change 
p-
value 
Function 
Bcat1 branched chain aminotransferase 1  1.21 0.11 catabolism of BCAA, cytosolic 
Bcat2 branched chain aminotransferase 2 -1.10 0.68 catabolism of BCAA, mitochondrial 
Bckdha branched chain ketoacid 
dehydrogenase E1, α 
-1.09 0.74 
inactivation of the branched-chain 
alpha-ketoacid dehydrogenase 
complex: the key regulatory enzyme 
of the valine, leucine and isoleucine 
catabolic pathways 
Bckdhb branched chain ketoacid 
dehydrogenase E1, β 
-1.19 0.56 
Bckdk branched chain ketoacid 
dehydrogenase kinase 
-1.03 0.85 
Dbt dihydrolipoamide branched chain 
transacylase E2 
-1.00 1.00 component of branched-chain alpha-
keto acid dehydrogenase complex 
Dld dihydrolipoamide dehydrogenase  1.04 0.85 carnitine transport out of the cell 
Slc16a9 solute carrier family 16, member 9  1.08 0.28 cellular carnitine import and export  
Slc22a5 solute carrier family 22, member 5 -1.05 0.42 carnitine transport into the cell 
Slc22a16 solute carrier family 22, member 16  nd  transport of acylcarnitines across the 
mitochondrial inner membrane  
Slc25a20 solute carrier family 25, member 20 -1.05 0.61 catabolism of leucine, isoleucine, 
and valine 
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Next to the changes in serum amino acid levels, OxR increased serum long-chain 
acylcarnitines, which confirms that mitochondrial oxidative phosphorylation is reduced 
during OxR. Elevated levels of long-chain acylcarnitines indicate incomplete FA 
oxidation (24, 25, 32) and are, in combination with a reduction in free carnitines, 
strongly correlated to hypoxic exposure in both humans and rodents (1-3, 49). At tissue 
level, a decrease in free carnitine levels leads to a decrease in the transport of fatty 
acids into the mitochondria, which further limits mitochondrial fatty acid oxidation, 
especially in those tissues that cannot synthesize carnitines by itself, such as skeletal 
muscle or adipose tissue (47). Consistently, acute hypoxia was recently shown to 
reduce fatty acid oxidation at whole-body level in mice (22). It is, however, as yet 
unclear which tissues are mostly responsible for changes in circulating acylcarnitine 
levels. It was recently hypothesized that mostly the liver and skeletal muscle contribute 
to changes in plasma acylcarnitines, for example during fasting (49), whereas another 
study showed no relation between tissue and plasma acylcarnitines (39).  
 
WAT does not contribute to the rise in serum acylcarnitine but rather seems to 
upregulate mitochondrial FA oxidation 
When oxygen availability does not match oxygen demand, oxidative ATP production 
generally decreases while glycolytic ATP production increases (23). This metabolic 
switch did, however, not occur in WAT during the exposure to OxR. Lactate levels 
remained unaltered, indicating no change in anaerobe glycolysis, and in contrast to the 
increase in long-chain acylcarnitines in serum, in WAT only short-chain acylcarnitines 
were increased by OxR. The C3- and C5- acylcarnitines, which were found to be 
increased in WAT, are byproducts of branched-chain amino acid (BCAA) catabolism. 
Interestingly, the BCAAs leucine and isoleucine were also significantly increased in 
WAT, but no genes in BCAA metabolism were regulated. WAT plays an important role 
in BCAA metabolism. The rate of BCAA oxidation per mg of tissue is even higher in 
WAT than in skeletal muscle (16). In obese or diabetic individuals, BCAA catabolism in 
WAT is reduced (28), presumably because other macronutrients are abundantly 
available in the obese state. In healthy individuals, BCAA oxidation only occurs during 
prolonged fasting and serves as a last resort to prevent hypoglycaemia. Amino acids 
can, however, be used to fuel high-energy demanding processes, such as 
gluconeogenesis, even when other fuels are available (50). It is as yet unclear why 
OxR would increase BCAA catabolism in WAT. Mice are kept in a fasted state, which 
implies that the adipose tissue is activated to release energy in the form of fatty acids. 
BCAA catabolism might complement fat catabolism to support energetic demands of 
other tissues, which energy metabolism is affected by the restricted oxygen availability. 
Alternatively, the increase in BCAAs and BCAA derivatives that we found in WAT might 
be produced in other organs, such as the liver, and taken up by WAT to clear them 
from circulation. This would also explain why none of the genes involved in BCAA 
catabolism was found to be regulated in WAT.  
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Methylmalonylcarnitine (C4-DC), which was also increased in WAT by OxR, is a 
byproduct of the TCA cycle. Its upregulation by OxR in WAT suggests that OxR 
increases TCA cycle activity. We have more reasons to believe that mitochondrial 
function in WAT is increased during OxR. First, the absence of changes in the level of 
long-chain acylcarnitines indicates that fatty acid oxidation is not disturbed. Second, in 
contrast to long-chain acylcarnitines, accumulation of short- and medium-chain 
acylcarnitines does not disturb mitochondrial activity (38). Third, free carnitine levels 
were increased in WAT by OxR, which promotes FA uptake into the mitochondria. 
Moreover, chronic hypoxic exposure was previously shown to increase rather than 
decrease oxidative metabolism in mouse WAT (45). Finally, this view is supported by 
the analysis of whole genome gene expression. 
 
Whole genome expression analysis confirms that WAT increases mitochondrial 
activity 
OxR did not lead to major changes in WAT gene expression, but several key metabolic 
genes were altered, of which Sirt4 is one of the best studied. SIRT4 plays an important 
role in the regulation of lipid metabolism and cell proliferation; it was recently shown to 
inhibit mitochondrial glutamine metabolism and fatty acid oxidation, and to promote 
anaplerosis, cell cycle arrest and lipid synthesis (21, 29). Furthermore, Sirt4 expression 
was found to be induced by DNA damage in vitro (21), and reduced in mouse WAT by 
fasting (29) and during dietary restriction (10). All mice were fasted prior to the 
exposure to OxR or normoxia, which thus likely reduced Sirt4 mRNA in WAT. OxR 
appeared to further downregulate Sirt4 expression, which would lead to an even larger 
increase in FA oxidation. OxR consistently led to a small decrease in whole-body RER, 
although this was only marginally significant (p=0.059). Second, OxR decreased the 
expression of Gpam, encoding the mitochondrial enzyme GPAT1 that is involved in the 
initial and committing step of triglyceride and glycerolipid biosynthesis. Its 
downregulation, therefore, prevents that FAs are diverted away from oxidation. The 
regulation of Sirt4 and Gpam suggests an increase in WAT FA oxidation and lipolysis, 
which is supported by others showing that acute hypoxia increases lipolysis in WAT 
(22). 
Next to the regulation of lipolysis and FA oxidation, SIRT4 plays an important role in the 
regulation of cell growth and survival. SIRT4 was, in fact, found to be down-regulated in 
human cancer, contributing to increased cell proliferation and to increased energy 
production via glutamine catabolism (6). Interestingly, whole-genome analysis in WAT 
revealed a large number of genes involved in cell proliferation and transcription and 
translation, which are regulated in the direction to stimulate cell proliferation and 
prevent apoptosis. 
Chchd3 is the third and final mitochondrial gene that was significantly regulated by 
OxR. CHCHD3,a mitochondrial inner membrane protein that faces toward the 
intermembrane space, is part of the mitochondrial inner membrane organizing system 
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(MINOS) and plays an important role in maintaining mitochondrial cristae morphology 
(7). Complete silencing of Chchd3 causes fragmentation of the mitochondrial network 
and changes in the shape of mitochondrial cristae, leading to a reduced capacity to 
generate ATP (7). The 20% decrease in Chchd3 expression that was observed in our 
study is obviously less dramatic than complete Chchd3 depletion, but the down-
regulation that occurred during OxR might have led to a decrease in cristae surface 
and/or a decrease in mitochondrial fusion. Reduction in cristae surface and reduction in 
fusion may both serve to decrease mitochondrial membrane potential, which decreases 
the formation of damaging reactive oxygen species and prevents cell damage (30). Of 
note, no clear changes were observed in genes involved in ER stress, autophagy or 
antioxidant response.  
Thus, in contrast to our expectations, OxR seems to increase in vivo FA oxidation and 
cell proliferation. Furthermore, tissue lactate levels suggest that WAT does not switch 
from oxidative to glycolytic ATP production.  
 
Conclusions 
Mild normobaric oxygen restriction reduces metabolic rate and disturbs mitochondrial 
fatty acid oxidation at whole-body level. Both metabolite and gene expression analysis, 
however, show that WAT mitochondrial FA oxidation is not disturbed by OxR. WAT 
even seems to increase mitochondrial activity via the down-regulation of Sirt4 and 
Gpam, and possibly via oxidation of acetyl-CoA generated from BCAA catabolism. 
Although it is yet unclear why WAT energy metabolism increased during OxR, it does 
not lead to an increase in oxidative stress markers, such as changes in the expression 
of genes involved in anti-oxidant response or reduction in aconitase activity. It can be 
postulated that WAT increases oxidative ATP production to compensate for the 
reduction in oxidative capacity at whole-body level. Previous research showed that OxR 
reduces oxygen saturation in WAT by almost three-fold (37). Healthy adipose tissue 
might be more flexible than expected, enabling the tissue to function normally under 
these circumstances and to prevent inflammation dysregulation of adipokine secretion 
that are seen in metabolic disease (20, 44). 
The joint regulation of Sirt4, Gpam, and Chchd3, moreover, emerges as a biomarker 
profile for WAT mitochondrial reprogramming in response to acute exposure to limited 
oxygen availability. 
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Supplemental table 1 Serum and WAT levels of amino acids, acylcarnitines and free 
carnitine in mice that were exposed to OxR or remained under normoxic conditions 
 SERUM WAT 
Metabolite 
  Conc. 
Norm  
Conc. 
OxR 
FC OxR/ 
norm 
p-value 
Conc. 
Norm 
Conc. 
OxR 
FC OxR/ 
norm 
p-value 
 Amino acids (µM) Amino acids (pM mg-1 WAT) 
Ala 140.1 150.4 1.07 0.44 154.0 204.0 1.33 0.14 
Cit 29.5 26.1 -1.13 0.89 10.1 9.6 0.95 0.83 
Glu 23.5 40.8 1.74 0.07 451.6 477.0 1.06 0.87 
Gly 11.9 21.3 1.79 0.21 71.0 55.1 0.78 0.66 
HydroxyPro 0.4 0.4 -1.11 0.33 nd nd - - 
Leu+Ileu 104.5 119.8 1.15 0.22 17.9 36.9 2.06 0.03 
Lys 1.0 1.4 1.39 0.00 nd nd - - 
Orn 35.9 91.1 2.54 0.00 14.3 21.1 1.47 0.73 
Phe 1.1 1.3 1.16 0.08 17.3 27.6 1.60 0.07 
Pro 37.7 43.4 1.15 0.10 19.7 27.4 1.39 0.18 
Ser 99.8 113.1 1.13 0.29 83.8 118.3 1.41 0.13 
Thr 108.8 106.7 -1.02 0.81 54.1 54.2 1.00 1.00 
Trp 16.3 16.3 1.00 0.96 45.9 51.0 1.11 0.58 
Tyr 42.1 53.2 1.26 0.04 17.9 25.5 1.43 0.18 
Val 44.1 45.0 1.02 0.79 13.8 14.8 1.07 0.81 
 Free carnitine (µM) Free carnitine (pM mg-1 WAT) 
C0 9.9 7.8 -1.26 0.00 42.7 64.3 1.50 0.01 
 
Short-chain acylcarnitines (nM) 
Short-chain acylcarnitines  
(pM g-1 WAT) 
C2 8767.5 8713.0 -1.01 0.94 15170.8 17824.5 1.17 0.34 
C3 102.8 103.5 1.01 0.92 330.4 743.8 2.25 0.04 
C3DC nd nd - - 2.8 3.0 1.06 0.76 
C4 132.1 138.2 1.05 0.52 394.4 708.7 1.80 0.06 
C4OH nd nd - - 342.0 423.6 1.24 0.31 
C4DC nd nd - - 1125.0 1633.4 1.45 0.04 
C5 23.0 24.0 1.04 0.59 89.5 232.9 2.60 0.02 
C5-1 3.4 4.2 1.24 0.31 0.1 1.4 15.59 0.01 
C5DC nd nd - - 14.7 42.6 2.90 0.02 
C6 29.0 33.5 1.15 0.10 102.2 108.1 1.06 0.80 
C6-1 nd nd - - 15.2 12.6 0.83 0.41 
C6DC 5.1 5.4 1.07 0.67 nd nd - - 
C7DC nd nd - - 65.8 70.1 1.06 0.80 
C7OH 1.3 1.0 -1.32 0.22 nd nd - - 
C8 8.6 9.4 1.09 0.49 49.4 45.8 0.93 0.68 
C8-1 18.2 18.8 1.03 0.61 52.0 48.6 -1.40 0.93 
 
Medium-chain acylcarnitines (nM) 
Medium-chain acylcarnitines  
(pM g-1 WAT) 
C10 6.7 9.2 1.36 0.00 19.3 11.1 0.58 0.20 
C10-1 11.9 16.0 1.34 0.01 14.5 13.1 0.90 0.60 
C10-2 2.4 2.8 1.17 0.37 3.8 3.7 0.98 0.92 
C12 11.9 13.3 1.12 0.40 144.7 109.6 0.76 0.37 
C12-1 2.1 4.9 2.40 0.00 18.8 11.1 0.59 0.18 
C12DC nd nd - - 7.0 5.8 0.82 0.53 
C14 2125.4 2166.1 1.02 0.91 284.2 243.7 0.86 0.61 
C14-1 2172.5 2372.5 1.09 0.65 85.0 49.6 0.58 0.19 
C14-2 565.3 777.7 1.38 0.08 11.7 6.2 0.53 0.14 
C14OH 60.3 84.1 1.39 0.33 78.2 74.4 0.95 0.87 
C14-1OH nd nd - - 101.5 72.0 0.71 0.30 
C14-2OH nd nd - - 27.0 18.8 0.70 0.26 
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Supplemental table 1 continued from page 139 
 SERUM WAT 
Metabolite 
  Conc. 
Norm  
Conc. 
OxR 
FC OxR/ 
norm 
p-value 
Conc. 
Norm 
Conc. 
OxR 
FC OxR/ 
norm 
p-value 
 
Long-chain acylcarnitines (nM) 
Long-chain acylcarnitines 
(pM g-1 WAT) 
C16 143.6 200.0 1.39 0.00 841.9 954.1 1.13 0.58 
C16-1 39.9 61.7 1.55 0.00 213.7 146.7 0.69 0.31 
C16-2 12.5 17.6 1.41 0.00 43.3 23.8 0.55 0.14 
C16OH 7.8 9.7 1.25 0.13 142.1 146.7 1.03 0.92 
C16-1OH 2.6 3.1 1.18 0.41 158.6 121.2 0.76 0.43 
C16-2OH nd nd - - 42.1 37.3 0.89 0.67 
C16DC 83.8 105.5 1.26 0.00 45.5 59.7 1.31 0.09 
C18 57.4 64.2 1.12 0.10 154.1 195.1 1.27 0.31 
C18-1 254.5 343.1 1.35 0.00 562.6 526.8 0.94 0.80 
C18-2 141.7 207.6 1.47 0.00 258.0 206.6 0.80 0.43 
C18-3 14.3 20.1 1.41 0.00 26.9 20.8 0.77 0.44 
C18OH 9.1 10.5 1.16 0.07 21.7 25.6 1.18 0.56 
C18-1OH 13.4 17.0 1.27 0.05 209.5 198.0 0.94 0.86 
C18-2OH 4.0 7.0 1.75 0.01 81.3 75.9 0.93 0.82 
C20 5.5 6.6 1.21 0.10 9.8 13.0 1.32 0.21 
C20-1 7.4 9.1 1.23 0.08 19.2 21.6 1.12 0.65 
C20-2 5.7 5.7 1.00 1.00 13.8 13.7 1.00 1.00 
C20-3 3.6 5.5 1.52 0.00 5.0 4.7 0.94 0.88 
C20-4 12.0 15.4 1.29 0.02 20.2 18.4 0.91 0.79 
Data are shown as the mean per group (n=12) and as the fold change (FC) of OxR mice over Norm 
mice. nd, not detected 
 
Supplemental table 2 Overview of genes that were significantly regulated by the 
exposure to OxR  (p<0.01) in WAT  
 
Gene symbol Gene name Fold change p-value 
Apold1 apolipoprotein L domain containing 1 1.31 0.003 
Clca1 chloride channel calcium activated 1 1.38 0.004 
Dusp9 dual specificity phosphatase 9 1.30 0.008 
Fam107a family with sequence similarity 107, member A 1.38 0.010 
Gpr65 G-protein coupled receptor 65 1.17 0.003 
Gpr65 G-protein coupled receptor 65 1.19 0.010 
Haus7 HAUS augmin-like complex, subunit 7 1.23 0.007 
Hbegf heparin-binding EGF-like growth factor 1.31 0.006 
Hspb7 heat shock protein family, member 7 (cardiovascular) 1.27 0.006 
Lhfp lipoma HMGIC fusion partner 1.21 0.005 
Med24 mediator complex subunit 24 1.21 0.006 
Ms4a4a membrane-spanning 4-domains, subfamily A, member 4A 1.31 0.004 
Mt1 metallothionein 1 1.40 0.004 
Nt5c2 5'-nucleotidase, cytosolic II 1.18 0.006 
Pdia5 protein disulfide isomerase associated 5 1.16 0.005 
Podxl2 podocalyxin-like 2 1.24 0.007 
Prdm4 PR domain containing 4 1.20 0.010 
Ren2 renin 2 tandem duplication of Ren1 1.84 0.006 
Retnlg resistin like gamma 1.62 0.007 
Samd14 sterile alpha motif domain containing 14 1.28 0.010 
Sec63 SEC63-like (S. cerevisiae) 1.19 0.004 
Stau2 staufen (RNA binding protein) homolog 2 (Drosophila) 1.29 0.004 
Synpo synaptopodin 1.29 0.002 
Tnks2 tankyrase, TRF1-interacting ankyrin-related ADP-ribose 
polymerase 2 
1.16 0.008 
Trim59 tripartite motif-containing 59 1.30 0.004 
Zfp319 zinc finger protein 319 1.19 0.001 
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Supplemental table 2 continued from page 140 
Genes are divided into genes that were significantly upregulated by the exposure to OxR or significantly 
downregulated and within each category shown in alphabetic order. Fold changes are calculated with  
the level of gene expression in OxR mice (n=10) compared to the level in Norm mice (n=12). Only 
genes with a known function are shown.   
 
Gene symbol Gene name Fold change p-value 
Adrbk2 adrenergic receptor kinase, beta 2 -1.18 0.006 
Atp2b4 AATPase, Ca++ transporting, plasma membrane 4 -1.26 0.001 
Cdip1 5730403B10Rik|cell death inducing Trp53 target 1 -1.19 0.008 
Chchd3 coiled-coil-helix-coiled-coil-helix domain containing 3 -1.21 0.000 
Derl3 Der1-like domain family, member 3 -1.27 0.004 
Gpam glycerol-3-phosphate acyltransferase, mitochondrial -1.29 0.004 
Homer1 homer homolog 1 (Drosophila) -1.16 0.001 
Hoxb3 homeobox B3 -1.20 0.004 
Hsf2 heat shock factor 2 -1.25 0.002 
Kifc2 kinesin family member C2 -1.24 0.001 
Olfr1466 olfactory receptor 1466 -1.18 0.006 
Pigc phosphatidylinositol glycan anchor biosynthesis, class C -1.15 0.005 
Rabgap1 RAB GTPase activating protein 1 -1.19 0.009 
Sirt4 sirtuin 4 -1.21 0.002 
Tchp trichoplein, keratin filament binding -1.13 0.010 
Traf4 TNF receptor associated factor 4 -1.24 0.008 
Tubgcp4 tubulin, gamma complex associated protein 4 -1.20 0.009 
Vamp1 vesicle-associated membrane protein 1 -1.20 0.006 
Zfp523 zinc finger protein 523 -1.18 0.004 
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The aim of this thesis was to assess metabolic health using transcriptome analysis and 
non-invasive challenge tests. In this thesis I focussed on transcriptome analysis in 
white adipose tissue (WAT) as a method to monitor multiple processes on organ level, 
and on the development and validation of non-invasive, indirect calorimetry (InCa) 
based challenge tests as a method to monitor the adaptive capacity, or flexibility, of the 
body as a whole. Both approaches are expected to contribute to research that aims to 
understand how dietary interventions can either improve or reduce metabolic health. In 
this chapter, the different methods that were used will be discussed on their relevance 
and applicability in nutrition-related research and recommendations for further research 
will be provided.  
 
Delineation of metabolic health and metabolic flexibility 
The terms ‘metabolic health’ and ‘metabolic flexibility’ are frequently used in nutrition-
related research. The exact definition of both terms is, however, complex and 
challenging to interpret given the diversity of studies in which they are employed. 
Therefore, to start this general discussion I will first further define both terms in the 
context of this thesis, which may help to interpret the results that were obtained.  
In a broad sense, metabolic health implies a physical state in which life-sustaining 
chemical transformations within the body are adequately regulated to ensure growth, 
reproduction, and cell survival. More specifically, metabolic health implies a state that 
enables the body to handle discontinuous nutrient supply during and in between meals 
by storing nutrients at times of surplus and releasing nutrients at times of need. The 
mechanism of energy metabolism has arisen in early evolution to meet to the 
requirements of free-living animals in nutrient-scarce environments (63). In modern 
human society, food is seldom scarce and therefore it should be noted that, for the 
Western civilization, metabolic health also implies that nutrients are oxidized rather than 
stored, or that food intake is limited, when nutrient stores are sufficiently filled. There 
are great differences in how individuals adapt their metabolism to caloric overload; 
some store most of this energy as fat, while others dissipate much of it through altered 
energy expenditure, including adaptive thermogenesis (55). A maladaptive response to 
caloric overload may lead to prolonged exposure to circulating nutrients or excessive 
WAT expansion: two conditions that are often associated with impaired metabolic 
health. Excessive WAT expansion, however, does not always lead to reduced 
metabolic health (33). As shown in chapter 5, mice can become overweight, but still 
exhibit normal glucose tolerance and adipose tissue health. Also in chapter 3, we 
showed that old, obese mice respond similarly to an InCa-based glucose tolerance test, 
compared to adult mice with a lower body weight. Also in humans, obesity can occur 
separately from changes in markers for metabolic disease (41), which indicates the 
relevance of suitable methods to assess metabolic health status. Metabolic flexibility 
can, in this context, be used as a relevant quantification of metabolic health. Metabolic 
flexibility was originally defined as the ability to switch from fat oxidation to glucose
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oxidation (44, 45), where it was applied to study substrate preferences of the insulin 
resistant muscle. Later on, it became apparent that metabolic flexibility can be applied 
to a broader range of substrates and was, hence, defined as the capacity to adapt fuel 
oxidation to fuel availability (22), which is also the definition that was used in this thesis. 
The InCa-based challenge tests that are described in this thesis all rely on the 
observation that under normal (non-starved) conditions – when protein stores are not 
depleted – mitochondrial substrate selection primarily depends on the availability of 
glucose, fatty acids and oxygen. Oxygen is the terminal electron acceptor of oxidative 
phosphorylation, while glucose and fat are the primary carbon sources that, via the 
TCA cycle and β-oxidation, feed oxidative phosphorylation. Therefore, these substrates 
can be seen as the core requirements for mitochondrial fuel oxidation. Restriction or 
rather (re)supplementation of either of these substrates requires mitochondrial 
substrate switching or changes in the level of total mitochondrial activity.  
 
The role of adipose tissue in maintenance of metabolic health: a transcriptomic 
approach 
In most chapters of this thesis, WAT was the major organ of interest. WAT is, indeed, 
crucial for maintenance of metabolic health. Next to its function in storage and release 
of fatty acids, WAT is now established as a major endocrine organ that regulates 
physiological function of several metabolic organs. WAT can represent 10 to 70% of 
total bodyweight, and therefore, it is not surprising that changes in WAT function can 
substantially modulate whole-body energy homeostasis. In this thesis, WAT function 
was analysed with whole-genome microarrays in two conditions that were expected to 
require WAT adaptation: dietary restriction (chapter 2) and exposure to ambient 
oxygen restriction (OxR) (chapter 6). Transcriptome analysis in chapter 6 was 
complemented with another ‘omics’ approach -metabolomics - to evaluate the effect of 
OxR on serum amino acid and (acyl)carnitine levels. Molecular adaptation to OxR was 
also studied with reverse transcription quantitative real-time polymerase chain reaction 
(RT-qPCR) in chapter 4. Dietary restriction appeared to have a large influence on WAT 
gene expression, whereas OxR appeared to elicit only minor changes in WAT gene 
expression. Below I will further discuss these findings and elaborate on the role of WAT 
in the improvement of metabolic health during dietary restriction. I will also examine the 
effect of diet on the response to OxR.  
 
WAT function during dietary restriction 
During dietary restriction, mice receive a limited amount of feed on a fixed time point 
per day. The restricted amount of feed is generally consumed within a few hours, which 
means that each day, mice are in a fed state for approximately one half of the day and 
remain in a fasted state for the remaining part of the day. This fixed pattern of fasting 
and re-feeding is significantly different from what we observe in ad libitum fed mice. 
Mice that have unlimited access to a high-fat diet never display a period of absolute fat 
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oxidation and the diurnal fluctuation of the respiratory exchange ratio (RER) is levelled 
off (see Figure 1).  
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The ability of WAT to store energy during feeding and release energy during fasting, or 
FA flux (Figure 2), is crucial for mouse survival during dietary restriction. A stable FA 
flux in WAT implies that during each re-feeding period enough energy is stored to meet 
the energetic demands of the subsequent fasting period in order to prevent further 
weight loss. Interestingly, in chapter 2 we show that body weight stabilized after 5 
weeks of dietary restriction, indicating that at that time point the WAT FA flux is 
stabilised and that mice have come to a state where energy intake and storage sustain 
total diurnal energy expenditure. In this stable phase, mice were considered 
metabolically healthy, as determined by their increased glucose tolerance and serum 
adiponectin levels and decreased serum leptin, glucose, and insulin levels, compared 
to the ad libitum fed mice.  
 
 
 
The beneficial health effects of dietary restriction can, in the first place, be attributed to 
the limitation of feed intake, leading to a reduction of adipose mass and ectopic fat 
storage (4, 90). A decrease in adiposity is associated with improved insulin sensitivity 
(1, 23) and reduced levels of circulating markers for inflammation (17) and oxidative 
stress (88).  
Next to the reduction in total adiposity, the occurrence of timed feeding that results from 
the fixed FA flux of DR-mice seems to play an important role in health improvement. 
Figure 2 Fatty acid flux in adipose tissue. 
Fatty acids are derived from the bloodstream and 
can be stored in the form of triglycerides. During 
fasting, triglycerides are converted back to fatty 
acids by lipolysis. Most fatty acids that are 
released during fasting are released into the 
bloodstream to be oxidised by other organs. A 
small proportion of the fatty acids is oxidised in 
the adipocyte itself. 
Figure 1 Diurnal pattern of RER of dietary 
restricted and ad libitum fed mice. Mice 
that are dietary restricted (HF-DR) have a 
fixed diurnal pattern for feeding and fasting, 
which can be visualised with the fluctuation of 
RER. Ad libitum fed mice (HF-AL), on the 
other hand, lack a clear pattern of fasting and 
feeding and remain in a fed state for the 
entire day. (data from (34)) 
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The effect of timed feeding on whole-body metabolism was already shown in 1989 in 
an experiment in which rats received a meal on a fixed time point each day. As 
expected, feed consumption increased circulating insulin levels; insulin levels, however, 
also increased during the fixed time period on the day when no meal was provided, 
suggesting that metabolism can be programmed (35). Later, the effect of timed feeding 
was substantiated with the recognition of clock genes that function as an endogenous 
circadian clock and are found in the brain but also in peripheral tissues, such as the 
liver, intestine, and adipose tissue (2, 21). Timed feeding did not only lead to circadian 
oscillation in response to the feeding schedule, but also improved the metabolic health 
of mice fed a high-fat diet, even though absolute caloric intake did not differ from mice 
that had ad libitum access to the high-fat diet (81). These observations suggest that 
metabolism becomes more efficient in handling of dietary fat when the body expects 
and is prepared to deal with the diet-induced increase in circulating lipid levels, which 
prevents lipotoxicity and insulin resistance and improves metabolic health. 
Notably, a novelty of the study described in chapter 2 is that mice were restricted on a 
high-fat diet, while in most studies restriction is based on a low-fat diet (e.g. 31, 54, 71). 
HF-DR mice eat less calories compared to HF-AL mice, but still consume twice as 
much fat compared to mice fed a standard low-fat diet (Figure 3). In contrast to mice 
that received the HF-diet on an ad libitum basis, HF-DR mice seem better equipped to 
deal with the high amount of fat in the diet and manage to maintain metabolic health. 
Transcriptome analysis confirmed the drastic metabolic reprogramming of HF-DR mice. 
Although mice were sacrificed in a fasted state, we observed a strong upregulation of 
genes involved in lipid metabolism and mitochondrial activity. We hence concluded that 
dietary restriction of a high-fat diet increases substrate efficiency; mice become more 
efficient in storage of circulating lipids, thereby preventing lipotoxicity and related 
ailments.  
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Interestingly, we also found an increase in de-novo lipogenesis (DNL) in HF-DR mice, 
which is the synthesis of fatty acids from non-lipid precursors, such as glucose. An 
increase in DNL in WAT during dietary restriction on a high-fat diet might seem 
contradictory to their high dietary fat intake. DNL primarily leads to the formation of 
Figure 3 Energy and fat intake of 
dietary restricted and ad libitum fed 
mice. Diurnal fat (A) and energy (B) 
intake of mice that had ad libitum (HF-
AL) or restricted (HF-DR) access to a 
high-fat diet (data from chapter 2), and 
of mice that had ad libitum access to a 
low-fat diet (LF-AL). (data derived from 
(34)). Data represent mean ± SEM 
(n=12) of 11 weeks of feeding feed 
intake of male C57BL/6JOlaHsd mice 
that were 24 weeks of age and after 11 
weeks of feeding the dietary regime of 
interest. 
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palmitate. Palmitate can then be desaturated by stearoyl-CoA desaturase (Scd1), 
which was significantly upregulated in HF-DR mice, increasing the ratio of unsaturated 
fatty acids to saturated fatty acids. High ratios of unsaturated to saturated fat in adipose 
tissue are associated with improved insulin resistance (82), and a decrease in WAT 
DNL is, consistently, associated with obesity and type 2 diabetes (16).  
Metabolic reprogramming, possibly due to oscillation of metabolic activity in response 
to timed feeding, increased substrate efficiency, and increased DNL, thus, contribute to 
healthy adipose tissue. 
 
WAT function during oxygen restriction 
The metabolic response to oxygen restriction depends on the interplay between several 
metabolic organs. Each organ reacts in a specific way to match its oxygen demand with 
its functional capacity and metabolic function. During the OxR challenge, mice were in 
a fasted state. During fasting, WAT is activated to release and oxidise fatty acids. 
Exposure to OxR might impede this function, leading to metabolic adaptation and 
related transcriptional changes. In chapter 4, molecular adaptation to OxR was studied 
by RT-qPCR in mice on two different diets: low-fat (LF) and a high-fat (HF) diet. In 
chapter 6, molecular and metabolic consequences of adaptation to OxR were studied 
on a single dietary background with whole genome micro-arrays for gene expression 
and metabolomics for amino acid and (acyl)carnitine levels in WAT. In chapter 4, we 
observed that HF-fed mice fail to initiate the transcriptional changes in WAT that were 
observed in LF-fed mice. LF mice showed an increase in the expression of genes 
involved in the antioxidant response, mitochondrial activity and DNL after the exposure 
to OxR, whereas this response was completely absent in WAT of HF-fed mice. Also in 
chapter 3 we found that, in mice fed a low-fat diet, OxR increased the expression of 
hexokinase in WAT. Hexokinase performs the first step of glycolysis and is therefore 
seen as key regulator of glycolysis. We then hypothesised that the transcriptional 
response to OxR in HF-mice could remain masked by the transcriptional response to 
high-fat feeding: HF feeding as such (under normoxic conditions), indeed, led to 
functional adaptations to support adipose expansion.  
We also hypothesised that the transcriptional response of WAT to OxR might be bigger 
after a longer period of HF-feeding: when WAT might be more adapted to the 
experimental diet and the WAT depot has expanded. Unexpectedly, whole genome 
analysis did not reveal a large effect of OxR on WAT gene expression after 6 weeks of 
HF-feeding (chapter 6). Only 78 genes were found to be significantly regulated by 
OxR, compared to the more than 8600 genes that were significantly regulated by 
dietary restriction (chapter 2). We did expect that OxR would induce an increase in 
anaerobic glycolysis or carbohydrate oxidation to spare oxygen consumption, leading to 
transcriptional downregulation of genes involved in mitochondrial activity or fatty acid 
oxidation and transcriptional upregulation of genes involved in glycolysis. OxR might 
also lead to transcriptional changes of genes involved in the antioxidant response to 
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prevent cell damage by oxidative stress, which might arise from the reduction in oxygen 
availability. Instead, we only identified three genes involved in mitochondrial structure 
and function: Sirt4, Chchd3, and Gpam that were all significantly downregulated. The 
downregulation of those genes indicates an increase in mitochondrial activity in WAT 
during OxR. Most of the other significantly regulated genes were involved in cell 
survival, proliferation, transcription and translation. The metabolite analysis revealed an 
increase in FA uptake in mitochondria, increased TCA activity, and increased protein 
catabolism by OxR. Thus, in contrast to our expectations, OxR did not lead to major 
changes in energy metabolism in WAT of mice fed a HF-diet. Moreover, the few 
changes that occurred seem to point towards an increase in mitochondrial FA 
oxidation, rather than the expected decrease.  
I have three possible explanations for the absence of major changes in gene 
expression by OxR in WAT of HF-mice. At first, it might be that after 6 weeks of HF-
feeding, gene expression is, like described in chapter 4, still masked by the adaptations 
required for WAT expansion. Adipose expansion is, in fact, at its maximum in the first 
weeks of HF feeding when total fat mass can increase by 1 to 2 grams per week. 
Adipocytes in eWAT, however, continue to grow even after week 6 (Figure 4), during 
which it is still considered beneficial to increase expression of genes involved in WAT 
remodelling and the antioxidant response. Similar pathways are involved in WAT 
expansion during HF feeding and adaptation to OxR, which can explain why we do not 
detect significant changes in gene expression in WAT after the exposure to OxR. 
 
 
Figure 4 Adiposity and adipocyte size during high-fat feeding. Total adiposity mostly increases 
during the first weeks of HF-feeding and stabilises after approximately 14 weeks. Adipocytes continue to 
grow after week 6 and adipocytes are larger in week 27 compared to week 6 at borderline significance 
(p=0.055). Data represent the mean ± SEM, n=11 for adiposity and n=5 (week 6) and n=8 (week 27) for 
cell size. (data from chapter 5 (HFpu mice)).  
 
Second, it might be that expanding adipocytes are less sensitive to cues that indicate 
limited oxygen availability, such as elevated glucose, insulin or lactate levels. The 
relation between adipocyte hypertrophy and insulin resistance and glucose intolerance 
is apparent (76, 91), but also lactate plays an important role in regulation of metabolism 
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in adipocytes (6), and the sensitivity to lactate is likewise reduced by high-fat feeding 
(89). WAT response to OxR might thus be blunted in HF-fed mice due to a reduced 
sensitivity to circulating cues that indicate WAT hypoxia, which is a direct hallmark of 
reduced metabolic flexibility. 
Third, it may be that eWAT of HF-fed mice is already in a hypoxic condition due to the 
enlarged size of the eWAT depot, and that OxR does not further reduce oxygen 
availability in eWAT. eWAT expansion is, on the other hand, also known to reduce 
oxygen consumption in eWAT to prevent deficits in oxygen availability (28). This 
reduction in total eWAT activity that is already present prior to the exposure to OxR 
might circumvent major metabolic switching during OxR.  
From these studies it can be extrapolated that the response of WAT to OxR depends 
on dietary background and/or the level of WAT expansion. The effect of OxR on whole 
genome gene expression in WAT of LF mice, however, still needs to be established.  
 
Mitochondrial density in WAT and effect on metabolic health 
Metabolic health is thought to depend on adequate mitochondrial function because of 
the association of metabolic disease with ROS formation (69) and the association 
between caloric intake and mitochondrial overload and associated mitochondrial 
dysfunction (51). Apart from the effect on mitochondrial function, we found that dietary 
restriction increased mitochondrial density in WAT (chapter 2). Dietary restriction was 
previously found to be positively related to changes in both the respiratory capacity of 
mitochondria and the cellular amount of mitochondria in different tissues (reviewed in 
29). Next to dietary fat intake and ROS formation, mitochondrial density and function 
depend on endocrine factors (64), environmental temperature (80), and oxygen 
availability (57, 67).  
In adipocytes, mitochondrial ATP production is required for e.g. cell maintenance, 
triglyceride synthesis and adipokine synthesis and secretion. Furthermore, next to their 
role in the regulation of adipocyte differentiation and apoptosis, WAT mitochondria can 
prevent fat accumulation by release or oxidation of fatty acids (reviewed in 52). Under 
normal conditions, WAT FA oxidation represents only around 1 to 3.5% of total WAT 
activity (20). WAT FA oxidation can, however, be increased by transcriptional activation 
of the electron transport chain, which has been shown to decrease total fat mass in 
rodents (94). Mitochondrial dysfunction in WAT is, on the other hand, associated with 
the pathogenesis of obesity and insulin resistance (10, 25, 43, 68). Interestingly, in 
chapter 3 we found that WAT mitochondrial density was significantly reduced during 
aging, which further supports the idea that mitochondrial density in WAT can be used 
as a marker for healthy WAT functioning. Mitochondrial function and mitochondrial 
density are, in fact, closely related and positively regulated by the transcriptional 
peroxisome proliferator-activated receptor γ co-activator 1 (Pgc1α, mouse annotation: 
Ppargc1a) (93). Pgc1α expression decreases during the development of obesity and 
type 2 diabetes (14, 75, 79), which might explain the negative association of 
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mitochondrial density with body weight (38). Furthermore, it was found that high-fat 
feeding reduces mitochondrial density and Pgc1α expression in WAT (84). On the other 
hand, transgenic mice with enhanced Pgc1α expression in WAT have a higher 
mitochondrial density and are lean and insulin sensitive despite normal or increased 
caloric intake (42). Moreover, stimulation of Pgc1a signalling increases mitochondrial 
density in adipose tissue and decreases fat mass in rodents (40). Next to the decrease 
in mitochondrial density in WAT during the development of obesity by high-fat feeding, 
mitochondrial density and Pgc1α signalling was found to be decreased in adipocytes of 
insulin-resistant rodents and humans (13, 15, 30, 60). These studies, thus, support the 
notion that mitochondrial density in WAT might serve as functional marker for metabolic 
health. The mechanistic relation between mitochondrial density and metabolic health, 
however, still remains unclear (38), which offers opportunities for further research.  
 
The value of InCa-based challenge tests 
InCa-based challenge tests have major advantages over other challenge tests to 
measure metabolic flexibility. The most relevant advantage is that InCa-based 
challenge tests are non-invasive. Routine animal handling, injection, and oral gavage 
lead to significant elevations of heart rate, blood pressure, and glucocorticoid 
concentrations that persist for 30 to 60 minutes after the event (reviewed in 3). 
Procedures that are necessary for, for example, a standard oral glucose tolerance test 
significantly increase stress levels and might thereby influence the outcome of the test. 
Blood collection via the tail tip, for example, causes a three-fold increase in mouse 
corticosterone levels (87), and increases blood glucose levels with more than 40% (85). 
Simple handling of mice already doubles corticosterone levels in mice (77) and even 
moving of the cage increases blood glucose levels with 30% (85) (illustrated with a 
literature example in Figure 5). Invasive experiments, therefore, do not only affect 
wellbeing of laboratory animals but also increase data variability, which decreases the 
statistical power of the experiment.  
Another advantage is that InCa measures the response of the ‘whole metabolic 
system’. In the case of the fasting and re-feeding challenge this means: food digestion, 
nutrient absorption, transport and cellular uptake and, finally, nutrient oxidation or 
storage. This may better reflect overall metabolic health, since metabolic flexibility also 
depends on adequate functioning of the whole metabolic system. Furthermore, there is 
a higher chance to pick up differences in health status, because several components of 
metabolism are targeted.  
In this thesis three InCa-based challenge tests were used: the OxR challenge 
(chapters 3, 4, 5, and 6), which will be further discussed in the section below, the re-
feeding challenge (chapter 5) and the glucose challenge (chapter 3).  
The two nutrient-based tests were already described for their ability to analyse 
metabolic flexibility (e.g. 18, 36, 49) and were only used once in this thesis. The 
glucose challenge did not reveal differences between old and adult mice but it is 
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possible that the old and adult mice that were used in this study, indeed, had a similar 
glucose tolerance. Also in the study described in chapter 5 we observed that the 
C57BL/6JOlaHsd mice, even after prolonged high-fat feeding, remained relatively 
tolerant to glucose and had fasting glucose levels within the normal range.  
Notably, we observed that during the glucose challenge in chapter 3, mice only 
achieved maximal RER values around 0.80, which is much lower than the expected 
value of 1 to indicate glucose oxidation. Probably, the amount of glucose that was 
provided was too small to initiate complete nutrient switching. In our study, mice 
received 2 gram glucose per kg body weight. For an average mouse this means a 
pellet of around 70 mg. Mice that received a larger amount of glucose (225 mg per 
mouse), indeed reached higher RER values of around 0.90 (18). Consistently, 
supplying mice with an even smaller glucose load of 1gr/kg body weight hardly 
increased RER values (49). Supplying mice with a larger glucose load might have 
improved the functionality of the test.  
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The re-feeding challenge did reveal differences in metabolic flexibility in the experiment 
described in chapter 5. The advantage of the re-feeding challenge is that the actual 
RER value that should be achieved after feeding can be deducted from the food 
quotient of the diet. When performing the re-feeding challenge on mice fed different 
experimental diets, it is important that all dietary groups are re-fed on a diet with similar 
macronutrient composition for correct interpretation of metabolic flexibility. Comparing 
mice re-fed e.g. a high- and low-fat diet is misleading because dietary fat delays gastric 
emptying and thereby delays mitochondrial substrate switching. Moreover, a diet with a 
high carbohydrate content will lead to a larger increase in RER than a diet with a low 
carbohydrate content. For the re-feeding challenge it is alos important to restrict feed 
intake to ensure that all mice have the same caloric intake, preferably within the same 
small time window.  
Interestingly, in chapter 5 we show that mice fed different isocaloric high-fat diets with 
similar food quotients do not differ in RER under normal conditions, but show a 
significantly different response to the re-feeding challenge. The re-feeding challenge is 
Figure 5 Circulating markers of stress 
response induced by mouse handling 
and the use of invasive methods. Moving 
of the animal cage and blood collection via 
the tail significantly elevate blood glucose in 
mice. Blood collection also increases 
corticosterone levels. Control mice were 
either not moved in their cage, or did not 
receive a tail cut. To study the effect of tail 
bleeding, mice were decapitated to collect 
blood samples. (data from (85) and (87)). 
154   l   CHAPTER 7 
 
an effective method because it ‘synchronises’ mice in a similar fasting and feeding 
pattern, which is very different from the ad libitum situation in which mice might be in 
different feeding states at any given time point (Figure 6).  
The re-feeding challenge is, furthermore, effective because the switch from total fat 
oxidation during fasting to partial glucose oxidation during re-feeding requires the 
(transcriptional) activation and/or translation of the required enzymes for these 
conversions (e.g. pyruvate dehydrogenase). In the ad libitum situation, mice are never 
in an absolute fasted state and enzymes involved in both carbohydrate and fat 
oxidation might be continuously present and activated. In other words: during ad libitum 
feeding the capacity to switch between fat and carbohydrate oxidation is not targeted, 
masking relevant differences in metabolic flexibility.  
Due to their non-invasive nature and the synchronization of mouse behaviour, the re-
feeding and glucose challenge are promising methods for health assessment. Further 
optimization may be achieved by increasing the glucose load or by trying different 
experimental diets within one animal experiment. Also, mice could be sacrificed in 
challenged and non-challenged condition to further investigate the mechanistic 
background behind the observed differences in the flexibility to respond to the 
metabolic challenge.  
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Figure 6 RER and feed intake during ad libitum high-fat feeding. Individual RER values (A) and 
cumulative feed intake (B) of three mice with ad libitum access to a high-fat diet (HFpu diet after 20 
weeks of HF feeding). The continuous incline in feed intake shows that mice eat continuously 
throughout both the light and dark phase. The RER values confirm that mice do not achieve a fasting 
state. (data from chapter 5).  
 
Introduction of OxR as a novel InCa-based challenge test 
A major part of this thesis was dedicated to the development and validation of OxR as a 
challenge test to measure metabolic flexibility. Oxygen is essential for mitochondrial 
functioning and mitochondrial are responsible for 90% of whole body oxygen 
consumption (74). Exposure to oxygen restriction, therefore, requires metabolic and 
physiological adaptation to assure that ATP production matches ATP demand. The 
novelty of the OxR challenge is that, although metabolic switching is expected, mice 
GENERAL DISCUSSION   l   155 
 
 
7  
remain in a fasted state during the challenge, which implies that the response is 
independent of the diet and less affected by confounding factors, such as inter-
individual differences in the timing and amount of feed intake or the efficiency of 
digestion. In setting up the OxR challenge test, we hypothesized that mice that differ in 
metabolic health would show a different response to OxR, which can be visualised by 
differences in oxygen consumption, respiratory exchange, circulating metabolite or 
hormone levels, or gene expression. Results that were obtained with the OxR 
challenge in this thesis are summarized in table 1 and will be discussed. 
 
OxR and metabolic rate 
Mammals are known to decrease metabolic rate when exposed to ambient oxygen 
restriction, which can be detected by a decrease in whole-body oxygen consumption 
(VO2) (19, 32). The extent of the reduction depends on body size. Small animals 
generally have a high metabolic rate to compensate for passive heat loss due to their 
large surface area relatively to their inner mass (26). Since their metabolic rate is 
already high under resting conditions, small animals can achieve a larger reduction in 
metabolic rate during OxR compared to large animals (reviewed in 24). Consistently, 
the reduction in metabolic rate by OxR increases when ambient temperature was 
reduced prior to the exposure (73), which indicates that the drop in VO2 depends on the 
discrepancy between room temperature and the thermoneutral zone of an animal. The 
reduction in metabolic rate can thus partly be achieved by a reduction in thermogenesis 
(61). A reduction in metabolic rate can, however, also be achieved by changes in 
mitochondrial substrate oxidation (67).  
All studies described in this thesis confirm that OxR decreases VO2 and thus energy 
expenditure (EE). The comparison of dietary groups between and within studies, 
indeed, reveals differences in the extent of the reduction. The reduction in VO2 and EE 
is, for example, larger in young, lean mice (chapter 4), compared to old, obese mice 
(chapter 3) (24% in lean versus 9% in obese mice). However, before the extent of the 
drop in metabolic rate can be related to metabolic health status, it is important to 
evaluate whether mice already differed in resting metabolic rate prior to the exposure, 
as explained above.  
Although conflictingly reported in literature (39, 86), lean mice might have a higher 
resting metabolic rate during normoxia compared to obese mice, enabling them to 
achieve a larger reduction in metabolic rate during OxR. However, such a difference 
was not observed in our studies. In chapter 4 it was shown that, when under normoxic 
conditions and fasted and at rest, LF-fed and HF-fed mice do not differ in VO2. During 
OxR, however, LF-mice had a lower VO2 than HF-mice. This was also shown in 
chapter 5, in which mice fed a HF-diet with poly unsaturated fatty acids (HFpu) or a 
HF-diet with saturated fatty acids (HFs) did not differ in VO2 in normal air when fasted 
and at rest, but VO2 was significantly reduced in HFpu versus HFs mice during OxR 
(Figure 7). The differences in oxygen consumption during OxR, therefore, cannot be 
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attributed to differences in metabolic rate prior to the exposure and point towards a 
difference in the flexibility to adapt metabolism to low oxygen availability. Analysis of 
the response to OxR with InCa thus provides a useful strategy to analyse metabolic 
health in mice. To investigate whether the differences in the adaptation of oxygen 
consumption really reflect a difference in metabolic flexibility, it is necessary to focus on 
the physical and metabolic changes that underlie the reduction in metabolic rate. 
 
OxR and physical activity  
A reduction in physical activity might be one of the first mechanisms to reduce whole-
body oxygen consumption, but it does not reflect metabolic health status. Therefore, all 
mice were tested during the light phase. During the light phase, mice are in a resting 
state, which decreases the influence of physical activity on the outcome of InCa 
measurements. Activity levels seem to decrease by OxR, but this was not consistently 
reported in our 4 studies. The inconsistencies between the studies are most likely due 
to differences in the choice for a control group. In chapter 3 and 4, we decided to use 
the first two hours prior to exposure to OxR to analyse physical activity under normoxic 
conditions. These two hours are, however, more close to the dark period, during which 
mice are more active.  
In chapter 5 and 6 we decided to add an additional measurement under normoxic 
conditions on the day prior to the OxR exposure that completely resembles the 
measurement during hypoxic conditions in the procedure of fasting, duration of the 
measurement, and time period of the day. The comparison in chapter 5 and 6 can, 
thus, be considered as the most accurate estimation of the influence of OxR on 
physical activity, which implies that OxR does not affect physical activity levels in mice.  
 
OxR and RER 
During the exposure to OxR, mice are in a fasted state and, thus, primarily oxidize fat. 
A switch from 100% fat oxidation to 100% carbohydrate oxidation in a certain organ 
decreases oxygen consumption of the organ with approximately 7% (56) and can be 
visualized by an increase in RER. Whether this switch can be achieved depends on 
glycogen availability. As shown in table 1, the effect of OxR on RER levels seems 
inconsistent. This is probably due to the fact that, unlike in the normoxic situation, the 
RER during OxR shows a dynamic response. RER seems to decrease below normoxic 
levels at the start of the exposure, after which it inclines during the first 2 hours of 
exposure to reach a stable level for the final 4 hours. The RER during these last 4 
hours is slightly higher than the RER under normoxic conditions. The initial decrease in 
RER at the start of the exposure might indicate gluconeogenesis (11), whereas the 
slight increase at the end might indicate a strategy to spare oxygen, as discussed 
above. This dynamic response is levelled out when RER is analysed as the average 
over the complete exposure. It is, therefore, advisable - in addition to the analysis of the 
complete curve - to separately analyse the stable (final) phase of the curve.  
GENERAL DISCUSSION   l   157 
 
 
7  
Table 1 Changes in respiratory exchange, physical activity and circulating hormone 
and metabolite levels during exposure to OxR 
Measurable Chapter # Treatment group Response 
RER 3 adult = 
 3 old = 
 4 5 days LF 0.03 points ↓ 
 4 5 days HF 0.05 points ↓ 
 6 6 wks Hfpu = 
 6 6 wks HFs = 
 5 25 wks Hfpu 0.02 points ↑ 
 5 25 wks HFs = 
activity 3 adult 57.1% ↓ 
 3 old 60.4% ↓ 
 4 5 days LF 62.0% ↓ 
 4 5 days HF 63.4% ↓ 
 6 6 wks Hfpu = 
 6 6 wks HFs = 
 5 25 wks Hfpu = 
 5 25 wks HFs = 
oxygen consumption 3 adult 18.9% ↓ 
 3 old 14.4% ↓ 
 4 5 days LF 24.2% ↓ 
 4 5 days HF 22.9% ↓ 
 6 6 wks Hfpu 12.9% ↓ 
 6 6 wks HFs 12.5% ↓ 
 5 25 wks Hfpu 9.62% ↓ 
 5 25 wks HFs 8.66% ↓ 
energy expenditure 3 adult 18.2% ↓ 
 3 old 14.8% ↓ 
 4 5 days LF 27.3% ↓ 
 4 5 days HF 25.9% ↓ 
 6 6 wks Hfpu 12.7% ↓ 
 6 6 wks HFs 12.3% ↓ 
 5 25 wks Hfpu 8.05% ↓ 
 5 25 wks HFs 7.14% ↓ 
blood glucose 3 adult 15.1% ↑ 
 4 5 days LF 29.7% ↑ 
 4 5 days HF 17.4% ↑ 
 6 6 wks Hfpu 13.2% ↑ 
 6 6 wks HFs 12.9% ↑ 
 5 25 wks Hfpu = 
 5 25 wks HFs 9.06% ↑ 
serum lactate 3 adult 19.2% ↑ 
 4 5 days LF = 
 4 5 days HF = 
serum adiponectin 6 6 wks Hfpu = 
serum free carnitine 6 6 wks Hfpu 20.9% ↓ 
serum amino acids 6 6 wks Hfpu Tyr: 26.4% ↑ 
serum short-chain acylcarnitines 6 6 wks Hfpu = 
serum medium-chain acylcarnitines 6 6 wks Hfpu 30-140% ↑ 
serum long-chain acylcarnitines 6 6 wks Hfpu 25-75% ↑ 
Overview of measurables that display the response to OxR at whole body level. The table summarises 
data from chapter 3, 4, 5, and 6. The response is displayed as the percentage increase (↑) or decrease 
(↓, highlighted cells) or no significant change (=) from the control (normoxia) group. The response in 
RER is displayed as the absolute reduction in RER. 
 
It should, however, be noted that the increase in RER in the final phase embodies only 
a small change in RER (only a 0.03 RER difference), and thus reflects a minor switch in 
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nutrient oxidation at whole-body level or a larger switch in a single organ only. In 
conclusion, the small increase in RER contributes to the observed reduction in oxygen 
consumption, but cannot fully account for this reduction. 
Another strategy to reduce oxygen consumption is to decrease mitochondrial oxidation 
by increasing ATP formation via anaerobic glycolysis, which can be regulated by the 
transcription factor hypoxia-inducible factor 1 alpha (Hif1α) (47). HIF1α protein is 
formed and degraded when sufficient oxygen is available. Hif1α degradation diminishes 
when oxygen availability decreases, leading to an increased level of the protein and 
transcriptional activation of its target genes to e.g. initiate (anaerobic) glycolytic ATP 
production (59, 78). A switch from fat oxidation to anaerobic glycolysis is a more 
effective way to reduce oxygen consumption. Anaerobic glycolysis, however, yields 
lactate, which may lead to acidosis, a condition that is harmful for normal metabolic 
functioning. Lactate can be cleared from circulation by hepatic gluconeogenesis. The 
conversion of lactate to glucose, however, requires ATP. Glycolytic metabolism is 
therefore only beneficial when ATP needed for lactate clearance does not exceeds the 
amount of ATP produced by glycolysis. A switch to anaerobic glycolytic ATP production 
in peripheral tissues can, however, not by visualised by a change in RER, therefore, we 
also analysed changes in several circulating metabolites. 
 
Figure 7 Oxygen consumption during normoxia and OxR. Mice fed the HFpu or HFs diet do not 
differ in resting oxygen consumption during normoxia (A), whereas HFs mice have a significantly higher 
oxygen consumption during OxR (B). Oxygen consumption was, in each condition, monitored during the 
same period in the light phase, when mice are at rest and fasted. (data from chapter 5)  
 
OxR, glucose metabolism and acylcarnitines 
To further investigate the effect of OxR on mitochondrial substrate use and glycolytic 
metabolism, we measured circulating levels of glucose, lactate and acylcarnitines. 
Acute OxR was previously shown to increase blood glucose and insulin levels in mice 
(66, 72). Blood glucose levels are expected to increase because of gluconeogenesis 
from lactate to glucose by the liver (12), but it is also proposed that hypoxia decreases 
insulin sensitivity (37, 70, 72) and thereby increases blood glucose and insulin levels. 
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Lactate release by e.g. adipocytes increases upon exposure to OxR as a consequence 
of anaerobic metabolism (92). 
Blood levels of free carnitine and acylcarnitines are seen as a marker for hypoxia (5, 8, 
83). Acylcarnitine levels increase when oxygen availability is limited and represent 
incomplete mitochondrial FA oxidation, whereas free carnitine levels decrease during 
OxR, leading to a decrease in mitochondrial uptake of fatty acids (50, 51, 62). 
Our studies confirmed that OxR increases blood glucose levels. The largest increase in 
blood glucose levels was seen in the LF-fed mice in chapter 4, which suggests that the 
response in blood glucose might serve as a reliable marker for metabolic flexibility. 
Although the response in blood glucose levels seems to decline with increasing age 
and/or adiposity, mice fed a HF-diet with PUFAs (HFpu) did not increase blood glucose 
upon OxR, whereas mice fed a high fat diet with saturated fatty acids (HFs), that 
displayed a reduced metabolic flexibility, did (chapter 5). Based on these results, 
glucose levels after OxR are not recommended as a marker for metabolic flexibility 
when using OxR as a challenge test. Serum lactate levels were found to be increased 
by OxR in chapter 3, which confirms that a switch to glycolytic metabolism is used as a 
strategy to reduce VO2. These results could, however, not be confirmed in chapter 4, 
where no significant differences were found between serum lactate levels of mice that 
were exposed to OxR and mice that remained in normal air. One explanation for this 
discrepancy might be that in chapter 3, mice were anaesthetized in hypoxic air before 
decapitation, whereas mice in chapter 4 were not anaesthetized prior to decapitation, 
which slightly prolonged the time spend in normoxic air before blood collection. 
Whether the very short exposure to normoxic air (around 15 to 30 seconds) prior to 
decapitation can revert increased lactate levels back to normal values remains to be 
studied.  
Finally, we showed that OxR increases serum long acylcarnitines and decreases free 
carnitine, whereas it increased levels of short-chain acylcarnitines in WAT. The 
increase in circulating acylcarnitines indicates a decrease in mitochondrial FA oxidation 
at whole body level (50, 51, 62). The increase in short chain acylcarnitines in WAT, on 
the other hand, indicates increased protein catabolism. Autophagy and protein 
catabolism were previously shown to be induced by acute hypoxia in muscle (58), and 
may contribute to the reduction in oxygen consumption at whole body level. Tissue and 
serum levels of (acyl)carnitine levels in response to OxR were not yet compared 
between different dietary groups, but this is an interesting topic for further research that 
may reveal whether inhibition of mitochondrial FA oxidation is differently affected by 
OxR in mice with varying metabolic health states. 
 
To summarize, OxR, which examines short term response to a limitation in oxygen 
availability, reduces whole body energy metabolism in mice. Next to the decrease in 
total (mitochondrial) energy expenditure, we found that OxR influenced mitochondrial 
fuel selection. The increase in serum lactate, glucose, and acylcarnitine levels, and the 
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slight increase in RER, indicate that OxR induces a switch from fatty acids to glucose 
oxidation and/ or an increase in anaerobic glycolytic metabolism. It is, as yet, unclear, 
which organ or organ system is responsible for the observed differences in glucose and 
fat metabolism. The whole genome expression analysis that was performed in chapter 
6 suggests that, in HF-fed mice, WAT plays only a minor role in whole-body adaptation 
to OxR.  
 
Recommendations for further research 
Based on the data described in this thesis, I would like to postulate that InCa-based 
challenge tests should become a standard procedure for the analysis of metabolic 
health. One important advantage is that InCa-based challenge tests are non-invasive, 
which decreases stress-related variation between animals. Moreover, the InCa-based 
challenge tests appeared to be more sensitive and integrative than the standard 
challenge tests, such as the oral glucose tolerance test.  
Whole genome gene expression analysis proved to be a useful method to investigate 
the molecular background underlying changes in health status. Transcriptome analysis 
would, however, be more informative when combined with a challenge approach. Gene 
expression is often studied in a steady state: when mice are fasted. This steady state is 
expected to display animal physiology under normal conditions, but in principal it 
displays the animal that has switched to fatty acid oxidation. It would be an asset to 
nutrition-related research to compare whole-genome analysis between mice with 
different physiological states, depending on the focus of the study: e.g. fasted vs. fed or 
at thermoneutrality vs. room temperature (7). In the gene expression study described in 
chapter 2, for example, the inclusion of InCa and transcriptome analysis in WAT of HF-
DR fed vs. HF-DR fasted and HF-AL fed vs. HF-AL fasted would have given us ultimate 
proof for the hypothesis that HF-DR mice have an improved ability to adequately 
respond to high dietary fat intake, including the underlying mechanisms.  
 
Table 2 Contribution of different organs to basal metabolic rate in lean humans and 
rodents  
 
Organ weight 
(% of body weight) 
 Metabolic rate 
(% of total) 
Organ Human ♂ Human ♀ Rat  Human ♂ Human ♀ Rat 
Liver 2.6 2.4 5.0  21 21 20 
Brain 2.0 2.1 1.5  20 21 3 
Heart 0.5 0.4 0.5  9 8 3 
Kidneys 0.4 0.5 0.9  8 9 7 
Muscle 40.0 29.3 42.0  22 16 30 
Adipose tissue 21.4 32.8 -  4 6 - 
Other tissues 33.1 32.6 -  16 19 - 
Total body weight 70 kg 58 kg 150 g     
Total EE (kcal/day)     1680 1340 - 
Organ weight and metabolic rate of the reference male (♂), reference female (♀) and reference rat. 
Metabolic rate of adipose tissue was not supplied for the rat. (data from (48, 74)) 
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It would also be interesting to use whole-genome analysis to verify whether high-fat 
feeding indeed blunts the transcriptional response in WAT during OxR compared to 
low-fat feeding, or to study the transcriptional response to OxR in other organs. WAT 
has, compared to other metabolic organs a low metabolic rate expressed per kg tissue 
and OxR might have more pronounced effects on organs that rely more on oxygen, 
such as skeletal muscle or the liver (also see table 2). 
Finally, the non-invasiveness of InCa-based challenge tests qualifies them to be 
applied to study metabolic flexibility of humans. Humans might not achieve the large 
decrease in metabolic rate as was observed in mice (27), but it was previously shown 
that OxR significantly decreases blood oxygen saturation and CO2 production (9, 27). 
Moreover, OxR increases blood glucose levels and alters glucose utilization in humans 
(46, 53, 65), which indicates that OxR also affects the metabolism of humans. The 
validation of OxR as a challenge test to measure metabolic health status in humans is a 
promising subject for further research.  
162   l   CHAPTER 7 
 
References 
 
1. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM Relationships of generalized 
and regional adiposity to insulin sensitivity in men. J Clin Invest. 1995;96: 88-98. 
2. Ando H, Yanagihara H, Hayashi Y, Obi Y, Tsuruoka S, Takamura T, et al. Rhythmic messenger 
ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue. 
Endocrinology. 2005;146: 5631-5636. 
3. Balcombe JP, Barnard ND, Sandusky C Laboratory routines cause animal stress. Contemp 
Top Lab Anim Sci. 2004;43: 42-51. 
4. Bowman TA, Ramakrishnan SK, Kaw M, Lee SJ, Patel PR, Golla VK, et al. Caloric restriction 
reverses hepatic insulin resistance and steatosis in rats with low aerobic capacity. Endocrinology. 
2010;151: 5157-5164. 
5. Bruder ED, Raff H Cardiac and plasma lipid profiles in response to acute hypoxia in neonatal 
and young adult rats. Lipids Health Dis. 2010;9: 3. 
6. Cai TQ, Ren N, Jin L, Cheng K, Kash S, Chen R, et al. Role of GPR81 in lactate-mediated 
reduction of adipose lipolysis. Biochem Biophys Res Commun. 2008;377: 987-991. 
7. Caimari A, Oliver P, Keijer J, Palou A Peripheral blood mononuclear cells as a model to study 
the response of energy homeostasis-related genes to acute changes in feeding conditions. 
OMICS. 2010;14: 129-141. 
8. Cam H, Yildirim B, Aydin A, Say A Carnitine levels in neonatal hypoxia. J Trop Pediatr. 
2005;51: 106-108. 
9. Charlot K, Pichon A, Richalet JP, Chapelot D Effects of a high-carbohydrate versus high-
protein meal on acute responses to hypoxia at rest and exercise. Eur J Appl Physiol. 2013;113: 
691-702. 
10. Chattopadhyay M, GuhaThakurta I, Behera P, Ranjan KR, Khanna M, Mukhopadhyay S, et al. 
Mitochondrial bioenergetics is not impaired in nonobese subjects with type 2 diabetes mellitus. 
Metabolism-Clinical and Experimental. 2011;60: 1702-1710. 
11. Chiolero R, Mavrocordatos P, Burnier P, Cayeux MC, Schindler C, Jequier E, et al. Effects of 
infused sodium acetate, sodium lactate, and sodium beta-hydroxybutyrate on energy expenditure 
and substrate oxidation rates in lean humans. Am J Clin Nutr. 1993;58: 608-613. 
12. Choi JH, Park MJ, Kim KW, Choi YH, Park SH, An WG, et al. Molecular mechanism of 
hypoxia-mediated hepatic gluconeogenesis by transcriptional regulation. Febs Letters. 2005;579: 
2795-2801. 
13. Choo HJ, Kim JH, Kwon OB, Lee CS, Mun JY, Han SS, et al. Mitochondria are impaired in the 
adipocytes of type 2 diabetic mice. Diabetologia. 2006;49: 784-791. 
14. Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, Espinoza D, et al. Peroxisome 
proliferator activator receptor gamma coactivator-1 expression is reduced in obesity - Potential 
pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. 
Journal of Biological Chemistry. 2007;282: 15439-15450. 
15. Dahlman I, Forsgren M, Sjogren A, Nordstrom EA, Kaaman M, Naslund E, et al. 
Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes 
independent of obesity and possibly involving tumor necrosis factor-alpha. Diabetes. 2006;55: 
1792-1799. 
16. Eissing L, Scherer T, Todter K, Knippschild U, Greve JW, Buurman WA, et al. De novo 
lipogenesis in human fat and liver is linked to ChREBP-beta and metabolic health. Nat Commun. 
2013;4: 1528. 
17. Festa A, D'Agostino R, Jr., Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, et al. The 
relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat 
Metab Disord. 2001;25: 1407-1415. 
18. Flachs P, Ruhl R, Hensler M, Janovska P, Zouhar P, Kus V, et al. Synergistic induction of lipid 
catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie 
restriction and n-3 fatty acids. Diabetologia. 2011;54: 2626-2638. 
19. Frappell P, Lanthier C, Baudinette RV, Mortola JP Metabolism and ventilation in acute 
hypoxia: a comparative analysis in small mammalian species. Am J Physiol. 1992;262: R1040-
1046. 
GENERAL DISCUSSION   l   163 
 
 
7  
20. Frayn KN, Langin D, Karpe F Fatty acid-induced mitochondrial uncoupling in adipocytes is not 
a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is 
increased. Diabetologia. 2008;51: 394-397. 
21. Froy O, Chapnik N Circadian oscillation of innate immunity components in mouse small 
intestine. Mol Immunol. 2007;44: 1954-1960. 
22. Galgani JE, Moro C, Ravussin E Metabolic flexibility and insulin resistance. Am J Physiol 
Endocrinol Metab. 2008;295: E1009-1017. 
23. Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, et al. Relationship between 
hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. 
Gastroenterology. 2007;133: 496-506. 
24. Gautier H Interactions among metabolic rate, hypoxia, and control of breathing. J Appl Physiol 
(1985). 1996;81: 521-527. 
25. Gianotti TF, Sookoian S, Dieuzeide G, Garcia SI, Gemma C, Gonzalez CD, et al. A decreased 
mitochondrial DNA content is related to insulin resistance in adolescents. Obesity (Silver Spring). 
2008;16: 1591-1595. 
26. Gillooly JF, Brown JH, West GB, Savage VM, Charnov EL Effects of size and temperature on 
metabolic rate. Science. 2001;293: 2248-2251. 
27. Golja P, Flander P, Klemenc M, Maver J, Princi T Carbohydrate ingestion improves oxygen 
delivery in acute hypoxia. High Alt Med Biol. 2008;9: 53-62. 
28. Goossens GH, Bizzarri A, Venteclef N, Essers Y, Cleutjens JP, Konings E, et al. Increased 
adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin 
resistance, impaired adipose tissue capillarization, and inflammation. Circulation. 2011;124: 67-
76. 
29. Gouspillou G, Hepple RT Facts and controversies in our understanding of how caloric 
restriction impacts the mitochondrion. Exp Gerontol. 2013;48: 1075-1084. 
30. Heilbronn LK, Gan SK, Turner N, Campbell LV, Chisholm DJ Markers of mitochondrial 
biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects. Journal 
of Clinical Endocrinology & Metabolism. 2007;92: 1467-1473. 
31. Higami Y, Pugh TD, Page GP, Allison DB, Prolla TA, Weindruch R Adipose tissue energy 
metabolism: altered gene expression profile of mice subjected to long-term caloric restriction. 
FASEB J. 2004;18: 415-417. 
32. Hill JR The Oxygen Consumption of New-Born and Adult Mammals - Its Dependence on the 
Oxygen Tension in the Inspired Air and on the Environmental Temperature. Journal of 
Physiology-London. 1959;149: 346-373. 
33. Hoevenaars FP, Bekkenkamp-Grovenstein M, Janssen RJ, Heil SG, Bunschoten A, Hoek-van 
den Hil EF, et al. Thermoneutrality results in prominent diet-induced body weight differences in 
C57BL/6J mice, not paralleled by diet-induced metabolic differences. Mol Nutr Food Res. 
2014;58: 799-807. 
34. Hoevenaars FPM, Keijer J, Herreman L, Palm I, Hegeman MA, Swarts HJM, et al. Adipose 
tissue metabolism and inflammation are differently affected by weight loss in obese mice due to 
either a high-fat diet restriction or change to a low-fat diet. Genes and Nutrition. 2014;9:  
35. Holmes LJ, Storlien LH, Smythe GA Hypothalamic monoamines associated with the cephalic 
phase insulin response. Am J Physiol. 1989;256: E236-241. 
36. Horakova O, Medrikova D, van Schothorst EM, Bunschoten A, Flachs P, Kus V, et al. 
Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and 
rosiglitazone in dietary obese mice. PLoS One. 2012;7: e43764. 
37. Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, et al. Intermittent 
hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir 
Crit Care Med. 2007;175: 851-857. 
38. Kaaman M, Sparks LM, van Harmelen V, Smith SR, Sjolin E, Dahlman I, et al. Strong 
association between mitochondrial DNA copy number and lipogenesis in human white adipose 
tissue. Diabetologia. 2007;50: 2526-2533. 
39. Kaiyala KJ, Morton GJ, Leroux BG, Ogimoto K, Wisse B, Schwartz MW Identification of body 
fat mass as a major determinant of metabolic rate in mice. Diabetes. 2010;59: 1657-1666. 
40. Kakuma T, Wang ZW, Pan W, Unger RH, Zhou YT Role of leptin in peroxisome proliferator-
activated receptor gamma coactivator-1 expression. Endocrinology. 2000;141: 4576-4582. 
41. Karelis AD, Brochu M, Rabasa-Lhoret R Can we identify metabolically healthy but obese 
individuals (MHO)? Diabetes Metab. 2004;30: 569-572. 
164   l   CHAPTER 7 
 
42. Katic M, Kennedy AR, Leykin I, Norris A, McGettrick A, Gesta S, et al. Mitochondrial gene 
expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin 
receptor knock-out mice. Aging Cell. 2007;6: 827-839. 
43. Keller MP, Attie AD Physiological insights gained from gene expression analysis in obesity 
and diabetes. Annu Rev Nutr. 2010;30: 341-364. 
44. Kelley DE, Mandarino LJ Fuel selection in human skeletal muscle in insulin resistance: a 
reexamination. Diabetes. 2000;49: 677-683. 
45. Kelley DE, Mandarino LJ Hyperglycemia normalizes insulin-stimulated skeletal muscle 
glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest. 1990;86: 
1999-2007. 
46. Kelly KR, Williamson DL, Fealy CE, Kriz DA, Krishnan RK, Huang H, et al. Acute altitude-
induced hypoxia suppresses plasma glucose and leptin in healthy humans. Metabolism. 2010;59: 
200-205. 
47. Kim JW, Tchernyshyov I, Semenza GL, Dang CV HIF-1-mediated expression of pyruvate 
dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 
2006;3: 177-185. 
48. Kinney JM. Energy metabolism: tissue determinants and cellular corollaries; 1992. 
49. Korach-Andre M, Parini P, Larsson L, Arner A, Steffensen KR, Gustafsson JA Separate and 
overlapping metabolic functions of LXR alpha and LXR beta in C57Bl/6 female mice. American 
Journal of Physiology-Endocrinology and Metabolism. 2010;298: E167-E178. 
50. Koves TR, Li P, An J, Akimoto T, Slentz D, Ilkayeva O, et al. Peroxisome proliferator-activated 
receptor-gamma co-activator 1 alpha-mediated metabolic remodeling of skeletal myocytes mimics 
exercise training and reverses lipid-induced mitochondrial inefficiency. Journal of Biological 
Chemistry. 2005;280: 33588-33598. 
51. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, et al. Mitochondrial 
overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell 
Metab. 2008;7: 45-56. 
52. Kusminski CM, Scherer PE Mitochondrial dysfunction in white adipose tissue. Trends in 
Endocrinology and Metabolism. 2012;23: 435-443. 
53. Larsen JJ, Hansen JM, Olsen NV, Galbo H, Dela F The effect of altitude hypoxia on glucose 
homeostasis in men. J Physiol. 1997;504 ( Pt 1): 241-249. 
54. Lee CK, Klopp RG, Weindruch R, Prolla TA Gene expression profile of aging and its 
retardation by caloric restriction. Science. 1999;285: 1390-1393. 
55. Levine JA, Eberhardt NL, Jensen MD Role of nonexercise activity thermogenesis in 
resistance to fat gain in humans. Science. 1999;283: 212-214. 
56. Livesey G, Elia M Estimation of energy expenditure, net carbohydrate utilization, and net fat 
oxidation and synthesis by indirect calorimetry: evaluation of errors with special reference to the 
detailed composition of fuels. Am J Clin Nutr. 1988;47: 608-628. 
57. Magalhaes J, Ascensao A, Soares JM, Ferreira R, Neuparth MJ, Marques F, et al. Acute and 
severe hypobaric hypoxia increases oxidative stress and impairs mitochondrial function in mouse 
skeletal muscle. J Appl Physiol (1985). 2005;99: 1247-1253. 
58. Masschelein E, Van Thienen R, D'Hulst G, Hespel P, Thomis M, Deldicque L Acute 
environmental hypoxia induces LC3 lipidation in a genotype-dependent manner. FASEB J. 
2014;28: 1022-1034. 
59. Mazzatti D, Lim FL, O'Hara A, Wood IS, Trayhurn P A microarray analysis of the hypoxia-
induced modulation of gene expression in human adipocytes. Arch Physiol Biochem. 2012;118: 
112-120. 
60. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1 
alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in 
human diabetes. Nature Genetics. 2003;34: 267-273. 
61. Mortola JP Implications of hypoxic hypometabolism during mammalian ontogenesis. Respir 
Physiol Neurobiol. 2004;141: 345-356. 
62. Muoio DM, Newgard CB Molecular and metabolic mechanisms of insulin resistance and beta-
cell failure in type 2 diabetes. Nature Reviews Molecular Cell Biology. 2008;9: 193-205. 
63. Neel JV The "thrifty genotype" in 1998. Nutr Rev. 1999;57: S2-9. 
64. Nelson BD Thyroid hormone regulation of mitochondrial function. Comments on the 
mechanism of signal transduction. Biochim Biophys Acta. 1990;1018: 275-277. 
GENERAL DISCUSSION   l   165 
 
 
7  
65. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Rook S, Schweiger U, et al. Hypoxia causes 
glucose intolerance in humans. Am J Respir Crit Care Med. 2004;169: 1231-1237. 
66. Ostreicher I, Meissner U, Plank C, Allabauer I, Castrop H, Rascher W, et al. Altered leptin 
secretion in hyperinsulinemic mice under hypoxic conditions. Regul Pept. 2009;153: 25-29. 
67. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC HIF-1 mediates adaptation to 
hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006;3: 187-
197. 
68. Patti ME, Corvera S The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr 
Rev. 2010;31: 364-395. 
69. Raffaello A, Rizzuto R Mitochondrial longevity pathways. Biochim Biophys Acta. 2011;1813: 
260-268. 
70. Regazzetti C, Peraldi P, Gremeaux T, Najem-Lendom R, Ben-Sahra I, Cormont M, et al. 
Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes. 2009;58: 95-103. 
71. Reimer RA, Maurer AD, Lau DC, Auer RN Long-term dietary restriction influences plasma 
ghrelin and GOAT mRNA level in rats. Physiol Behav. 2010;99: 605-610. 
72. Reinke C, Bevans-Fonti S, Drager LF, Shin MK, Polotsky VY Effects of different acute hypoxic 
regimens on tissue oxygen profiles and metabolic outcomes. J Appl Physiol (1985). 2011;111: 
881-890. 
73. Robinson KA, Haymes EM Metabolic effects of exposure to hypoxia plus cold at rest and 
during exercise in humans. J Appl Physiol (1985). 1990;68: 720-725. 
74. Rolfe DF, Brown GC Cellular energy utilization and molecular origin of standard metabolic 
rate in mammals. Physiological Reviews. 1997;77: 731-758. 
75. Rong JX, Qiu Y, Hansen MK, Zhu L, Zhang V, Xie M, et al. Adipose mitochondrial biogenesis 
is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes. 
2007;56: 1751-1760. 
76. Schneider BS, Faust IM, Hemmes R, Hirsch J Effects of Altered Adipose-Tissue Morphology 
on Plasma-Insulin Levels in the Rat. American Journal of Physiology. 1981;240: E358-E362. 
77. Seggie JA, Brown GM Stress response patterns of plasma corticosterone, prolactin, and 
growth hormone in the rat, following handling or exposure to novel environment. Can J Physiol 
Pharmacol. 1975;53: 629-637. 
78. Semenza GL, Roth PH, Fang HM, Wang GL Transcriptional regulation of genes encoding 
glycolytic enzymes by hypoxia-inducible factor 1. Journal of Biological Chemistry. 1994;269: 
23757-23763. 
79. Semple RK, Crowley VC, Sewter CP, Laudes M, Christodoulides C, Considine RV, et al. 
Expression of the thermogenic nuclear hormone receptor coactivator PGC-1 alpha is reduced in 
the adipose tissue of morbidly obese subjects. International Journal of Obesity. 2004;28: 176-179. 
80. Shabalina IG, Hoeks J, Kramarova TV, Schrauwen P, Cannon B, Nedergaard J Cold 
tolerance of UCP1-ablated mice: a skeletal muscle mitochondria switch toward lipid oxidation with 
marked UCP3 up-regulation not associated with increased basal, fatty acid- or ROS-induced 
uncoupling or enhanced GDP effects. Biochim Biophys Acta. 2010;1797: 968-980. 
81. Sherman H, Genzer Y, Cohen R, Chapnik N, Madar Z, Froy O Timed high-fat diet resets 
circadian metabolism and prevents obesity. FASEB J. 2012;26: 3493-3502. 
82. Sjogren P, Sierra-Johnson J, Gertow K, Rosell M, Vessby B, de Faire U, et al. Fatty acid 
desaturases in human adipose tissue: relationships between gene expression, desaturation 
indexes and insulin resistance. Diabetologia. 2008;51: 328-335. 
83. Solberg R, Enot D, Deigner HP, Koal T, Scholl-Burgi S, Saugstad OD, et al. Metabolomic 
analyses of plasma reveals new insights into asphyxia and resuscitation in pigs. PLoS One. 
2010;5: e9606. 
84. Sutherland LN, Capozzi LC, Turchinsky NJ, Bell RC, Wright DC Time course of high-fat diet-
induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the 
relationship to glucose intolerance. Am J Physiol Endocrinol Metab. 2008;295: E1076-1083. 
85. Tabata H, Kitamura T, Nagamatsu N Comparison of effects of restraint, cage transportation, 
anaesthesia and repeated bleeding on plasma glucose levels between mice and rats. Lab Anim. 
1998;32: 143-148. 
86. Trayhurn P, James WP Thermoregulation and non-shivering thermogenesis in the genetically 
obese (ob/ob) mouse. Pflugers Arch. 1978;373: 189-193. 
87. Tuli JS, Smith JA, Morton DB Corticosterone, adrenal and spleen weight in mice after tail 
bleeding, and its effect on nearby animals. Lab Anim. 1995;29: 90-95. 
166   l   CHAPTER 7 
 
88. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, et al. Oxidative 
stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 
2003;88: 4673-4676. 
89. Wanders D, Graff EC, Judd RL Effects of high fat diet on GPR109A and GPR81 gene 
expression. Biochem Biophys Res Commun. 2012;425: 278-283. 
90. Weindruch R The retardation of aging by caloric restriction: studies in rodents and primates. 
Toxicol Pathol. 1996;24: 742-745. 
91. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE Enlarged subcutaneous abdominal 
adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance. 
Diabetologia. 2000;43: 1498-1506. 
92. Wood IS, Stezhka T, Trayhurn P Modulation of adipokine production, glucose uptake and 
lactate release in human adipocytes by small changes in oxygen tension. Pflugers Arch. 
2011;462: 469-477. 
93. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, et al. Mechanisms 
controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. 
Cell. 1999;98: 115-124. 
94. Zhou YT, Wang ZW, Higa M, Newgard CB, Unger RH Reversing adipocyte differentiation: 
implications for treatment of obesity. Proc Natl Acad Sci U S A. 1999;96: 2391-2395. 
 
 
  
 
 
 
 
 
Appendices 
 
 
 
 
 
 
  
SUMMARY OF MAIN FINDINGS   l   169 
 
 
Summary of main findings 
 
Maintenance of metabolic health not only ensures that energy is made available in 
times of need and stored in times of excess, but also prevents resistance to nutritional 
cues, ectopic lipid accumulation and dysfunction of metabolic organs. The proportion of 
humans that is at risk for reduced metabolic health increases worldwide due to the 
current epidemic of obesity and the increase in both mean and maximum life span. 
Better understanding of the various factors that influence metabolic health may offer 
opportunities to fight this threat to human health. This thesis aims to assess metabolic 
health using transcriptome analysis and non-invasive challenge tests. Special focus is 
on the development and validation of InCa-based non-invasive challenge tests. In most 
chapters of this thesis white adipose tissue (WAT) formed the major organ of interest 
because of its key role in whole-body energy homeostasis. WAT function was, among 
others, studied with whole-genome gene expression analysis, which, compared to 
single parameter analysis, extends the scale and depth of understanding biological 
processes.  
Metabolic health was also quantified as metabolic flexibility, with the use of non-
invasive, indirect calorimetry (InCa) based challenge tests. One of the InCa based 
challenge tests described in this thesis, the oxygen restriction (OxR) challenge, is a 
novel approach to investigate metabolic flexibility in mice. In each study, OxR was 
applied acute ([O2] reduction within 30 minutes) and for a short period of 6 hours in 
fasted mice. The other two InCa-based challenge tests: fasting and re-feeding and 
fasting and glucose consumption are nutrient-based and were described previously, 
although in different formats and settings.  
 
In chapter 2 we demonstrate that dietary restriction on a high-fat diet (HF-DR) 
improves metabolic health of mice compared with mice receiving the same diet on an 
ad libitum basis (HF-AL). Already after five weeks of restriction, the serum levels of 
cholesterol and leptin were significantly decreased in HF-DR mice, whereas their 
glucose tolerance and serum adiponectin levels were increased. The body weight and 
measured serum parameters remained stable in the following 7 weeks of restriction, 
implying metabolic adaptation. To understand the molecular events associated with this 
adaptation, we analysed gene expression in WAT with whole genome microarrays. HF-
DR strongly influenced gene expression in WAT; in total, 8643 genes were differentially 
expressed between both groups of mice, with a major role for genes involved in lipid 
metabolism and mitochondrial functioning. DR also increases mitochondrial density in 
WAT. These results show that WAT, indeed, has an important role in the improvement 
of metabolic health of dietary restricted mice and suggest that the development of 
substrate efficiency plays an important role in the observed changes in health status. 
Finally, mitochondrial density might be used as a marker for WAT health status.  
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Chapter 3 shows how indirect calorimetry can be used to noninvasively assess 
metabolic and age-related flexibility in mice. In this study, we tested the sensitivity and 
response stability over time of three InCa-based treatments in old versus adult mice. 
For the first treatment, diurnal patterns of respiratory exchange ratio were followed for 
24 hours under standard conditions. For the second and third treatment, which were 
both based on a challenge approach, mice were fasted and either received a glucose 
bolus to test switch-effectiveness from fat to glucose oxidation (Treatment 2), or were 
exposed to oxygen restriction (OxR, Treatment 3) in the InCa system, which was 
introduced as a novel approach to asses metabolic flexibility. Opposite to the mice that 
were dietary restricted (chapter 2), aging appeared to increase adiposity and decrease 
WAT mitochondrial density, which further suggests that WAT mitochondrial density 
might be used as a marker for WAT health. We observed that the test results of the first 
treatment were not stable between test periods, possibly because of behavioural 
differences within the group of old mice between both measurements. For the second 
treatment, no differences between groups were observed. With Treatment 3, however, 
stable significant differences could be detected: old mice did not maintain reduced 
oxygen consumption under OxR during both measurements, whereas adult mice did. 
Further biochemical and gene expression analyses showed that OxR affected glucose 
and lactate homeostasis in liver and WAT of adult mice, supporting the observed 
differences in oxygen consumption. This was the first study to show that InCa analysis 
of the response to OxR is a sensitive and reproducible treatment to noninvasively 
measure age-impaired metabolic health in mice. Evaluation of metabolic health under 
non-challenged conditions may be confounded by behavioural-induced variation 
between animals 
 
The study described in chapter 4 followed up on the promising results that were 
obtained with the OxR challenge in chapter 3. In this study we tested whether OxR can 
also be used to reveal diet-induced health effects in an early stage. Early detection of 
diet-induced health effects might shorten animal experiments and reduce costs and 
age-related variation. Timely identification may increase options for reversal. Mice were 
exposed to a low-fat (LF) or high-fat (HF) diet for only 5 days, after which they were 
exposed to OxR or remained under normoxic conditions. The response to OxR was 
assessed by calorimetric measurements, followed by analysis of gene expression in 
liver and WAT. A novelty described in this chapter was the analysis of serum markers 
for protein glycation and oxidation, to detect differences in the response to OxR 
between LF and HF mice. Although HF feeding increased body weight, HF and LF mice 
did not differ in indirect calorimetric values under normoxic conditions and in a fasting 
state. Exposure to OxR however, increased oxygen consumption and lipid oxidation in 
HF mice versus LF mice. Furthermore, OxR induced gluconeogenesis and an 
antioxidant response in the liver of HF mice, whereas it induced de novo lipogenesis 
and an antioxidant response in eWAT of LF mice, indicating that HF and LF mice 
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differed in their adaptation to OxR. OxR also increased serum markers of protein 
glycation and oxidation in HF mice, whereas these changes were absent in LF mice. 
From this study we concluded that OxR is a promising new method to test food 
products on potential beneficial effects for metabolic health.  
 
The study described in chapter 5 aimed to assess differences in metabolic health of 
mice on iso-caloric diets differing in fatty acid composition using the OxR challenge. We 
also implemented a fasting and re-feeding challenge. One diet, the HFpu diet, 
predominantly contained poly-unsaturated fatty acids (PUFAs), which are considered to 
be healthier than saturated fatty acids (SFAs) that mainly made up the fat component of 
the second diet, the HFs diet. Since health effects of fatty acids also depend on the 
ratio of dietary omega-6 to omega-3 PUFAs (n6/n3 ratio), this ratio was kept similar 
between both diets. Mice received the isocaloric high-fat diets for six months, during 
and after which several biomarkers for health were measured. We found that HFpu and 
HFs diets only induce minor differences in static health markers: HFpu and HFs mice 
did not differ in body weight, total adiposity, adipose tissue health, serum adipokines, 
whole body energy balance, or circadian rhythm. HFpu and HFs mice also had a similar 
glucose tolerance, even though HFs mice had more triglycerides in liver and skeletal 
muscle and larger adipocytes in the eWAT depot. Interestingly, HFs mice were less 
flexible in their response to both fasting and re-feeding and OxR, which shows the 
relevance and sensitivity of InCa-based challenge tests. We concluded that InCa-based 
challenge tests are a valuable contribution to the analysis of metabolic health in mice. 
Challenge tests in the InCa system may, furthermore, reveal relevant consequences of 
small changes in metabolic health status, such as adipocyte hypertrophy or ectopic lipid 
storage.  
 
Chapter 6 describes an in-depth study to the response to OxR both at whole body level 
using InCa and serum metabolomics (amino acids and (acyl)carnitines) and at WAT 
level using transcriptomics and the analysis of amino acid and (acyl)carnitine levels. 
Serum and tissue amino acids levels indicate the level of protein catabolism and certain 
amino acids are, typically, increased in obese individuals. Serum and tissue 
(acyl)carnitine levels indicate the rate and completeness of mitochondrial fatty acid 
oxidation; serum acylcarnitine levels are significantly increased in individuals that suffer 
from ambient oxygen restriction. The metabolic adaptation to OxR was studied in diet-
induced moderately obese mice that received a high-fat diet (HFpu diet, as in chapter 
5) for 6 weeks, which is expected to lead to WAT expansion and possibly to reduce 
oxygen availability in WAT. We found that OxR reduced mitochondrial oxidation at 
whole-body level, as shown by a reduction in whole-body oxygen consumption and an 
increase in serum long-chain acylcarnitine levels. WAT did not seem to contribute to 
this serum profile, since only short-chain acylcarnitines were increased in WAT and 
gene expression analysis indicated an increase in mitochondrial oxidation, based on 
172   l   APPENDICES 
 
coordinate down-regulation of Sirt4, Gpam and Chchd3/Minos3. In addition, OxR did 
not induce oxidative stress in WAT, but increased molecular pathways involved in cell 
growth and proliferation. OxR increased levels of tyrosine, lysine and ornithine in serum 
and of leucine/isoleucine in WAT. This study shows that OxR limits oxidative 
phosphorylation at whole-body level, but in WAT compensatory mechanisms seem to 
operate. The down-regulation of the mitochondria-related genes Sirt4, Gpam, and 
Chchd3 may be considered as a biomarker profile for WAT mitochondrial 
reprogramming in response to acute exposure to limited oxygen availability. 
 
To conclude, the work presented in this thesis provides more insight in the analysis of 
metabolic health in mice with the use of transcriptome analysis and InCa-based 
challenge tests. We show that non-invasive tests using the InCa-system are more likely 
to reveal differences in metabolic flexibility than invasive challenge tests, such as the 
oral glucose tolerance test. Furthermore, we show that the challenge approach is more 
sensitive than analysis of metabolic health under non-challenged (free-feeding) 
conditions. Transcriptome analysis proved to be very valuable to provide in-depth 
molecular understanding of the mechanisms underlying reduced or improved metabolic 
health. Ideally, transciptomic or metabolomic approaches should be integrated with 
InCa-based challenge tests to further extent physiological understanding of diet-
induced health effects.  
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Samenvatting 
 
Metabole gezondheid is het vermogen om metabole processen steeds adequaat aan te 
passen aan veranderingen in de omgeving. Vetweefsel speelt een belangrijke rol in het 
behoud van metabole gezondheid. Gezond vetweefsel zorgt ervoor dat er energie 
wordt vrij gemaakt in tijden van schaarste en dat energie wordt opgeslagen in tijden 
van overvloed. Gezond vetweefsel voorkomt ook dat het lichaam ongevoelig wordt voor 
voedingsgerelateerde signalen en dat vet wordt opgeslagen in andere organen.  
Door de wereldwijde toename van overgewicht en obesitas, maar ook door de toename 
van de gemiddelde en de maximale levensduur, neemt de kans op een zwakke 
metabole gezondheid toe. Verlaagde metabole gezondheid kan leiden tot ernstige 
fysieke problemen, zoals diabetes type 2 en hart- en vaatziekten. Om te voorkomen dat 
veel mensen hier last van krijgen, is het belangrijk om onderzoek te doen naar de 
factoren die metabole gezondheid kunnen beïnvloeden.  
Het doel van het onderzoek beschreven in dit proefschrift, was om metabole 
gezondheid te onderzoeken met behulp van transcriptoom analyse en met niet-
invasieve challenge-testen. Hiervoor werd de muis gebruikt als model voor de mens.  
Transcriptoom analyse is een methode waarmee de expressie van alle genen in een 
bepaald weefsel op een bepaald tijdstip gemeten kan worden. Veranderingen in 
genexpressie leiden tot veranderingen in de hoeveelheid gecodeerde eiwitten. Dit kan 
bijvoorbeeld de activiteit van het weefsel veranderen en laat zien hoe het weefsel 
reageert op een bepaald dieet. In dit onderzoek ging de interesse met name uit naar 
genexpressie in wit vetweefsel (white adipose tissue; WAT).  
Met een challenge-test wordt gemeten in hoeverre het lichaam zich op korte termijn 
kan aanpassen aan veranderingen in het lichaam of in de omgeving, zoals 
veranderingen in de aanwezigheid van voedsel, of in de omgevingstemperatuur. Een 
challenge-test meet hoe flexibel het lichaam is; een gezonde muis kan zich goed 
aanpassen aan de 'challenge' en voorkomt op deze manier problemen op 
weefselniveau. Metabole flexibiliteit kan worden gezien als een maat voor metabole 
gezondheid. De challenge-test maakt op deze manier verschillen in metabole 
gezondheid zichtbaar die onder normale omstandigheden verborgen blijven.  
Voor het onderzoek beschreven in dit proefschrift hebben we metabole flexibiliteit 
bepaald met twee eerder beschreven challenge-testen: vasten gevolgd door 
voedselconsumptie en vasten gevolgd door glucoseconsumptie.  
Tijdens vasten vertrouwt het lichaam voornamelijk op vetverbranding, terwijl het tijdens 
voedselconsumptie over moet stappen op koolhydraatverbranding. De efficiëntie van 
deze overgang is een belangrijke maat voor metabole flexibiliteit.  
Beide testen zijn gebaseerd op de veel gebruikte orale glucose tolerantie test. Een 
groot verschil is dat we voor onze studies geen gebruik hebben gemaakt van invasieve 
methodes maar de respons op de challenge hebben geanalyseerd met InCa-metingen. 
De inzet van InCa maakte het mogelijke om niet-invasief het hele proces van metabole 
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omschakeling te analyseren, wat mogelijk leidt tot een gevoeligere en nauwkeurigere 
bepaling van metabole gezondheid.  
Naast de twee eerder beschreven challenge testen, hebben we ook een nieuwe 
challenge-test ontwikkeld, waarbij de hoeveelheid zuurstof in de lucht wordt verlaagd 
(oxygen restriction; OxR). Zuurstof is, net als nutriënten, essentieel voor mitochondriële 
activiteit en een verlaging in zuurstofbeschikbaarheid vraagt dus om adequate 
metabole adaptatie om goed te kunnen blijven functioneren.    
 
In Hoofdstuk 2 beschrijf ik dat de metabole gezondheid van muizen sterk verbeterd 
kan worden door dieetrestrictie, zelfs terwijl deze restrictie plaats vindt met een, in 
principe ongezond, hoog-vet dieet (high-fat dietary restriction; HF-DR). Al na 5 weken 
restrictie hadden HF-DR-muizen lagere serum cholesterol- en leptinewaarden, een 
betere glucosetolerantie en hogere serum adiponectinewaarden, ten opzichte van 
muizen die ad libitum (HF-AL) van het dieet konden eten. Het lichaamsgewicht van de 
HF-DR-muizen nam eerst af, maar na 5 weken restrictie bleef het lichaamsgewicht 
stabiel, net als de eerder genoemde gezondheidsmarkers. Het ontstaan van de stabiele 
fase geeft aan dat het metabolisme van HF-DR-muizen zich dusdanig heeft aangepast, 
dat het goed gedijt onder het gebruikte voedingsregime.  
Om het mechanisme achter deze aanpassing te begrijpen, hebben we de 
veranderingen in genexpressie in wit vetweefsel geanalyseerd met transcriptoom 
analyse. In totaal waren 8643 genen verschillend gereguleerd tussen HF-DR- en HF-
AL-muizen. Een groot deel van deze genen was betrokken bij vet metabolisme en 
mitochondriële functie. Dieetrestrictie verhoogde ook de mitochondriële dichtheid in 
WAT.  
Deze studie suggereert dat dieetrestrictie leidt tot een efficiënter gebruik van specifieke 
componenten van het dieet; in dit geval de grote hoeveelheid vet in het dieet. Tenslotte 
zou mitochondriële dichtheid kunnen worden gebruikt als maat voor de 
gezondheidstoestand van vetweefsel.  
 
Hoofdstuk 3 beschrijft 3 methodes waarop indirecte calorimetrie kan worden ingezet 
om niet-invasief de metabole flexibiliteit van muizen te meten. Tevens beschrijven we 
de meetgevoeligheid van de drie methodes en de stabiliteit van de testresultaten 
tussen twee afzonderlijke meetmomenten. Metabole gezondheid werd bepaald in oude 
muizen ten opzichte van volwassen muizen. Voor de eerste behandeling werd het 
dagelijkse patroon van substraatverbruik gevolgd, gedurende 24 uur onder 
standaardomstandigheden. De tweede en derde behandeling waren beide gebaseerd 
op een challenge: muizen werden eerst gevast en kregen dan een glucose bolus, of 
werden blootgesteld aan OxR.  
De oude muizen hadden meer vetweefsel en een lagere mitochondriële dichtheid in 
WAT, vergeleken met volwassen muizen. Dit is een volgende aanwijzing dat 
mitochondriële dichtheid in WAT gebruikt kan worden als marker voor de 
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gezondheidsstaat van vetweefsel. De resultaten van de eerste behandeling waren niet 
stabiel tussen de twee testmomenten, mogelijk door gedragsveranderingen binnen de 
groep oude muizen.  
Met de tweede behandeling werden geen verschillen tussen de twee groepen 
waargenomen. Behandeling 3, daarentegen, toonde wel significante verschillen aan 
tussen de oude en volwassen muizen: de volwassen muizen verlaagden hun 
zuurstofconsumptie tijdens de gehele periode van OxR (6 uur), terwijl de oude muizen 
dit alleen gedurende het begin van de blootstelling ‘volhielden’. 
Uit verdere biochemische analyses en analyse van genexpressie in lever en WAT van 
de volwassen muizen, bleek dat OxR invloed heeft op de glucose en lactaat 
homeostase, wat mogelijk de waargenomen verlaging in zuurstofverbruik kan 
verklaren. 
Dit is de eerste studie, die aantoont dat OxR in combinatie met InCa een gevoelige en 
reproduceerbare challenge oplevert, om leeftijdsgebonden veranderingen in metabole 
gezondheid bij muizen aan te tonen. Verder laat het zien dat InCa-metingen waarbij 
geen gebruik wordt gemaakt van een challenge-aanpak kunnen worden verstoord door 
gedragsgeïnduceerde variatie tussen dieren. 
 
De studie beschreven in hoofdstuk 4 haakt in op de veelbelovende resultaten die 
werden behaald met de OxR-challenge beschreven in hoofdstuk 3. In deze studie 
wilden we achterhalen of OxR ook gebruikt kan worden om kleinere, dieet-
geïnduceerde gezondheidseffecten aan te tonen in een vroeg stadium van een 
dierstudie. Als dergelijke gezondheidseffecten eerder kunnen worden aangetoond, 
kunnen dierexperimenten mogelijk worden verkort, wat weer leidt tot kostenverlaging 
en minder leeftijdsgebonden variatie tussen dieren. Daarnaast biedt vroege detectie 
van gezondheidsrisico’s meer mogelijkheden tot interventie van verdere 
gezondheidsproblemen. Voor dit experiment kregen muizen een laag-vet (LF) dieet of 
een hoog-vet (HF) dieet voor slechts 5 dagen. Daarna werd van beide groepen een 
deel blootgesteld aan OxR, terwijl het andere deel onder normoxie verbleef. De 
response op OxR werd gemeten met het InCa-systeem en aansluitend werd het effect 
op genexpressie in lever en WAT geanalyseerd. In deze studie werden ook markers 
voor eiwitglycatie en -oxidatie in serum bepaald, om te onderzoeken of er een verschil 
is in het ontstaan van oxidatieve stress tijdens OxR tussen HF- en LF-muizen.  
Hoewel HF-muizen een verhoogd lichaamsgewicht hadden, waren er geen verschillen 
in substraatverbruik of zuurstofconsumptie onder normale (normoxische) 
omstandigheden. Tijdens de blootstelling aan OxR daarentegen, hadden HF-muizen 
een hogere zuurstofconsumptie en meer vetverbranding dan LF-muizen. 
Ook de response in genexpressie was verschillend tussen HF- en LF-muizen: OxR 
verhoogde het proces van gluconeogenese en antioxidant respons in leverweefsel van 
HF- muizen, maar niet in LF-muizen, terwijl OxR in de LF-muizen leidde tot een 
176   l   APPENDICES 
 
verhoging van de novo lipogenese en antioxidant respons in WAT, wat niet werd 
gezien in de HF-muizen. 
OxR leidde ook tot een verhoging van serummarkers voor eiwitglycatie en -oxidatie in 
HF-muizen, terwijl deze verandering niet werd waargenomen in LF-muizen.  
Uit deze studie kunnen we concluderen dat OxR een veelbelovende nieuwe methode is 
om potentiële gezondheidsbevorderende effecten van voeding aan te tonen.     
 
Het doel van de studie beschreven in hoofdstuk 5, was om te bepalen of InCa-
gebaseerde challenge-testen ook gebruikt kunnen worden, om verschillen in metabole 
gezondheid te bepalen, tussen muizen gevoed, met iso-calorische hoog-vet diëten met 
verschillende vetzuursamenstellingen. Hiervoor hebben we gebruik gemaakt van twee 
challenge-testen: de OxR-challenge en een challenge, die bestond uit vasten, gevolgd 
door dieetconsumptie. 
Het ene dieet, het Hfpu-dieet, bevatte voornamelijk meervoudig onverzadigde vetzuren 
(PUFAs). Het tweede dieet, het HFs- dieet, bevatte voornamelijk verzadigde vetzuren 
(SFAs). PUFAs worden, ten opzichte van SFAs, als gezonder beschouwd. 
Gezondheidseffecten van een dieet worden ook bepaald door de ratio tussen omega-6 
en omega-3 PUFAs (n6/n3 ratio). De n6/n3 ratio werd om deze reden gelijk gehouden 
tussen beide diëten.  
De studie duurde in totaal 6 maanden en tijdens en na afloop van de studie werden 
steeds verschillende gezondheidsmarkers bepaald. Opvallend genoeg waren er niet 
veel verschillen tussen Hfpu- en HFs-muizen: beide groepen hadden een vergelijkbaar 
lichaamsgewicht, evenveel lichaamsvet en er waren geen verschillen in de 
gezondheidsstatus van vetweefsel, serum adipokines, glucosetolerantie, 
energieverbruik of circadiaan ritme.  
HFs-muizen hadden echter wel meer vetopslag (triglyceriden) in hun lever en 
spierweefsel en grotere vetcellen in WAT, vergeleken met Hfpu-muizen. HFs-muizen 
bleken daarnaast minder flexibel in de respons op de vasten- en dieetconsumptie-
challenge en de OxR- challenge, wat aantoont dat het HFs-dieet wel degelijk nadelige 
gezondheidseffecten heeft, ten opzichte van het Hfpu-dieet. Deze studie toont aan dat 
InCa-gebaseerde challenge-testen een waardevolle aanvulling zijn op de analyse van 
metabole gezondheid. 
 
Er is tot op heden slechts weinig bekend over de acute metabole adaptatie aan kort 
durende zuurstofrestrictie. Hoofdstuk 6 beschrijft daarom een studie waarin we de 
moleculaire respons op OxR verder hebben onderzocht, met behulp van metaboloom 
analyse van aminozuren en (acyl)carnitines in serum en wit vetweefsel, en 
transcriptoom analyse in wit vetweefsel. De niveaus van aminozuren in serum en 
vetweefsel zijn een maat voor het niveau van eiwitkatabolisme. Bepaalde aminozuren 
zijn, daarnaast, in verhoogde concentraties aanwezig in individuen met obesitas. 
Niveaus van (acyl)carnitines in serum en vetweefsel zijn een maat voor het niveau van 
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mitochondriële vetzuuroxidatie en geven tevens de volledigheid van vetzuuroxidatie 
weer. Zuurstofrestrictie leidt bijvoorbeeld tot een verhoging van de hoeveelheid 
acylcarnitines in serum, omdat mitochondriële oxidatie wordt beperkt. 
De metabole adaptatie aan OxR werd onderzocht in diëet-geïnduceerde, matig obese 
muizen, die een hoog-vet dieet (HFpu dieet, als in hoofdstuk 5) ontvingen gedurende 6 
weken. De verwachting was dat deze periode van dieetconsumptie zou leiden tot een 
toename van de hoeveelheid vetweefsel en daarmee mogelijk tot een verlaagde 
zuurstofspanning in vetweefsel.  
OxR verlaagde, net zoals in de voorgaande studies, de zuurstofconsumptie op 
lichaamsniveau. OxR verhoogde ook de concentratie acylcarnitines (lange ketens) in 
serum. Hieruit kunnen we opmaken dat de mitochondriële oxidatie op lichaamsniveau 
omlaag gaat tijdens OxR. In WAT was alleen de concentratie van korte-keten 
acylcarnitines verhoogd en vonden we een afname in de expressie van drie genen, die 
betrokken zijn bij mitochondriële functie: Sirt4, Gpam and Chchd3/Minos3. Hieruit 
kunnen we opmaken dat WAT niet bijdraagt aan de verhoogde concentratie lange-
keten acylcarnitines in serum en dat WAT eerder mitochondriële activiteit verhoogt, dan 
verlaagt tijdens de blootstelling aan OxR.  
We vonden in WAT ook geen toename van oxidatieve stress, maar wel een toename in 
expressie van genen, die betrokken zijn bij celgroei en celdeling. OxR  verhoogde de 
concentratie tyrosine, lysine and ornithine in serum en de concentratie van 
leucine/isoleucine in WAT.  
Deze studie toont aan dat OxR de oxidatieve fosforylering op lichaamsniveau remt, 
maar WAT lijkt op een andere manier te compenseren voor de verlaging in 
zuurstofspanning. De verlaging in de expressie van de mitochondriële genen Sirt4, 
Gpam, and Chchd3 kan beschouwd worden als een biomarkerprofiel voor 
mitochondriële herprogrammering in WAT, in reactie op een acute verlaging in 
zuurstofbeschikbaarheid.  
 
De resultaten, beschreven in dit proefschrift, leveren meer inzicht in de analyse van 
metabole gezondheid bij muizen met behulp van transcriptoom analyse en InCa-
gebaseerde challenge-testen. De InCa-gebaseerde challenge-testen bleken erg 
geschikt om verschillen in metabole gezondheid aan te tonen. De methodes 
beschreven in dit proefschrift leken zelfs gevoeliger dan methodes zonder challenge-
concept en invasieve methodes, zoals een orale glucose tolerantie test. Daarnaast 
laten we zien dat OxR een veelbelovende nieuwe methode is om, 
voedingsonafhankelijk, metabole flexibiliteit in muizen te bepalen. 
Transcriptoom analyse bleek erg waardevol om gedetailleerd moleculaire 
mechanismen achter verbeteringen of verslechteringen in metabole gezondheid in 
kaart te brengen. Idealiter zouden transcriptoom of metaboloom analyses worden 
gecombineerd met een challenge-aanpak om de fysiologie achter dieetgeïnduceerde 
gezondheidseffecten beter te begrijpen. 
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